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Applications of Stimulated Raman Scattering Microscopy: from Label-free to Molecular Probes 
Yupeng Miao 
The newly emerging Stimulated Raman Scattering (SRS) Microscopy has been proved to be a powerful 
tool in biomedical research. This advanced imaging platform offers high spatiotemporal resolution and 
chemical specificity, which greatly empowers the label-free biomedical imaging and small molecule 
metabolite tracing. Throughout the research introduced in this thesis, we focus on the exploration of more 
applications of SRS microscopy beyond aforementioned. Particularly, this new expedition involves more 
chemistry and answered two major questions: what SRS can do for chemistry and what chemistry can do 
for SRS. 
Chapter 1 introduces the basics of SRS microscopy, such as the physical fundamentals and start-of-
art instrumentations. Besides, this chapter discusses the design principles of vibrational reporters through 
a chemistry view. 
Chapter 2 introduces one of the major progresses of SRS microscopy beyond biomedical study. We 
use SRS microscopy to study the ion transportation and concentration polarization phenomena in lithium 
metal batteries (LMBs), with a strong focus in solid-state polymer electrolyte. A self-induced phase 
separation process over lithium metal electrode is observed and correlated with local lithium ion 
concentrations, which inspires a protection mechanism for durable LMB design. 
Chapter 3 discusses the use of SRS microscopy for in-vivo drug tracing in mammalian cells. A novel 
alkyne tag is incorporated into bio-engineered natural depsi-peptides and serves as Raman reporter. The 
mode-of-action of the labeled drug is visualized with SRS microscopy. 
Chapter 4 heavily focuses on the development of synthetic molecular probes for super-multiplexed 
optical imaging. We systematically synthesize a library of molecular probes based on 9-cyanopyronin, and 
their Raman features are characterized to build a model that correlates photophysical properties with 
structures. The Raman shifts of probes can be tuned with high precision. The multiplexing capability of the 
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“Why going for Ph.D.?” This question keeps haunting around, no matter before I started applying for 
doctoral program, pursuing the degree, or I believe even after it’s done. I know the answer can be diverse. 
It reminds me of many moments where the answer is showing up. 
The first answer could be “seeking knowledge”. Firstly, I would like to thank all the people who infused 
me with knowledge. I had wonderful time in the classes with the excellent faculty and staff at Columbia 
Chemistry. I can still feel excited when recalling the time discussing kinetics with Prof. Jack Norton, and I 
can feel the nervous in biophysical chemistry class where Prof. Ruben Gonzalez, Prof. Ann McDermott, 
and Prof. Arthur Palmer sitting back the room and listening to my naïve talk. And I’m particularly grateful for 
the help from Dr. Brandon Fowler and Dr. John Decatur, who endlessly answered my questions regarding 
structural characterization and assisted me with instruments. 
A second answer could be “learning, mentoring, and teamworking”. I met great folks in Min Lab. As a 
pure novice in biomedical imaging, I was so grateful to my mentor Fanghao Hu for the guidance in almost 
every lab practice. I must acknowledge almost everyone in Min Lab means a mentor to me, even the 
youngers. I grabbed a bit and a bit from everyone, and composed my skill set. Throughout the years, I also 
mentored many new labmates such as Naixin Qian. In our mutual leaning and mentoring, we came up with 
many fantastic ideas and spent so much lab time together. The collaborative environment in the group is 
incredibly valuable and enjoyable, and I believe it becomes indispensable in my Ph.D. training. 
When it approached to the end of this Ph.D. lesson, I found the most important part. Just think of what 
I was five years ago, a young student only knows a bit of organic synthesis, now turns to an imaging scientist. 
I can clearly recall the first day I met Prof. Wei Min in his office. We had a great symphony on what chemistry 
can do for SRS imaging. Throughout the years, Wei kept reminding me “jumping out of the comfortable 
zone” and pushed me to adapt into new research topics. It is Wei that let me realize the Ph.D. lesson is not 
only about learning things and researching in depth but also developing a way and the desire of learning. 
Wei warned me not to tie myself into specific fields but be open and prepared to exposure to new things. 
Even after this degree is fulfilled, I’m still on the way of learning, hopefully until the end of my life. I am so 
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Chapter 1: Principles of Super-multiplexed Vibrational 
Probes for Stimulated Raman Scattering (SRS) Microscopy  
The contents of this chapter have been published in: 
Miao, Y., Shi, L., Hu, F. & Min, W. Probe design for super-multiplexed vibrational imaging. Phys Biol 16, 
041003 (2019). 
1.1 Introduction 
Multiplexing technologies, as obtaining information from a large number of targets simultaneously, 
have been increasingly demanded to characterize complex biological species and their hidden interactions 
[1-3]. Recent advances in high-throughput molecular techniques, especially single-cell sequencing, provides 
informative links under cell linage, cell-type signatures and functional states [4].  As we enter the era of 
system biology, multi-dimensional information will be indispensable to provide insights on a wide range of 
fields, including biology, medicine, and clinical diagnostics.   
Though various approaches have enhanced the multiplexing capability, super-multiplexed methods 
that enable in situ study of cellular spatial organization or subcellular heterogeneity in details are still very 
challenging. Biological systems are intrinsically complex with a series of hierarchical networks at multiple 
scales, ranging from organs, single cells, to subcellular compartments, and to specific biomolecular 
structures. For example, spatial heterogeneity is a fundamental feature of tumor microenvironment, which 
is crucial to study tumor therapy resistance [5,6]. Therefore, to directly and simultaneously visualize a large 
number of distinct molecular species in situ will allow comprehensive investigation of spatial variations 
across the whole region of interest and temporal progression of important biological processes in real time 
(such as in brain development and tumor invasion) [7,8]. It is being realized that super-multiplexed imaging 
techniques will be powerful for research across a broad range of fields such as performing in situ RNA 
profiling for spatial transcriptome[9]; revealing structure–function relationships in central nervous system[10]; 
and studying the intricate subcellular organelle interactions (“organelle interactome”) of live cells[11]. 
Optical imaging techniques, with superb spatial resolution and three-dimensional sectioning, offers 




most popular and powerful optical imaging modalities. However, all forms of fluorescence microscopy face 
a fundamental challenge: it cannot image a large number of targets simultaneously. Fluorescence spectra 
are intrinsically broad and featureless due to fast electronic dephasing at room temperature, thus limiting 
the resolvable fluorescent colors to 2-5 at a time[13]. This is known as the fundamental “color ceiling” of 
fluorescence microscopy.  
To meet the increasing demand of super-multiplexing, many efforts have been devoted in fluorescence 
imaging. For example, simultaneous 6-9 colors have been demonstrated through hyper-spectral and/or 
lifetime-based fluorescence imaging using complicated instrumentation or specialized reporters [14-17]. As a 
result, these methods are limited for additional color extension and incompatible with live cell study. Besides 
simultaneous detection, a number of sequential imaging methods have been developed to visualize 
multiplexed targets through dye-cycled labeling, such as sequential fluorescence in situ hybridization or 
sequencing of RNA or DNA [18-23], DNA-based exchange imaging [24,25], cyclic immunofluorescence [26,27]. 
However, these methods are time- and labor- intensive, requiring multiple imaging cycles. More importantly, 
they only work with fixed (i.e., dead) samples as the procedures require repeated cycles of staining, imaging 
and elution under stringent conditions. Hence, almost all live cell applications are beyond the reach of these 
sequential imaging methods. Therefore, there are still bottlenecks and challenges in current multiplexed 





Fig. 1.1 Principles of SRS microscopy and vibrational frequencies. (a) Schematic illustration of SRS microscopy. 
Spatially and temporally synchronized Pump beam and Stokes beam are guided to a commercial confocal microscope 
and tightly focused on the sample. After passing through the sample, the stokes beam is filtered while the pump beam 
is captured by photodiode detector. Stimulated Raman Loss (SRL) is extracted by lock-in amplifier and sent to computer 
as signal. (b) Vibrational energy diagram in SRS light-molecule interaction. When the energy difference between Pump 
photon and Stokes photon matches the vibrational frequency (ωvib), a Pump photon is annihilated and a Stokes photon 
is generated. As the Stokes beam is modulated, the SRL in Pump beam will be modulated after interacting with the 
sample. (c) Classical description of molecular vibrations. A spring model is used to depict the vibration behavior. The 
intrinsic frequency of oscillation is determined by force constant k and reduced mass μ. 
Vibrational microscopy presents an appealing strategy to overcome the “color barrier” in a profound 
way. Unlike fluorescence that interrogates the electronic excited state, vibrational transition exhibits about 
100-times narrower spectral linewidth due to a much longer dephasing time of vibrational state. For example, 
the linewidth of CC bond can be as narrow as 10 cm-1 while the FWHM of fluorescence excitation/emission 
band is usually 1500 cm-1 wide. Thus, if one can harness the specific vibrational frequency as the imaging 
contrast, a 100 times denser spectral imaging can be achieved in principle, thereby providing many more 
resolvable colors.  
Vibrational imaging can be achieved by either infrared (IR) absorption or inelastic Raman scattering. 
Fourier-transform IR (FTIR) microscopy has been extensively applied for hyperspectral chemical imaging 
of histological slices [28]. However, for biological applications, it usually suffers from strong water absorption 




with small transition cross sections. Therefore, spontaneous Raman scattering is usually restricted by low 
image speed, which is undesirable for fast dynamic study in living systems. To improve the sensitivity, 
surface-enhanced Raman scattering (SERS) offers single-molecule detection [29] and has achieved 
multicolor imaging applications [30-33]. Recently, a new technique named coherent Raman scattering 
(CRS) microscopy allows video-rate live cell imaging by enhancing the weak Raman signal through 
nonlinear excitation [34-37]. The advanced stimulated Raman scattering (SRS) microscopy emerges as 
the most promising vibrational microscopy for biological imaging which can accelerate the feeble 
vibrational transition by 108 times [37,38] (Fig. 1.1a and Fig. 1.1b). Furthermore, SRS is free of non-
resonant background and has linear concentration dependence which allows for quantitative live cell 
imaging [38].  
To achieve super-multiplexing vibrational imaging, new probe development with well-resolved 
vibrational peaks and strong cross section is essential but underemphasized. Unlike fluorescence probes, 
which are well developed with a long history  dated back to the first synthesis of fluorescein in 1871[39], 
rational design of vibrational probes is a brand new territory. Though various Raman reporters have been 
used in SERS, most of them focus on commercially available substrates. In this article, we summarize the 
design strategies for vibrational probes and review current Raman probe development, with the emphasis 
on two generations of vibrational probe libraries for super-multiplexing application demonstrated with SRS. 
We hope to convey the idea that these bioorthogonal, single-peak, spectrally well-resolved Raman probes 
will be useful to expand the boundary of multiplexed imaging, not only with coherent Raman microscopy, 
but also for conventional Raman and to couple with plasmonic enhancement in SERS microscopy. 
1.2 Vibrational reporters and design strategies 
1.2.1 Raman reporters on the finger-print region. 
Many chromophores such as Nile blue, malachite green, cyanine dyes, crystal violet, Rhodamine 6G, 
DTTC are well-known SERS reporters [40,41] which display strong SERS signals up to ultimate single-
molecule sensitivity [42]. Notably, the fluorescence emission is usually quenched on the metal surface due 
to energy transfer which helps get rid of the strong fluorescence background. Few papers have also 
presented rational-designed novel reporters with strong SERS signals [43,44]. With careful choosing of 




detection [30] and in vivo imaging [31]. For example, 5-color SERS imaging can be realized on the live mouse 
[31].  
Besides SERS imaging, a group of far-red to near-infrared commercial dyes have also been 
characterized with SRS under electronic (pre)resonance conditions [45,46]. Coupling electronic 
(pre)resonance to SRS can invoke profound signal enhancement which will be more thoroughly discussed 
in 2.3. With this technical development, 8-color SRS-fluorescence tandem imaging is easily to reach with 
all commercial dyes in both fixed and living cell culture [45].  
However, for most commercial dyes, their signature peaks are all in the fingerprint region which is 
usually very crowded and contains multiple peaks. Compared to fingerprint region, a spectrally cell-silent 
window (1800-2800 cm-1) where no vibrational peaks exist for intrinsic biological components becomes 
more appealing[47]. Aiming for a powerful super-multiplexing technique, demand on narrow-band, single-
peak, biorthogonal vibrational probe library will become more obvious. 
1.2.2 General design strategies for bioorthogonal multiplexing vibrational probe. 
The strategy to develop vibrational probes can be elucidated in comparison with fluorescence imaging 
but their main differences must be noted. Firstly, the background interference in fluorescence imaging is 
mainly contributed from autofluorescence, which can be easily overcome by increasing the dye’s quantum 
yield or shifting the probe to near-infrared (NIR) region[48,49]. However, for vibrational imaging, the 
microscopes have to face a concentrated stew of chemical bonds. The components include but not limited 
to water (O-H bond), proteins (C-C, C-N, C-H, N-H, C=O, C=C, etc.), lipids (C-C, C-O, P-O C-H, etc.) and 
saccharides (C-C, C-O, C-H, etc.) which are highly abundant in biological environments, resulting in 
considerably intense and complicated vibrational background. Such intrinsic intense Raman noise will 
seriously hinder vibrational probes detection which calls for bioorthogonal reporters. Moreover, Raman 
cross-sections are several orders of magnitude weaker compared with electronic absorption, raising a 
demand on sufficient signal enhancements for vibrational tags to function as probes. Furthermore, 
considering more than 100-fold narrower linewidth of Raman compared to fluorescence band, the need of 
multiplexing can be fulfilled by tuning the Raman peak of reporters with multiple chemical strategies. How 




informative. Therefore, all these challenges call for sophisticated design of vibrational probes and we 
summarize the design guidelines to address these challenges herein. 
1) Bond moieties within the cell-silent window. As to work on the cell-silent window, we may quickly 
notice this region usually accommodates the common triple bonds such as alkyne (C≡C) and nitrile (C≡N), 
which barely present in cells. In addition to triple bonds, carbon-deuterium (C-D) bonds and azide bonds (-
N3) also exhibit Raman peaks within the cell-silent window. Besides the suitable wavenumbers, their small 
sizes and biochemical inertness are favored for imaging with minimal perturbations to metabolism so live 
cell imaging could be done. Hence, a series of vibrational probes based on alkyne or nitrile were developed 
and successfully exploited in biomedical imaging [50]. 
2) Color extension with isotope doping and substituent edition. In the classical description of 










                                                                      (1) 
where k is called force constant and the other one, μ is reduced mass on the two sides of the chemical 
bond (Fig. 1.1c). To rationally tune the frequency, we can thereby work on the manipulation of either k or 
μ. The force constant, which reflects the electron density and distribution along the bond, varies significantly 
if the substituent groups on the two ends are changed. The effect is not limited to the substituents on the α 
position (adjacent to the atoms forming the bond). Substituting groups at further positions also bring subtle 
changes to the wavenumber, facilitating fine-tuning on the Raman shifts[33]. On the other hand, the reduced 
mass is directly determined by the masses of two atoms forming the bond, which means replacing the 
atoms without affecting the force constants is another good strategy to shift the vibrational frequency. In 






Fig. 1.2 Isotopic editing on alkyne derivatized metabolic labeling reagents (a) Isotopic editing on EdU. (top) 
Structures of alkyne tagged EdU (1) and its isotopic analogs (2 and 3). (bottom) Raman spectrum from nucleus regions 
of HeLa cells incubated with three compounds. The major peaks at 1655 cm-1 are amide bond stretching used as 
reference. (b) Structures of alkyne labeled RNA marker (EU), DNA marker (EdU) and fatty acid marker (17-ODYA). 
Raman spectrum around triple bond region were shown. (c) Structures of isotopically edited markers. Three markers’ 
Raman shifts are well resolved after isotope editing. (d) Multicolor SRS imaging of nascent DNA, RNA, fatty acyl 
derivatives and total amides in live HeLa cells. Reprinted with permission from Ref. 51. © 2014 American Chemical 
Society. 
 In 2014, Chen et al. published our advances in developing multicolor alkyne labels[51]. We first used 
5-ethynyl-2′-deoxyuridine (EdU) and its isotopologues, EdU-13C and EdU-13C2, which can be incorporated 
into newly synthesized DNA, to label and visualize the nucleus in live cells[52]. As demonstrated in the study 
(Fig. 1.2a), the vibrational frequencies of the three aforementioned probes are 2125 cm-1, 2077 cm-1 and 
2048 cm-1, respectively. The participation of 13C significantly enlarged the reduced mass so that the 
wavenumber was pulled to a smaller value. More importantly, such shifts provide enough spacing between 
the centers of adjacent peaks, making the three peaks well resolved in Raman spectrum. Apart from 
imaging the nucleus, two additional markers, ethylnyluridine (EU), a marker of RNA synthesis, and 17-
octadecynoic acid (17-ODYA), a marker of lipid were considered to achieve simultaneous imaging of 
multiple bio-components. The Raman features of the three markers, EdU, EU and 17-ODYA without isotope 




from being resolved considering an average FWHM of 14 cm-1. Such results also hinted the peripheral 
substituents groups have minor influence on wavenumbers compared to changing the reduced mass. 
Nonetheless, their Raman spectrum could be clearly distinguished after isotope editing. The bis-13C labeled 
EU (EU-13C2) showed a shifted peak at 2053 cm-1 (Fig. 1.2c). Together with the EdU-13C at 2077 cm-1 and 
17-ODYA at 2120 cm-1, newly synthesized DNA, RNA and fatty acyl derivatives were simultaneously 
visualized in live HeLa cells shown in Fig. 1.2d. 
3) Signal enhancement mechanisms. Settling the spectral resolution problem is just one step 
towards multiplexed imaging. As stated before, probes with strong cross-section are still in demand. Single 
alkyne or nitrile may work well for molecules with high abundance like glucose and lipids[53-57], or those 
enriched in specific regions such as DNA and RNA[47,51,57-59], but may not offer sufficient signal for other 
targets such as organelles and specific proteins. Unlike fluorescent labels whose quantum yields can be 
adjusted through modifying molecular structures, alkyne and nitrile bonds can hardly be modified and their 
cross-sections are almost invariable in different physical environments (temperature, pH, permittivity, 
viscosity, etc.). Increasing the number of reporter bonds may help but it will be limited to the same order of 
magnitude if the signal just get enhanced linearly. Such difficulty in molecular design forced researchers to 
seek solutions on the instrumentation side. One of them is to use electronic (pre)-resonance which is known 
to dramatically enhance the Raman cross section. This mechanism has been successfully incorporated 
into SERS as surface enhanced resonance Raman scattering [40,42] and into SRS as electronic pre-
resonance SRS [45]. Another promising way is to utilize the superlinear enhancement effect in conjugation 
system. For example, the cross-section of 4-conjugated alkyne is found to be about 100 times larger than 
a single alkyne [60]. 
1.3 Super-multiplexing vibrational probes library 
1.3.1 Invention of first-generation super-multiplexed vibrational probes with electronic pre-
resonance stimulated Raman scattering (epr-SRS) microscopy. 
In 2017, Wei et al. published the first generation of vibrational probes containing a series of near-
infrared absorbing molecules [45]. With optimization on both the instrumentation side and probe side, 
sensitive, high-specific, super-multiplexed vibrational imaging has been achieved in together with multiple 




normally insensitive, a new electronic pre-resonance stimulated Raman scattering (epr-SRS) microscopy 
has been invented [45,61]. By combining the quantum amplification with electronic pre-resonance 
enhancement which give another more than 105-fold signal boost compared to normal SRS (Fig. 1.3a). 
This is a breakthrough technique as it achieves the sensitivity down to several tens of molecules 
(comparable to fluorescence) while retaining fine vibrational selectivity [45]. On the imaging probes side, a 
set of completely new Raman chromophores called Manhattan Raman scattering dyes (MARS) has been 
built. This is a unique vibrational palette consisting of novel dyes bearing conjugated and isotopically-edited 
triple bonds, each displaying a single epr-SRS peak in the cell-silent spectra window. Fig. 1.3b shows the 
design principle of nitrile-based MARS probes with well-separated vibrational peaks. Here, three strategies 
have been applied toward color expansion including xanthene core fine tuning, ring number variation and 
isotope edition. Coupling with commercial dyes, up to 24 resolvable colors are currently achieved with great 
potential for further expansion. A proof-of-concept 16-color imaging on live cells has also been successfully 
achieved in HeLa cells (Fig. 1.3c). This super-multiplex optical imaging approach promises to facilitate 
untangling the intricate interactions in complex biological systems and can also find broad applications in 
photonics and biotechnology in general. 
Although MARS probes can fulfill both superb sensitivity and super-multiplexing, they require certain 
excitation scheme to gain signal enhancement from electronic pre-resonance. These probes can also be 
utilized in vibrational imaging platforms other than SRS, though they may encounter fluorescence 
background in spontaneous Raman microscopy. Fluorescence will usually be quenched at the near field 
under SERS. Therefore, MARS probe will be very promising for certain multiplexed SERS applications. 
1.3.2 Invention of second-generation super-multiplexed vibrational probes based on polyyne 
scaffold. 
In addition to the advances based on electronic pre-resonance effect, other effort on the probe design 
side has been made. As mentioned in the design strategies, linearly accumulating isolated reporters may 
not bring much enhancement to sensitivity, but some non-linear effects may help a lot. Polyyne, also called 
carbon-atom wire which is a linear chain of sp-hybridized carbon atoms with conjugated triple bonds, was 
found to have shifting wavenumbers and superlinearly increasing cross sections with increasing atom 





Fig. 1.3 Super-multiplexing imaging with epr-SRS. (a) principle for epr-SRS microscopy. (left) A typical non-
resonance SRS spectrum of pure methanol (~25 M) with the corresponding energy diagram. Here, the pump laser 
energy (ωpump) is well below that of molecular absorption energy (ω0). (right) A representative epr-SRS spectrum of 
ATTO740 dye with the corresponding energy diagram, in which ωpump is much closer to, but still 3 away from ω0.  ~ 
700 cm-1, for homogeneous linewidth of electronic absorption. Electronically enhanced C=C band is marked with arrow-
head. Enhancement factor (EF) is more than 105 times compared to the arrowed C-O peak. (b) MARS palette with well-
resolved epr-SRS peaks in the cell-silent Raman region. Inside shows the scheme of nitrile-based MARS palette design. 
(c) 16-color live-cell imaging with eight MARS dyes, four fingerprint commercial vibrational dyes and four fluorescent 
dyes (with asterisks). Image reprinted from Ref. 45. 
In 2012, Yamakoshi and colleagues first gave a quantitative examination of structure-Raman 
shift/intensity relationships of various single alkynes and diynes.[50] In this study, alkynes with diverse 
capping groups were synthesized and their Raman shifts and Raman intensity versus EdU (RIE) were 
characterized (listed in Fig. 1.4a). By comparing conjugated diyne with monoyne, they found the diyne 
displayed unambiguously blue-shifted wavenumber. Interestingly, the RIEs of diynes are roughly 5 times 
larger compared to those of monoynes. Changing capping groups also greatly affected the RIE. The 
conjugation of polyyne with aromatic rings enhanced the RIE markedly and even the type and position of 
substituents in the aromatic ring influence the Raman intensity. These findings helped build general 





Fig. 1.4 From single alkyne tag to diyne tag. (a) Average RIE and range of Raman shifts of typical monoynes and 
diynes with varying substitutions. Adapted with permission from Ref. 50. © 2012 American Chemical Society. (b) 
Examples of molecules (cholesterol, anisomycin and ferrostatin) using diyne as labels. (c) SRS images of PhDY-Chol 
in live CHO cells. (top) Live CHO cells incubated with 50 μM PhDY-Chol for 16 h. Scale bar: 10 μm. (middle) Control 
cells without avasimibe (Acyl-CoA cholesterol acyltransferase inhibitor) treatment. (bottom) CHO cells with avasimibe 
treatment. PhDY-Chol was no longer stored in LDs after acyltransferase inhibition. Reprinted from Ref 63. (d) Time-
lapse imaging of BADY-ANS uptake in live SKBR3 cells. Images were acquired every 5 minutes. Images at 35, 40, 50, 
and 55 min were omitted for conciseness. Scale bars: 10 μm. Reprinted from Ref. 66. Published by The Royal Society 
of Chemistry. 
As the diyne gives preferable sensitivity, a number of low abundance molecules with diyne labels were 
reported (shown in Fig. 1.4b). Continuing their advances in diyne study, Yamakoshi et al. functionalized 
the diyne reporter with triphenylphosphonium (TPP) moiety to obtain a mitochondria-targeting Raman probe, 
MitoBADY [62]. The probe showed a 27 folds stronger Raman peak than EdU and it successfully colocalized 
with commercial fluorescent probe Mito-Tracker and endogenous biomolecule cytochrome c, which are 




in live cells and C. elegans by labeling cholesterol with phenyl-diyne label[63]. As they first considered the 
selection of Raman labels, the simulation results suggested the local polarizabilities of each alkyne unit 
increases with the number of conjugated alkynes[64,65]. The phenyl capping groups function as both donor 
and acceptor for the π-electron oscillation thus further boost the polarizability of polyyne. As a result, adding 
a capping phenyl group gives a 9-fold enhancement in Raman intensity compared to a single terminal 
alkyne. Phenyl-diyne, when two enhancements get combined, gives a 52 times stronger Raman cross 
section. When measured with SRS microscopy, phenyl-diyne labeled cholesterol (PhDY-Chol) showed a 
detection sensitivity of 31 µM, corresponding to ~1800 molecules within the focal volume. After confirming 
the linear dependence of SRS contrast versus the concentration of labeled compounds, culturing with 
PhDY-Chol was done in CHO cells and the SRS imaging results indicated the labeled cholesterol retained 
cholesterol’s activity such as membrane incorporation and esterification (Fig. 1.4c). Moreover, the 
lysosomal accumulation of labeled cholesterol was observed in Niemann-Pick type C disease model. Its 
translocation to lipid droplets (LDs) after hydroxypropyl β-cyclodextrin (HPβCD), a cholesterol mobilizing 
drug treatment was visualized, indicating PhDY-Chol faithfully mimics the behavior of natural cholesterol, 
thus it can be used as a reliable biomarker. Apart from cholesterol, drugs are also investigated with diyne 
labels as it offers good sensitivity at relatively low concentration while its small size doesn’t perturb the 
drugs’ action much. With vibrational microscopy, the drug’s mode of action can be visualized. In 2017. 
Tipping et al. studied the uptake process of anisomycin with SRS[66]. The anisomycin was labeled with 5-
phenyl-2,4-pentadiyn-1-yl (PhDY-ANS) and 4-(4-phenyl-1,3-butadiyn-1-yl)benzyl (BADY-ANS) groups to 
be tracked with SRS imaging. Notably, a time-lapse imaging was carried out on SKBR3 cells shown in Fig. 
1.4d. The uptake process of BADY-ANS was captured every 5 minutes and the accumulation of Raman 
signals could be clearly observed inside the cells. 
With indispensable effort in synthesis, Hu and Zeng et al. published a library of polyynes with 20 well-
resolved colors, named “Carbow”, as new optical super-multiplexing agents[60]. By changing the number of 
conjugated triple bonds, adjusting capping substituents, and doping with isotopes, the Raman shifts of the 
polyynes can be fine-tuned from 2000 cm-1 to 2300 cm-1 (Fig. 1.5). Additionally, though multiple triple bonds 
are engaged in the structure, the polyynes all display one major intense Raman scattering peak. Their 




law exponent of 2.77. Such characteristics, including the narrow bandwidth, single peak and nonlinearly 
increased cross section are highly desirable for multiplexed imaging. Apart from tuning the frequency with 
the number of triple bonds, systematical modifications of K and μ are utilized as well. Doping the conjugation 
system with 13C2 units shifts the central wavenumber to smaller value, as the vibration backbone gets 
heavier. At meantime, changing the substituents on the capping phenyl rings causes smaller shifts to the 
peak positions. A general trend indicates the electron-donating groups (e.g. dimethylamino group) will red 
shift the peak while electron-withdrawing groups (e.g. trifluoromethyl group) induces blue shift. 
Combinations of these two modifications can thereby facilitate both coarse and fine tuning of the vibrational 
frequency. After functionalized with organelle targeting groups, five Carbow probes were proved to 
incorporate well into cells and localize at the targeted organelles in consistent with commercial fluorescent 
markers (Fig. 1.6a and Fig. 1.6b). Furthermore, these five Carbow probes were successfully combined 
with other five fluorescent probes to carry out a simultaneous ten-color imaging of subcellular structures in 





Fig. 1.5 The construction of “Carbow” library. (a) Raman spectra of polyynes with varying numbers of conjugated 
triple bonds. Spectra are normalized and vertically offset for clarity. (b) Three strategies to extend the “color” of polyynes. 
(c) Frequency coarse-tuning by doping 13C≡13C alkyne units. (d) Frequency fine-tuning by varying substituents on the 
end-capping phenyl groups. The two dashed spectra are spectra centered at 2,119 cm-1 and 2,141 cm-1 in (c). e) 
Raman spectra of selected Carbow probes. The peaks of 20 polyynes are well resolved in cell silent window. Reprinted 
from Ref. 60. 
1.3.3 Multiplexing with optical barcoding. 
High through-put analysis and diagnostics require a vast number of identifiable labels for analytes. 
Small molecule probes alone may not satisfy this need especially in the case of screening groups of 
biomarkers or drugs, where hundreds or even thousands of targets are in our interest. A rapidly developing 
technology, Suspension Array, proposes a solution based on a combinatorial strategy that a group of 




or the carrier itself functions as reporter such as quantum dots[67-69]. The signal from the carrier can then be 
identified as a barcode, thus the multiplexing capacity will be greatly enhanced through combinations. 
Fluorescence-based suspension array techniques was invented decades ago and has been 
commercialized, but their coding capacity are fundamentally confined by the “color ceiling” of 
fluorescence[70-72]. Although small molecule vibrational probes have been utilized in suspension array, 
frequently with SERS, most of the barcoding method suffered from background in fingerprint region, 
crosstalk between adjacent peaks, and signal intensities that cannot be quantified, resulting in an overall 
low coding capacity[73,74]. Barcoding on other dimensions such as size and lifetime, are also reported but 
most of them rely on complicated fabrication of microcarriers and the size of carriers limits the flexibility in 
practical applications[75,76].  
The invention of Carbow probes greatly promoted the barcoding as Carbow displays narrow bandwidth, 
minimal crosstalk and single intense peak. With polystyrene beads as microcarrier and digitized intensity 
levels of “0”, “1” and “2”, five Carbow probes can easily reach a coding capacity of 59,048, which exceeded 
the previous record[77] around 1,000.  Moreover, Carbow-loaded micro beads are notably robust. Besides 
exhibiting reproducible barcodes after long-term storage in aqueous condition, they are also free of 
photobleaching and energy transfer processes which are commonly observed in fluorescence-based 
suspension array. In addition to in-vitro diagnosis, Carbow-encoded beads can serve to label individual 
cells (Fig. 1.6c and Fig. 1.6d). With poly-lysine coating, polystyrene beads can be endocytosed into HeLa 
cells. The barcodes stored in beads can be readout unambiguously by either spontaneous Raman or SRS 
on a single bead level. The combination of multiple barcodes can be used as identification number to track 
the life of individual cells. Moreover, as polystyrene beads are considerably larger than polyyne probes, the 
size of beads can vary from nanometers to tens of micrometers without affecting the even distribution of 
probes inside the carrier. Thus, the Carbow-based suspension array will be promising in various scales of 





Fig. 1.6 Supermultiplexed optical imaging and barcoding with Carbow. (a) Chemical structures of five organelle-
targeting Carbow probes. (b) Ten color optical imaging of plasma membrane (Carbow2141-PM), endoplasmic reticulum 
(Carbow2226-ER), Golgi (BODIPY TR), Mitochondria (Carbow2062-Mito), Lipid droplets (Carbow2202-LD), Lysosome 
(Carbow2086-Lyso), nucleus (NucBlue), tubulin (SiR650), actin (GFP) and FM4-64 in live HeLa cells. (c) Single bead 
readout with spontaneous Raman spectroscopy. HeLa cells were labeled with barcoded polystyrene beads. Raman 
spectrum of individual bead is shown in insets. (d) Hyperspectral SRS imaging of encoded polystyrene beads in live 
HeLa cells. Images at different Raman shifts were scanned. The brightness of beads shows “dark”, “dim” and “bright”, 





1.4 Summary and outlook 
With rapidly increasing demand on multiplexed analysis, to develop new approach becomes urgent. 
Vibrational imaging is one of the solutions to expand the capacity of multiplexing and this concept has been 
demonstrated in multiple imaging scales including tissues, cells and subcellular structures. The SRS 
imaging technique has been greatly developed since its invention a decade ago. On the instrumentation 
side, the effort in this field have achieved volumetric SRS imaging and hyperspectral SRS imaging, which 
provide information in additional dimensions[78-81]. The SRS imaging was also successfully combined with 
flow cytometry to facilitate high throughput analysis[82]. Moreover, SRS imaging is now used in materials 
science as it reveals the submicron structures and captures the material dynamics with high temporal 
resolution and chemical specificity[78,83-85].  
On the chemistry side, new imaging techniques call for the invention and optimization of the 
corresponding probes. Effort in chemistry will be indispensable to extend the applicability of SRS 
microscopy. We summarized the probe designing principles into three guidelines. First, search for bond 
motifs within cell-silent window to make bioorthogonal Raman reporters. Secondly, modify either the force 
constant, K, or the reduced mass, µ to achieve super-multiplexing. Finally, enhancements are needed to 
make the reporter more detectable. The effects may originate from (pre)resonance, plasmonic effect or 
superlinear enhancement in conjugated systems. We reviewed two major generations of multiplexed 
vibrational probes, MARS and Carbow, which are based on two distinct mechanisms but address the same 
challenge that traditional triple bond Raman probes cannot offer adequate signal in most of the imaging 
objects and it lacks rational design principle to tune the vibrational frequency. The MARS probes rely on 
the electronic pre-resonance to amplify the scattering signal. The Carbow probes extend from single triple 
bond to use conjugated polyynes as label, whose vibrational signals are superlinearly enhanced with 
second hyperpolarizability. Both series were successfully used in live cell imaging, showing high staining 
efficiency and biocompatibility. With SRS microscopy, super-multiplexed live cell imaging was well 
demonstrated. 
However, we realized the development of vibrational probes is still at its early stage. Though two 
generations of multiplexed vibrational probes were invented, there are still some problems remained to 




theory yet, resulting in unnecessary trials and errors on the synthesis side. We hope more computational 
study to assist the design of new vibrational probes. Such assistance can help search for new probe 
scaffolds especially in the case of MARS, where chromophores have major impacts on triple bonds’ 
wavenumbers. In addition, the current MARS palette is based on xanthene scaffold. The introduction of 
other chromophores may bring more available probes to this palette, thereby extending the capacity of 
multiplexing. Regarding the Carbow platform, we realized the number of available probes still has a huge 
potential to be exploited. Probes with more alkyne units, varied isotope doping and other substituents await 
to be explored. 
Besides extending the multiplexing capacity, other potential modifications may help further optimize 
the probes’ performance and expand the scope of applications in bio-medical imaging. First, it is of our 
interest that whether a synergy of electronic pre-resonance effect and polyyne can result in even higher 
sensitivity, thus more highly sensitive and multiplexed probes will be built upon combinations. The 
enhanced sensitivity can extend the application of vibrational imaging to a wider range such as antigens 
with relatively low abundance and DNA or RNA strands. It is also in our anticipation that probes with high 
sensitivity may promote the development of super resolution SRS imaging. Secondly, more 
functionalization on vibrational probes is desired in the future. Due to the challenges in synthesis, these 
reported probes commonly function as static labels lacking the ability to track the dynamics of targets. We 
expect these Raman reporters can be modified into chemical sensors to probe microenvironment 
parameters (e.g. permittivity, pH and viscosity)[86,87] or small molecule species (e.g. hydrogen sulfide, 
hydrogen peroxide)[88]. A mitochondria-targeting Raman sensor was reported by Zeng et al. in 2018, which 
exhibits ratiometric response to hydrogen sulfide. We believe this work can inspire the design of more 
Raman sensors for multiple targets detection. Moreover, the probes may arm with photo-reactive scaffolds 
to build photo-activable/switchable probes featuring optical control and release thus providing more 
flexibility for vibrational imaging[89]. Once again, as vibrational imaging technology draws increasing 
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Chapter 2: Ion Depletion-induced Phase Transformation in 
Polymer Electrolytes Unveiled by SRS microscopy 
The contents of this chapter have been published as preprint: 
Cheng, Q., Miao, Y., Liu, Z., Borovilas, J., Zhang, H., Liu, S., Wang, H., Chen, X., Chen, L.-Q., Min, W. & 
Yang, Y. Stabilizing Lithium Metal Anode by Ion Depletion-Induced Phase Transformation in Polymer 
Electrolytes. ChemRxiv (2021). doi:10.26434/chemrxiv.13726243.v1 This content is a preprint and has not 
been peer-reviewed. 
2.1 Introduction 
Lithium-metal batteries (LMBs) have attracted significant attention in recent years for next-generation 
energy storage with high energy density[1-3]. Li metal anode has a theoretical capacity of 3860 mAh g–1, ten 
times that of the conventional graphite anode, and an ultralow electrode potential (-3.04 V vs. standard 
hydrogen electrode / SHE). However, lithium deposition is prone to being non-uniform, leading to rough 
morphologies such as mossy and dendritic lithium[4-7]. Such uneven deposition not only results in a large 
electrode surface area which promotes side reactions with electrolyte and decreases coulombic efficiency 
and cycle life[8,9], but also imposes potential safety hazards such as internal shorting and thermal runaway, 
especially in combination with conventional flammable liquid electrolytes (e.g. ethers and carbonates)[10-13]. 
Polymer electrolytes are appealing for enhancing the thermal stability of LMBs as they are much more 
thermally stable than liquid electrolytes[14-16]. For example, the flash points (f.p.) of poly (ethylene oxide) is 
250 °C [17], much higher than dimethyl carbonate (21.5 °C)[18], 1,3-dioxolane (2 °C)[19] and 1,2-
dimethoxyethane (–2 °C)[17] in liquid electrolytes. Polymer electrolytes are also compatible with conventional 
battery manufacturing processes and easy to scale up[20]. Unfortunately, Young’s moduli of PEO-based 
polymer electrolytes are typically in the range of 20 to 70 MPa [21-23], much lower than the proposed threshold 
of 1 GPa needed to suppress Li dendrites[11,24]. Hence, the fast growth of Li dendrites in polymer electrolytes 
is widely observed in literature[24-26]. The dendrite growth becomes even more severe with the introduction 
of plasticizers for enhancing ionic conductivity, as they further soften the electrolyte[23,27]. This issue is 




interspace between ceramic fillers. Currently, Li dendrite growth remains one of the major challenges in 
polymer electrolyte-based LMBs.[29] 
Addressing this issue requires fundamental understanding of the embedded dynamic Li metal/polymer 
electrolyte interface, such as how Li+ heterogeneity evolves at the Li anode surface and how the Li anode 
interacts with solid electrolytes. While remarkable advances have been achieved recently in characterizing 
the Li anode and solid electrolyte interphase (SEI) in liquid electrolytes, such as cryo-transmission electron 
microscope (TEM),[30-32] nuclear magnetic resonance (NMR),[33,34] in-situ and environmental TEM,[35,36] 
synchrotron,[37,38] and ambient pressure XPS[39], there is limited progress towards imaging the interaction 
between Li+ transport in the electrolyte and Li dendrite growth. This arises from challenges in visualizing 
ions in the electrolyte, which not only has a low concentration (0.01-2 M), but also possesses fast dynamics 
(diffusivity of ~10–7-10–6 cm2 s–1) compared to solid electrodes (10-50 M, and <10–9 cm2 s–1). Hence, ultra-
high chemical sensitivity (~1-10 mM), high speed (~1 s/image), and fine spatial resolution (<1 µm) are 
simultaneously required to image the electrolyte, especially during ion depletion. Such resolutions and 
sensitivity are beyond the capability of conventional characterization tools.  
Recently we utilized stimulated Raman scattering (SRS) microscopy to image ion transport profile in 
liquid electrolytes, which simultaneously offers high sensitivity (< 1 mM), fast imaging speed (~2 μs per 
pixel), and fine spatial resolution (down to 300 nm)[40-42]. SRS microscopy uses two temporally and spatially 
synchronized laser beams with an energy difference equal to that of the target bond’s vibrational mode. 
The synergy of the two beams amplifies the otherwise weak vibrational signal by up to 108 times. It thus 
enables the desired resolutions, imaging speed, and sensitivity (Fig. 2.1a, Supplementary Fig. 2.1).[43] 
Using this emerging microscopy, we visualized for the first time the heterogeneity of ion depletion in liquid 
electrolytes and how it correlated with lithium dendrite growth.[40] We observed that ion depletion at the 
Li/electrolyte interface led to faster dendrite growth due to the enhanced electrical field and larger 
concentration heterogeneity, which agreed with theoretical predictions.[1,44] 
In this report, we further explored the solid polymer electrolyte/electrode interaction and observed 
unexpected opposite phenomena. Instead of promoting dendrite formation, ion depletion strongly 
suppressed dendrite growth in PEO electrolytes and led to reversible lithium plating and stripping. Further 




in the polymer electrolyte and subsequent mechano-chemical coupling inside (Fig. 1b). Once ions deplete, 
a new PEO-rich phase was formed at the lithium/electrolyte interface with a high modulus ~ 1-3 GPa, as 
measured by atomic force microscopy (AFM). Such a high modulus suppressed dendrite growth and led to 
uniform lithium deposition. Based on this discovery, we developed a PEO electrolyte with an optimal 
composition (EO/Li = 6, ~1.6 M Li salt), which showed stable cycling over 200 times in an LFP/PEO/Li cell 
at 38 °C. In contrast, LFP/PEO/Li cells with concentrated electrolyte (EO/Li = 3, ~2.7 M Li salt) failed quickly 
after 10 cycles due to the rapid growth of lithium dendrites and dramatically increased impedance. This 
work proposes a new strategy for using self-forming mechanically strong phases to stabilize the lithium 
metal anode in solid-polymer-electrolyte-based LMBs. 
 
 
Fig. 2.1 The schematics of operando SRS imaging of the Li/PEO electrolyte interface. The schematics of SRS 
observations on a, high concentration polymer electrolyte (HCPE) and b, low concentration polymer electrolyte (LCPE) 
in Li/Li cells. In LCPE, the ion depletion-induced phase transformation leads to a mechanically strong PEO-rich phase 
at the lithium/electrolyte interface, which helps suppress lithium dendrites. c, the bright field of a Li/PEO/Li cell in 




microscope. d, the Raman spectrum of LCPE, where signature peaks for LiTFSI, SN, and PEO are labeled. The 
corresponding composition of LCPE is EO: Li: SN = 12: 1: 2.64. e, the plot of Raman intensity of the LiTFSI peak at 
1245 cm-1 versus the Li: EO ratio in PEO electrolytes with 40 wt% SN, showing good linearity. The points of 1.1 M and 
1.8 M LiTFSI correspond to LCPE and HCPE, respectively. 
2.2 Results 
2.2.1 SRS imaging of Li / solid polymer electrolyte interaction. 
Home-made parallel cells were used to visualize the Li / PEO electrolyte interaction via SRS 
microscopy (Fig. 1c). In this cell, the PEO electrolyte filled in the gap between two pieces of lithium, and all 
components were sandwiched between two glass slides and sealed by epoxy. The distance between two 
electrodes was typically ~ 0.5 mm. The PEO electrolyte contained lithium bis(trifluoromethanesulfonyl) 
imide (LiTFSI) as the salt and succinonitrile (SN) as the plasticizer[45] to enhance ionic conductivity and 
enable operation at room temperature. Wavenumbers at 1245 cm–1 (CF3 stretching),[46] 2250 cm–1 (C≡N 
stretching),[47] and 2800 cm–1 (CH2 stretching)[48] were selected for SRS imaging of LiTFSI, SN and PEO, 
respectively (Fig. 2.1d). Due to the requirement of electroneutrality, [Li+] could be considered to be equal 
to [TFSI–], even at the nanoscale, with an error smaller than 0.1 mM.[40] Therefore, [TFSI–] was measured 
to represent the local [Li+]. The Raman intensity of TFSI– is proportional to its concentration. Hence the 
Raman signal can be easily converted to chemical concentrations (Fig. 2.1e). The chemical sensitivity of 
LiTFSI was calculated to be 0.012 M. 
2.2.2 Lithium growth in PEO electrolytes with high and low concentration.  
As two representatives, the high-concentration polymer electrolyte (HCPE) and the low-concentration 
polymer electrolyte (LCPE) were studied with EO: Li: SN = 12: 2: 2.64 and 12: 1: 2.64 in molarity, 
respectively, which corresponded to 1.8 M LiTFSI and 2.4 M SN for HCPE, and 1.1 M LiTFSI and 2.9 M 
SN for LCPE. The weight ratios of SN to PEO were fixed at 40% in both cases. Their ionic conductivities 
are 1.7 × 10–4 S cm–1 (HCPE) and 1.0 × 10–4 S cm–1 (LCPE) at room temperature, respectively 
(Supplementary Fig. 2). Due to the relatively low ionic conductivities at room temperature, a current 





Fig. 2.2 Lithium growth at the lithium/PEO electrolyte interface with HCPE or LCPE. a-d, lithium dendrite growth 
in HCPE. a, the bright field and corresponding SRS images of [Li+] = [TFSI-] at three representative stages. b, the 
voltage profile of the Li/Li cell. c, [Li+] = [TFSI-] versus time, and d, the lithium growth rate (v) versus time. Interface 1 
refers to the boundary between the lithium electrode and the PEO electrolyte. e-h, lithium growth in LCPE. e, the bright 
field and SRS images of [Li+] at three representative moments. f, the voltage profile of the Li/Li cell. The yellow shading 
corresponds to the appearance of the PEO-rich phase and the green shading indicates the regime where the PEO-rich 
phase has covered the entire lithium surface. g, [Li+] = [TFSI-] versus time, and h, the lithium growth rate (v) versus 
time. Interface 2 refers to the boundary between the new PEO-rich phase and the isotropic bulk polymer electrolyte, as 
marked by dash lines in SRS images in e. Scale bars are 50 µm. Zoom-in SRS images of a & e are shown in 
Supplementary Fig. 4. 
In the case of HCPE (Fig. 2a), the applied current gradually depleted [Li+] on the lithium surface ([Li+]0 
m) from 1.8 M at t = 0 to 1.2 M at t = 27 min, after which [Li+]0 m remained at ~1.2 M in a steady state (Fig. 
2b & c). Meanwhile, the lithium growth rate (v) quickly increased from 0.27 ± 0.18 µm min–1 at t = 0 to 0.9 
± 0.46 µm min–1 at t = 27 min (Fig. 2d). The growth was in the form of mossy lithium, and statistical analysis 
showed a normal distribution of v (Supplementary Fig. 3a-c). Afterwards, v was drastically increased to 
~1.5 µm min–1 for the remaining time, leading to an ultrahigh porosity of 97%, indicating that the HCPE 
could not suppress dendrite growth at all. A dual-peak normal distribution was observed at this stage 




regions (> 2 µm min–1), showing the heterogeneous dendrite growth on lithium electrode. This dual-peak 
mode may arise from SEI properties and non-uniform depletion of ions. These results shows that if no 
phase transformation occurs, ion depletion at the Li/polymer electrolyte interface promotes dendrite growth, 
similar to our previous observations in gel electrolyte.[40] 
In contrast to the conventional behaviors observed in HCPE, we find that ion depletion in LCPE induced 
a phase transformation process at the lithium/electrolyte interface that unexpectedly suppressed lithium 
dendrite growth, as observed by both SRS and bright-field (BF) images (Fig. 2e). First, the new phase 
appeared as the blue color region in SRS and granular-like region in BF, which was confirmed by the 
spontaneous Raman spectrum (Supplementary Fig. 5). This new phase had a much lower [LiTFSI] than 
that in the isotropic bulk LCPE, as shown by the contrast between [LiTFSI] at the Li/electrolyte interface 
(interface 1), and [LiTFSI] outside the boundary between the new phase and the isotropic bulk electrolyte 
(interface 2). This difference increased from 0.79 M vs. 0.74 M at t = 15 min, to 0.87 M vs. 0.61 M at t = 30 
min, and 0.89 M vs. 0.43 M at t = 79 min (Fig. 2g). Further study showed that the new phase was also poor 
in SN, [SN] was only ~1.8 M at the interface, compared to 3.8 M outside the interface 2 (Supplementary 
Fig. 6 and 7). 
The appearance of this new phase unexpectedly but effectively suppressed the growth of lithium 
dendrites. Although the lithium dendrite growth was observed at t = 0 with v of ~ 0.3 µm min–1 (87% porosity), 
v quickly dropped to 0.048 µm/min at t = 30 min after the initial formation of PEO-rich phase (Fig. 2h), 
equivalent to a porosity of 16%. At this stage, the PEO-rich phase progressively formed on the lithium metal 
surface. After the new phase fully covered the Li metal surface, the average v from 30 min to 63 min was 
only 0.044 µm min–1, which corresponded to a low porosity of 9.2%, about one thirtieth of that in HCPE, 
indicating a dense and uniform lithium deposition. Such behavior is not only self-forming but also self-
reinforcing during ion depletion. For example, if Li dendrite grows fast at a certain location, the local current 
density will increase and lead to faster ion depletion and hence thicker new PEO-rich phase, which in turn 
suppresses dendrite growth. This active protection mechanism is distinct from other conventional passive 
protective layers, which requires perfect uniformity and durability. This suppression mechanism has not 




2.2.3 The suppression mechanism and underlying mechano-chemical coupling. 
To understand how the new PEO-rich phase formed and suppressed dendrite growth, we first 
constructed the ternary phase diagram of PEO-LiTFSI-SN with the assistance of SRS (Fig. 3a), as it could 
measure the composition of each phase in a high-throughput fashion. The phase diagram illustrates a 
single-phase isotropic zone (I-zone) in the middle (orange), and three two-phase regions at the corners 
(white & contour region). Representative SRS images of each region are shown in Supplementary Fig. 8. 
As shown in Fig. 3a, the composition of HCPE is at the center of the I-zone. When a low-to-mid-level current 
is applied, it progressively reduces [LiTFSI] on the lithium metal surface (Path A in Fig. 3a). Due to the high 
salt concentration in HCPE, the electrolyte composition at the Li/electrolyte interface remains within the I-
zone during ion depletion, and thus no phase transformation occurred. In contrast, the composition of LCPE 
is close to the boundary between the single-phase I-zone and the two-phase region, making it susceptible 
to undergoing a phase transformation in response to ion depletion (Path B in Fig. 3a), since forming two 
phases is thermodynamically more stable than staying in one phase. This phase transformation reduces 
not only [LiTFSI], but also [SN] in the new phase, as confirmed by the redistribution of [SN] during the phase 
transformation (Supplementary Fig. 2.6 & 2.7). 
The effective suppression of Li dendrites by the new PEO-rich phase is hypothesized to arise from 
mechano-chemical coupling during the phase transformation at the Li/electrolyte interface. To verify this, 
AFM was used to measure the Young’s moduli of solid polymer electrolytes (SPE) with different 
compositions, including both the I-zone and the PEO-rich phase, and the results are superimposed onto 
the phase diagram in Fig. 2.3a. For the composition of the HCPE (1.8 M LiTFSI and 2.4 M SN), the 
approaching curve showed no deformation of the cantilever when the tip was pressed into the electrolyte, 
indicating that the electrolyte was very soft (Fig. 2.3b). Large cantilever deflection is detected during tip 
retraction, confirming that the tip was pressed inside HCPE and the electrolyte was sticky. All SPEs within 
the I-zone and the isotropic phase of SPEs in the two-phase regions in Fig. 2.3a displayed similar results 
(Young’s modulus E < 10 MPa), indicating they could not mechanically suppress lithium dendrite growth. 
Conversely, a classic force curve was observed for the PEO-rich phase formed in SPE. The sample had 
an overall composition of 0.6 M LiTFSI and 3.3 M SN, and the PEO-rich phase inside contained 0.52 M 




beyond the threshold to suppress lithium dendrites in previous studies,[24] thus explaining why dendrite 
growth was suppressed in LCPE. The conductivity of the as-formed PEO-rich state is in the order of 10–5 S 
cm–1, which still allows Li+ to shuttle (Supplementary Fig. 2.9). 
 
Fig. 2.3 The phase diagram and the mechanical properties of PEO-LiTFSI-SN polymer electrolytes. a, the ternary 
PEO-LiTFSI-SN phase diagram in weight percentage. The orange color marks the region of the isotropic single-phase 
region, while other regions represent two phases. The rainbow color at the top of the triangle is the contour of Young’s 
moduli of as-formed PEO-rich phases at corresponding compositions in the phase diagram. b & c, the AFM extending 
and retraction force curves of b, the isotropic bulk phase (I-zone, HCPE). No cantilever deformation is detected. c, the 
as-formed PEO-rich phase with a composition of 0.52 M LiTFSI and 2.6 M SN (See Supplementary Table 1 for details). 
d, the corresponding force-indentation curves for samples in b and c. e, Young’s moduli of the PEO-rich phase with 
different salt concentrations. The sample compositions are along the path A / B in a. All samples have the same SN/PEO 
ratio as HCPE and LCPE (40 wt%), but different [LiTFSI]. The exact composition of each phase is listed in 
Supplementary Table 1. The solid and empty squares show Young's moduli of the PEO-rich phase and the isotropic 
bulk phases, respectively. f-g, phase-field simulations of Li electrodeposition in solid polymer electrolytes with f, high 
concentration (2 M salt) and g, low concentration (1 M salt) at 0.5 mA cm–2.  
To further understand mechano-chemical coupling at the Li/electrolyte interface, the composition-




measured by AFM. As shown in Fig. 3e, the modulus of the PEO-rich phase quickly rises to 1.2 and 1.8 
GPa when [LiTFSI] is reduced to 0.80 and 0.44 M in the PEO-rich phase (see Supplementary Table 1 for 
exact compositions in PEO rich phase). Further contour on the Young’s moduli of the PEO-rich phases in 
the I + PEO-rich two-phase region (Fig. 3a) shows that the modulus is typically above 1 GPa when [LiTFSI] 
is less than 0.8 M. The contour indicates that the mechanism of ion depletion-induced stabilization of lithium 
deposition is effective in a wide range of electrolyte compositions.  
The proposed suppression mechanism is also supported by phase-field simulations which take the 
mechano-chemical coupling into account. Since no new phase was formed in HCPE, lithium dendrites grew 
fast in the soft isotropic bulk polymer electrolyte (E =10 MPa, Fig. 2.3f & Supplementary Fig. 2.10a). In 
contrast, the rigid PEO-rich phase was formed (E =1.6 GPa) once [Li+] was depleted below 0.85 M, 
effectively suppressing lithium dendrite growth (Fig. 2.3g & Supplementary Fig. 2.10b). The deposited 
lithium was largely uniform and the [Li+] heterogeneity was low on the lithium surface. These simulation 
results strongly agree with experimental observations, supporting the hypothesis that the formation of the 





Fig. 2.4 Cycling stability of the lithium metal anode in LCPE and HCPE. a-b, the bright-field images of the lithium 
electrodes during lithium plating and stripping in a. LCPE and b. HCPE. The scale bars are 100 µm. c, the cycling 
performance of LiFePO4/Li metal battery with LCPE and d, the corresponding voltage profiles. e, An SEM image of the 
lithium metal surface after 100 cycles. f, the cycling of LiFePO4/Li metal battery with HCPE and g, the corresponding 





2.2.4 Ion depletion-induced stabilization of Li anode in Li/Li and LFP/PEO/Li cells.  
With the understanding that the formation of a mechanically rigid PEO-rich phase can stabilize lithium 
deposition, we further examined the effectiveness of this strategy in repeated cycles. First, as a proof-of-
concept experiment, 0.5 mA cm–2 was applied to a Li/PEO-LCPE/Li symmetric cell with a deposition 
capacity of 0.25 mAh cm–2 for 20 cycles at room temperature. As observed with the optical microscope (Fig. 
2.4a), no obvious lithium dendrites formed in the first deposition, and the lithium protrusions were frozen by 
the growing PEO-rich phase, leading to stable lithium deposition. During the lithium stripping, both the PEO-
rich phase and lithium metal electrode shrank without forming any dead lithium. Upon cycling, the lithium 
surface moved forward slightly after 20 cycles, indicating that this suppression mechanism was effective 
upon multiple cycles.  Further tests showed that such a reversible behavior could be achieved in a wide 
range of currents from 0.25 to 1 mA cm–2.  It should be noted that the PEO-rich phase sometimes did not 
fully disappear during lithium stripping, which is attributed to its disappearance being a kinetically slow 
process. In contrast, without the PEO-rich phase, fast dendrite growth was observed within the first several 
cycles for Li/Li cells with HCPE, forming large amounts of dead lithium during the repeated stripping process 
(Fig. 2.4b). 
The effectiveness of this strategy was further demonstrated in LFP (~4 mg cm–2)/PEO/Li cells at 0.25 
C and 40 °C. The PEO electrolyte was 100 m-thick without a separator (Supplementary Fig. 2.11). Stable 
cycling was achieved with LCPE. The initial discharge capacity was 120 mAh g–1 and slowly increased to 
141 mAh g–1 in the 4th cycle due to activation. After 100 cycles, the capacity remained at 140 mAh g–1, 
corresponding to a retention of 99%. The average CE for cycle 5-100 is 99.6% (Fig. 2.4c). The voltage 
profile shows that the internal resistance only increases slightly and there is no sign of dendrite-induced 
short-circuit (Fig. 2.4d). SEM further revealed that the lithium metal surface was relatively flat after 100 
cycles, with occasionally island-like morphology, demonstrating the effectiveness of the PEO-rich phase in 
suppressing lithium dendrites (Fig. 2.4e). On the other hand, the LFP/Li cell with HCPE quickly failed with 
the capacity dropping from 143 to 50.7 mAh g–1 after only 14 cycles (Fig. 2.4f). The voltage profile showed 
drastically increased overpotential, and the unstable voltage curve in charging suggests possible dendrite 
growth and micro-shorting (Fig. 2.4g). The average CE is only 97.4%, which probably arises from the 





Fig. 2.5 Cycling stability of the lithium metal anode in Li/Li cells and LFP/Li cells with PC/LiDFOB-LiBF4 dual 
salt-based LCPE and HCPE. a/b, the bright-field images of the lithium electrodes in Li/Li cells with (a) LCPE and (b) 
HCPE at room temperature and 0.75 mA cm-2. The scale bars are only 25 µm to better show the as-formed new PEO-
rich phase (The dashed cyanic area). c/d, the cycling performance of LiFePO4/Li metal batteries with (c) LCPE (EO/Li+ 
= 6) and (d) HCPE (EO/Li+ = 3) at 38 °C. The current density is 0.3 mA/cm2. In both LCPE and HCPE, PC is used as 
the plasticizer and it is 90 wt % of PEO. 
Such phase separation-induced dendrite suppression is universal in PEO electrolytes. In another PEO 
electrolyte of lithium difluoro(oxalato)borate (LiDFOB) and lithium tetrafluoroborate (LiBF4) as salts and PC 
as plasticizer, a similar phenomenon was also observed. In this system, phase separation exists when 
EO/Li+ > 6 and it diminishes at EO/Li = 5.3 (Supplementary Fig. 12), therefore, a PC-based LCPE with 
EO/Li+ = 6 (2.9 mS cm-1) was tested in a Li/Li cell at 0.75 mA cm-2. A PEO-rich layer was clearly observed 
during lithium deposition and capable of suppressing lithium dendrites (Fig. 2.5a). In contrast, phase 
separation was not observed in the PC-based HCPE with EO/Li+ = 3 (5.2 mS cm-1), and obvious dendrites 
and dead lithium were formed (Fig. 2.5b). The effectiveness of the strategy was also demonstrated in full 
cells. In an LFP/PC-based LCPE/Li cell with 5 mg LFP cm-2 and 40 μm thin lithium (Fig. 2.5c), the cell 
shows steady cycling over 200 cycles at 0.3 mA cm-2 (122, 140 and 129 mAh g-1 in cycle 1, 25 and 200, 
respectively). In contrast, when LCPE was replaced by HCPE, the cell dies after ten cycles due to dendrite-
induced internal shorting (Fig. 2.5d). The corresponding voltage profiles are shown in Supplementary Fig. 
2.13. Batteries with 10 mg LFP cm-2 (1.3 mAh cm-2) and 40 μm lithium also showed stable cycling. The cell 
capacity is 116 mAh g-1 in cycle 1, 131 mAh g-1 in cycle 20 and 119 mAh g-1 in cycle 80 (Supplementary 






The dynamic ion depletion, phase transformation in polymer electrolytes, and their correlations with 
lithium deposition were observed for the first time thanks to the high chemical, temporal, and spatial 
resolutions of SRS microscopy. We successfully unveil phase transformation in the polymer electrolytes 
induced by ion depletion and the formation of a new PEO-rich phase at the electrode/electrolyte interface. 
This new phase has a high Young's modulus of up to 3 GPa, which is effective in mechanically suppressing 
lithium dendrite growth by functioning as a reversible, self-reinforcing protective layer on lithium anode. In 
contrast, without such phase transformation, conventional polymer electrolytes have a small modulus < 10 
MPa, leading to fast lithium dendrite growth. This strategy is universal and effective with different salt and 
plasticizers. By utilizing this unexpected mechano-chemical coupling mechanism, we successfully 
demonstrated LiFePO4/PEO/Li cells with 200 stable cycles, while cells without this mechanism failed quickly 
within 10 cycles. This study shows that phase transformation can be used as a new strategy to suppress 
lithium dendrite. This strategy is compatible with state-of-the-art battery materials and manufacturing 
processes without extra needs to control the conformability of protective layers in previous literature. It will 
facilitate the development of solid polymer electrolyte-based lithium metal batteries with enhanced thermal 
stability and high energy density. 
2.4 Methods 
2.4.1 Preparation of solid polymer electrolyte (SPE) precursors 
To prepare LCPE / HCPE, 0.19 g / 0.38 g lithium bis (trifluoromethanesulfonyl) imide (LiTFSI, Gotion) 
was dissolved in 5 g acetonitrile (Sigma-Aldrich) along with 0.35 g poly (ethylene oxide) (Mw 600,000, 
Sigma Aldrich) and 0.14 g succinonitrile (SN, Tokyo Chemical Industry). Then the solutions were stirred 
overnight to form a translucent solution. SPEs with other compositions were prepared similarly and the PEO 
is typically 7 wt % of acetonitrile. For PC based LCPE / HCPE, the preparation procedure is similar. LiDFOB 
and LiBF4 are mixed first with a molar ratio of 1:1, then the dual salts, PEO, and PC were dissolved in 5 g 
acetonitrile with a weight of 0.16 g / 0.32 g, 0.35 g, and 0.315 g for LCPE / HCPE, respectively.   
2.4.2 Preparation of the lithium-lithium symmetric cells 
40 µm thick of lithium foil and 50 µm thick of SPEs were used in the Li/Li symmetric cells while the 




onto a glass slide, and two chambers (~1 × 1 cm for each) and a channel (~1 × 6 mm) to connect two 
chambers were cut inside Kapton tapes. The lithium foil was cut to the desired size and soaked in dimethyl 
sulfoxide (DMSO) with 0.2 wt% H3PO4 solution for 1 min to form a thin Li3PO4 protective layer to isolate the 
contact between Li and acetonitrile in the SPE precursor above. Lithium electrodes were then placed to two 
ends of the chamber, and the precursor of SPE above was dropped between two Li electrodes and rest to 
evaporate acetonitrile. Finally, Cu foils with similar sizes were placed on the two ends of lithium as an 
external electrical contact, and a glass cover is placed on top of the Li/Li cell, followed by sealing with epoxy. 
The whole process is done in a glove box with O2 and water level < 0.1 ppm.  
2.4.3 Preparation of the LFP-PEO-Li cells 
For SN-based PEO electrolyte, LiFePO4 (LFP) was selected as the cathode material due to its stability 
with the PEO electrolyte. LFP, carbon black, and polyvinylidene fluoride (PVDF) were mixed with a mass 
ratio of 8:1:1, then stirred in N-methyl-2-pyrrolidone (NMP) overnight to form a uniform slurry. Then the LFP 
slurry was coated on an Al foil using the doctor blade, followed by drying at 110°C for 12 hours. The mass 
loading of LFP is ~ 4 mg cm–2. Then the LFP electrodes were assembled with lithium metal as anode and 
LCPE/HCPE as the electrolyte in an argon-filled glove box with both H2O and O2 below 0.1 ppm. A Kapton 
ring with a thickness of 100 µm was used to fixate the distance between the LFP electrode and lithium 
metal. The cells were tested at 40 °C, which enhances ionic conductivity but the formation of the new PEO-
rich phase still occurs. The cells were rested for 15 minutes and 1 hour after each charging and the 
discharging step, respectively. 
For PC-based PEO electrolyte, the preparation procedure is similar, except that 0.7 wt% of CNT was 
added into the LFP electrodes to achieve better rate performance at high mass loading (5 mg~ 10 mg). The 
electrode will be infiltrated with PEO/PC/dual salts electrolyte, then roll-pressed, and assembled with 40 
µm thick lithium metal. The batteries are tested under 38 °C.  
2.4.4 Electrochemical characterizations 
All electrochemical tests, including galvanostatic charging and discharging, impedance measurements, 




2.4.5 Stimulated and spontaneous Raman scattering microscopy 
The detailed SRS setup has been previously reported by the authors.[40] Briefly, A commercial laser 
source (picoEmerald, Applied Physics & Electronics, Inc.) was used to generate both the Pump and Stokes 
beams with 6 ps pulse width and 80 MHz repetition rate. The wavelength of Stokes is fixed at 1064 nm 
while the Pump beam has a tunable wavelength between 720 nm to 990 nm achieved by an optical 
parametric oscillator (OPO). Notably, the Stokes beam is modulated at 8 MHz by a built-in electro-optical 
modulator. The two beams are spatially and temporally overlapped and coupled into a commercial confocal 
laser-scanning microscope (FV1200MPE, Olympus), then tightly focused on the sample with a 25× water 
objective (XLPlan N, N.A.=1.05, Olympus). After passing through the sample, two beams are collected by 
a high N.A.=1.4 condenser (Oil immersion, Olympus). The Stokes beam is filtered off with a high O.D. 
bandpass filter (890/220 CARS, Chroma Technology), while the Pump beam is focused and detected on a 
large area silicon photodiode (FDS1010, ThorLabs) with 64 V DC voltage. The current output is terminated 
by a 50 Ω terminator and demodulated by a lock-in amplifier (HF2LI, Zurich instrument). The X-output (i.e. 
Pump loss signal) generated by the amplifier is fed into the software interface (FV10, Olympus) as pixel 
intensity. 
All spontaneous Raman spectra were acquired with a commercial Raman microscope (Xplora, Horiba 
Jobin Yvon). A 532 nm diode laser is used as excitation light and focused by a 50×, N.A.=0.75 air objective 
(MPlan N, Olympus). All spectra were obtained with 5 s acquisition time and 3 times averaging then 
processed with LabSpec 6 software. 
2.4.6 Measurement of Young’s modulus using Atomic Force Microscopy 
Bruker Multimode 8 AFM was used in this study. The SPEs with thicknesses of ~ 10 µm were coated 
on stainless steel plates. The AFM chamber was purged by dry N2 prior to the tests. The spring constant, 
half angle and Poisson's ratio of AFM tips are ~ 3 N/m, 15°, and 0.4, respectively. The force curve is fitted 
by the Sneddon model to get Young's modulus. The approaching curve in the extending line will be fitted 
first to determine the indentation start point, then the force can be calculated using cantilever deformation 




2.4.7 Theoretical Analysis of Electroneutrality in the electrolyte  
In this paper, the electroneutrality does not mean the difference between [TFSI–] and [Li+] is zero; the 
difference is small enough to be neglected at given resolutions of SRS microscopy. We can consider a 
planar electrode: 









  = − 
  (1) 
Where F is the Faraday constant (96485 C mol–1), ε is the relative permittivity of electrolyte and ε0 is 
the vacuum permittivity (8.85×10–12 F m–1), and zi and ci are charge number and concentration of all ions in 
the electrolyte. In our cell, the maximum voltage is 5 V, and the distance is around 500 μm. Even if we 
consider an extreme condition, in which the maximum gradient of an electrical field (–▽2Ф) is 5V μm–2, and 
relative permittivity is 10, the difference in anion and cation concentration (C+–C–) is still < 5 μM. Therefore, 
Li+ can be reflected by TFSI– outside the double layer region (Debye length is 48.7 nm for 5 μM LiTFSI) 
which is much less than our spatial resolution. More detailed experimental and simulation results can be 
found in Fig. 2.2 in the authors’ previous work.1 
2.4.8 Phase-field simulation 
To simulate Li electrodeposition and the concurrent multiphase evolution in the lithium 
salts/plasticizer/PEO solid polymer electrolyte, we developed a phase-field model for a half-cell system 
incorporating diffusion, elasticity, and nonlinear Butler-Volmer kinetics. This model contains two phase-field 
order parameters, i.e. 𝜉 and 𝜙, to differentiate each phase by describing their relative mass densities: (𝜉 =
1; 𝜙 = 0) for Li metal, (𝜉 = 0; 𝜙 = 1) for PEO precipitate and (𝜉 = 0; 𝜙 = 0) for electrolyte. At each phase 
boundary, order parameters vary continuously between 1 and 0 to form a diffuse interface of finite thickness. 
The total free energy of the system, including local, interfacial, electrostatic and mechanical contributions, 
is written as 




where ?̃?𝑖 = 𝑐𝑖/𝑐0 is a set of dimensionless concentrations of species (e.g. 𝑖 = 𝐿𝑖
+), where 𝑐0 is the bulk 
concentration of the solid phase. 𝜑 is the electrostatic potential. We formulated the bulk energy density in 
the standard reference state (𝛩) as 𝑓𝑙𝑜𝑐𝑎𝑙 = 𝑓0(𝜉, 𝜙, 𝑐) + 𝑐0𝑅𝑇 ∑ ?̃?𝑖𝑖 𝑙𝑛?̃?𝑖 + ∑ 𝑐𝑖𝜇𝑖
𝛩
𝑖 , where the local free energy 
density 𝑓0(𝜉, 𝜙) = 𝑊1𝜉
2(1 − 𝜉)2 + 𝑊2𝜙
2(1 − 𝜙)2 +
𝐴3
2
𝜉2𝜙2 + 𝑓𝑝𝑟𝑒𝑐(𝜙, 𝑐) . Based on experimental 
observation, PEO precipitates when salt concentration (𝑐𝑝𝑟𝑒𝑐) falls below 85% of the original in the lean salt 
concentration (1 mol/L) electrolyte. Therefore, the energy density of electrolyte and PEO precipitate was 
constructed as 𝑓𝑝𝑟𝑒𝑐(𝜙, 𝑐) = [1 − ℎ(𝜙)]𝑓𝑙(𝑐) + ℎ(𝜙)𝑓𝑃𝐸𝑂(𝑐), where the energy densities 𝑓𝑙 = 𝐴1(𝑐 − 𝑐𝑝𝑟𝑒𝑐  )
2  
and  𝑓𝑃𝐸𝑂(𝑐) = 𝐴2𝑐
2  were interpolated by function ℎ(𝜉) = 𝜉3(10 − 15𝜉 + 6𝜉2). Considering the low salt 
solubility in PEO, we set parameters to be 𝐴1 =
1
10
𝐴2 = 1. The phenomenological parameters are set to be 
𝑊1 = 𝑊2 =
1
3
𝐴3 = 1, so that the equilibrium states are represented by the degenerate minima with equal 








2, where 𝜅𝜉 and 𝜅𝜙 are 
gradient energy coefficients associated with the surface/interface energies of Li metal and PEO precipitate, 
respectively. The PEO phase is assumed isotropic and thus 𝜅𝜙 is constant. The anisotropic Li dendrite 
growth is governed by an orientation-dependent gradient energy coefficient 𝜅𝜉(𝜃) = 𝜅𝐿𝑖[1 + 𝛿cos (𝜔𝜃)], 
where 𝜅𝐿𝑖 is related to the Li metal surface energy, 𝛿 and 𝜔 are the strength and mode of the anisotropy, 
and 𝜃 is the angle between the normal vector at the interface and the reference axis. Given the random 
interfacial orientation between Li metal and electrolyte/PEO phases, we considered the isotropic elasticity 
in this study. The elastic energy density is written as 𝑓𝑚𝑒𝑐ℎ =
1
2





+ [1 − ℎ(𝜉) − ℎ(𝜙𝑖)]𝐸𝑖𝑗𝑘𝑙
𝑙  is expressed in term of interpolating function ℎ(𝜉), and the 




) and electrolyte (𝐸𝑖𝑗𝑘𝑙
𝑙 ). The electrostatic energy density is in 
the form of 𝑓𝑒𝑙𝑒𝑐(𝑐, 𝜑) = 𝐹 ∑ 𝑧𝑖𝑐𝑖𝜑𝑖 , where 𝐹 is Faraday constant and 𝑧𝑖 is the valence of charged species. 
Therefore, the phase morphology evolution equation for the Li metal phase is governed by the Butler-




























 are interface mobility and reaction constant, respectively. 𝛼  is the Butler-Volmer 










} + 𝛿𝑁 
where 𝑀𝜙  is the interface mobility of solid electrolyte and 𝛿𝑁  is a Dirac delta function for PEO 
nucleation, which are detailed in reference.2 The evolution of each phase-field was solved simultaneously 
with ionic diffusion, charge conservation, and mechanical equilibrium equations. The model details and 
parameter table are in references.2-4 
All phase-field simulations were performed by COMSOL Multiphysics 5.2 in a 300 × 300 𝜇𝑚2 half-cell. 
Two scenarios of low (1 mol/L) and high (2 mol/L) electrolyte salt concentrations were simulated for PEO 
precipitation and no precipitation scenarios, respectively. Major simulation parameters are set to be 
consistent with the available experimental data. The Li-ion conductivities in electrolyte and PEO precipitate 
are 10−3 𝑆/𝑐𝑚 , 2 × 10−4 𝑆/𝑐𝑚 , respectively. The elastic modulus of Li metal, PEO precipitate and 
electrolyte are 4.9𝐺𝑃𝑎, 1.6 𝐺𝑃𝑎, and 10 𝑀𝑃𝑎, respectively. The mechanical interaction between Li metal 
and electrolyte in the high salt concentration system was considered negligibly small due to the extremely 
low modulus of the electrolyte phase and the complication of introducing plasticity. Neglecting the impact 
of the SEI layer, the surface energies of Li metal and PEO used in this simulation are 0.48 𝐽/𝑚2 and 
0.05 𝐽/𝑚2, respectively.5, 6 Dirichlet boundary conditions were applied for electrolyte bulk concentration. 
Identical smooth anode surfaces were used as initial morphologies for both simulations (Fig. 2.3f & 2.3g). 





2.5 Supplementary Information 
 
Supplementary Fig. 2.1. The comparison between spontaneous Raman scattering and stimulated Raman scattering 
(SRS). Only one laser is used as the excitation laser in spontaneous Raman, and the photons will have an energy loss 
of Ω after inelastic scattering. In SRS, two different lasers with an energy gap matching Ω will be simultaneously used 
and result in 108 times faster Raman transitions. 
 
 
Supplementary Fig. 2.2. Ionic conductivities of HCPE and LCPE at different temperatures. The ionic conductivities of 






Supplementary Fig. 2.3. Frequency analysis of the lithium deposition rate in the cell with HCPE. a-c, the mossy lithium 
growth stage (t = 0 to 27 min), where the lithium growth pattern fits the normal distribution. d-h, the dendrite growth 
stage (t = 27 to 72 min), in which the lithium growth pattern fits dual peak normal distribution, showing that dendrite 





Supplementary Fig. 2.4. The zoom-in SRS pictures show the fine structures of lithium electrodes and ionic 
concentration. a, the zoom-in picture of Fig. 2a at t = 45 minutes. b, the zoom-in picture of Fig. 2e at t = 30 minutes. 
Scale bars are 10 µm. 
 
 
Supplementary Fig. 2.5. Spontaneous Raman spectra of the new PEO-rich phase formed during lithium deposition 








Supplementary Fig. 2.6. Line scans of [LiTFSI] and [SN] along the direction that is perpendicular to the electrode 
surface show the existence of two phases. a, the concentration of LiTFSI and b, the concentration of succinonitrile. 
The data is from the same cell in Fig. 2e with LCPE electrolyte. The current density is 0.5 mA cm–2 and the deposition 
time is 79 min. The green and the orange region correspond to the PEO-rich and the isotropic bulk phase, respectively. 
The PEO-rich phase is poor in both SN and LiTFSI, while the isotropic phase has a much higher [SN] and [LiTFSI]. 
The excessive SN in the PEO rich phase is repelled into the isotropic bulk polymer electrolyte during phase 
transformation, leading to an SN-rich region outside the new phase, as marked by the high [SN] in the dashed box in 
b. Hence, the new phase formed at the Li surface is denoted as the PEO-rich phase. 
 
 
Supplementary Fig. 2.7. Change of [SN] upon the formation of the new PEO-rich phase. Interface 1 and Interface 2 
refer to the boundary between the lithium electrode and the PEO electrolyte, and the boundary between the new PEO-
rich phase and the isotropic bulk polymer electrolyte, respectively. The increasing [SN] difference along interface 2 
shows that the plasticizer (SN) is progressively repelled from the PEO-rich phase to the bulk electrolyte during the 






Supplementary Fig. 2.8. The bright field and SRS pictures of PEO electrolyte with different compositions, including 
those in the two-phase regions and the single-phase region. Wavenumbers at 1245 cm–1, 2250 cm–1, and 2800 cm–1 
are selected for SRS imaging of LiTFSI, SN and PEO, respectively. a, the isotropic HCPE. b, the co-existence of the 
isotropic phase and the LiTFSI-rich phase. The weight percentage of PEO: LITFSI:SN is 17.9%: 67.8%: 14.3%.  c, the 
co-existence of the isotropic phase and the PEO-rich phase. The weight percentage of PEO: LITFSI:SN is 59.8%: 
16.2%: 23.9%. d, the co-existence of the isotropic phase and the SN-rich phase. The weight percentage of PEO: LiTFSI: 
SN is 7.3%: 13.2%: 79.5%. It worth noting that the bright field image and SRS images do not match in this case. SN-
rich phase prefers to form thin sheets at different z-heights and stacks in bright field images. Due to the confocal nature 






Supplementary Fig. 2.9. Ionic conductivities of PEO-rich phases formed at lithium surface at different temperatures. 
The compositions of depletion state 1 and 2 are 0.52 M LiTFSI / 2.6 M SN and 0.38 M LiTFSI / 2.3 M SN, respectively, 
as determined by the SRS microscopy. The ionic conductivities of polymer electrolytes at these two depletion states 
are 2.3× 10–5 S cm–1 and 4.9× 10–5 S cm–1 at 21 oC, respectively. 
 
 
Supplementary Fig. 2.10. Phase-field simulations of Li electrodeposition in solid polymer electrolytes at different 




concentration of Li salt, where 0 means lithium metal. The simulated current density is 0.5 mA cm–2. The phases of Li 
metal, PEO precipitate and electrolyte have elastic moduli of 4.9 GPa, 1.6 GPa, and 10 MPa, respectively. The ion 
conductivities in the bulk electrolyte and the PEO-rich phase are 10–3 S cm–1 and 2×10–4 S cm–1, respectively. a, the 
electrolyte with 2 M salt, so ions are not depleted even at the final state (t = 400 s) and b, the electrolyte with 1 M salt. 




Supplementary Fig. 2.11. The schematics of an LFP/PEO/Li full cell. A ring made of Kapton tape with a thickness of 
~100 µm is used to make sure that the distance between LFP cathode and lithium metal anode is fixed. 
 
Supplementary Fig. 2.12. The optical images of PEO/LiDFOB+LiBF4/PC based electrolytes. When the EO : Li is below 






Supplementary Fig. 2.13. The voltage profiles of LFP/PEO/Li cells with PC-based (a) LCPE and (b) HCPE. The 
composition of LCPE is PEO: LiDFOB: LiBF4 = 12:1:1 (EO/Li+ = 6) and the composition of HCPE is EO: LiDFOB: LiBF4 
= 6:1:1 (EO/Li+ = 3).  In both LCPE and HCPE, propylene carbonate (PC) is used as the plasticizer, whose weight is 
90% of PEO. 
 
 
Supplementary Fig. 2.14. LFP/PEO/Li cell with cathode mass loading of 10 mg cm-2, 40 µm thick lithium metal, and 
PC-based LCPE. The areal capacity of this cell is around 1.3 mAh cm-2. 
 
Supplementary Table 2.1. The compositions of overall electrolytes, corresponding PEO-rich and isotropic bulk phases 
in PEO electrolytes for all points in Fig. 3e. The concentration is determined by Raman intensity in SRS images and 
calibration curves for each material. Wavenumbers at 1245 cm–1 and 2250 cm–1 are selected for SRS imaging of LiTFSI 



















3.8 0 3.8 0 N/A N/A 
3.7 0.23 2.3 0.22 3.2 0.38 
3.5 0.44 2.3 0.38 3.9 0.70 
3.3 0.63 2.6 0.52 4.6 0.82 
3.2 0.80 3.0 0.65 5.7 0.93 
3.0 0.99 3.5 0.79 6.6 1.0 
2.9 1.1 N/A N/A 2.9 1.1 
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Chapter 3: Live-cell Imaging Analysis of Antimycin-Type 
Depsipeptides via SRS Microscopy 
The contents of this chapter have been published in: 
Seidel, E. R.*, Miao, Y*. et al. Structure-activity-distribution relationship study of anti-cancer antimycin-type 
depsipeptides. Chem. Commun. 55, 9379-9382 (2019). *Co-first author. 
3.1 Introduction 
Nature's small molecules have played an enormous role in the history of medicinal and pharmaceutical 
chemistry. For example, it has been estimated that over 70% of anti-cancer small molecule treatments are 
natural products, their derivatives or mimics.[1] Although the pharmaceutical value of natural products has 
been widely recognized, it is still difficult to transform medicinally active natural products into drugs. One of 
the major challenges is to understand the complex interplay between natural products and the network of 
cellular machinery beyond the specific protein targets.[2] This has spurred the development of advanced 
imaging techniques to obtain views of natural products in cells, but often in a static and destructive manner 
using bulky fluorescent probes.[3,4] An improved imaging technique, which provides dynamic views of 
natural product uptake and distribution in live cells, will have a profound impact on natural product-based 
drug discovery and development.[5] Tagging natural products with a bio-orthogonal alkyne functionality 
coupled with the Stimulated Raman Scattering (SRS) microscopy offers such promise.[6] 
Raman imaging has evolved greatly over the past decade, with improved sensitivity, resolution, and 
scanning speeds offered by the latest SRS technology (Fig. 3.1).[7-9] More importantly, compared with other 
vibrational imaging platforms such as Coherent Anti-Stokes Raman Scattering microscopy, SRS is free of 
spectral distortion and non-resonant background thus enables quantitative determination of Raman 
reporters. The vibrational Raman reporter can be as simple as an alkyne,[6,10] delivering chemical specificity 
and biocompatibility for natural product visualization and quantification in complex living systems with 
minimal activity perturbation of compounds. Compared to fluorescent imaging, SRS imaging offers 
additional advantages of minimal phototoxicity and photobleaching, allowing prolonged dynamic imaging 




alkyne-tagged small-molecule derivatives that have high local intracellular concentrations.[11-14] Despite the 
great potential, few natural products have been imaged using SRS microscopy to probe their intracellular 
behavior.  
 
Fig. 3.1 Schematic representation of Stimulated Raman Scattering (SRS) microscopy setup. The Stokes and 
pump beams are temporally and spatially sychronized while the Stokes beam is modulated with a frequency of 8 MHz. 
The beams are guided onto the sample by a laser scanning microscope. The transmitted and detected pump lose 
signal is demodulated by a lock-in amplifier.  
Here, we’ve applied SRS imaging to study antimycin-type depsipeptides, a class of complex natural 
products that have attracted recent attention due to their anti-cancer potential.[15] This family of natural 
products share a common structural skeleton consisting of a macrocyclic ring with an amide linkage to a 3-
formamidosalicylate unit, and primarily differ in the size of their macrolactone ring (Fig. 3.2a). The well-
recognized members of this family are the 9-membered antimycins, for which multiple modes of action have 
been proposed, including inhibition of mitochondrial electron transport chain,[16] anti-apoptotic proteins 
Bcl2/Bcl-xL,[17] K-Ras plasma membrane localization,[18] and ATP citrate lyase activity.[19] The levels of 
contributions of these different mechanisms are unclear. Much less is known about the 15-membered 
neoantimycins, despite the fact that they have also shown promising anti-cancer activities toward various 
cancer cell lines.[20] The inhibitory activity of K-Ras plasma membrane localization was shown to be shared 
between antimycins and neoantimycins,[18] but neoantimycins lacked the Bcl-xL inhibitory activity and were 
demonstrated to inhibit the expression of GRP-78,[21,22] a molecular chaperone in the endoplasmic reticulum 




stress.[23] To gain additional insights into anti-cancer activities of antimycin-type depsipeptides, we 
performed a structure-activity-distribution study of both antimycin and neoantimycin against live cancer cells. 
 
Fig. 3.2 Antimycin-type depsipeptides and their alkyne-tagged derivatives. (a) Selected examples of natural 
antimycin-type depsipeptides. The ring size is indicated in red numbers. (b) Generation of 5 through both bioengineering 
and chemical derivatization. (c) Generation of 6 through C-11 esterification. (d) Generation of 7 and 8 through acid 






To increase the sensitivity of SRS imaging toward bioactive small molecules which are typically used 
in the low to mid micromolar range,[24] we chose a conjugated diyne with a terminal phenyl ring as a Raman 
tag. This tag is known to possess increased Raman scattering cross section due to conjugation within the 
poly-yne chain and the presence of an aryl end-capping group also improves the stability of poly-ynes.[11] 
This tag has recently been used in separate studies to image a phenyl-diyne anisomycin derivative in 
mammalian cells and to track the distribution of a cholesterol derivative in Caenorhabditis elegans where a 
detection limit of ~30 μM was attained.[11,25] Since bioactive antimycins naturally have high structural 
variations at the C-7 alkyl and C-8 acyloxy moieties (Fig. 3.2a) and the previous introduction of an alkyne 
side chain at C-8 did not significantly change cytotoxic activity nor binding of compounds to cancer cells,[4] 
we reasoned that the Raman tag could be readily introduced at this position with minimal functional 
perturbation. To prepare phenyl-diyne antimycin (PhDY-Ant, 5), C-8 deacylated antimycin (4) was first 
purified from the culture of Streptomyces albus ΔantB in which the last step of C-8 acyloxy formation is 
abolished in antimycin biosynthesis due to the deletion of the dedicated C-8 acyltransferase AntB.[26] A 
phenyl-diyne carboxylic acid was chemically synthesized and then coupled to the purified 4 via Steglich 
esterification to yield 5 (Fig. 3.2b and Supplementary Fig. 3.1). As expected, the MTT proliferation assays 
with both HeLa (human cervical cancer) and MCF-7 (human breast cancer) cell lines confirmed that PhDY-
Ant retained a comparable activity to the natural antimycin (Table 1, Supplementary Fig. 3.2).  
Table 3.1. GR50 values (µM) for selected antimycins and neoantimycins against two cancer cell lines in vitro. 
Compound HeLa MCF-7 







Deformylated neoantimycin (7) 
31.8 ± 10.4 
 





28.8 ± 9.7 
 
24.4 ± 5.5 
 
40.9 ± 22.8 
 
> 1000 
[a] All data were collected in at least triplicate and GR50 values were averaged between at least three biological replicates with error given in 
standard error of the mean (SEM). 




PhDY-Ant (5) was then incubated with HeLa cells and SRS images were acquired by tuning the 
frequency difference between the pump and Stokes lasers to be resonant with intracellular components 
such as proteins (CH3, 2953 cm-1) and lipids (CH2, 2844 cm-1), and in the bio-orthogonal region of the 
Raman spectrum (alkyne, 2251 cm-1; off-resonance, 2000 cm-1) (Fig. 3.1). 5 was used at solution 
concentrations ranging from 1-100 µM to probe the detection limit. Intracellular signal could be distinguished 
at concentrations as low as 10 µM, and contrast was dramatically improved by increasing the solution 
concentration of 5 to 50 µM (Fig. 3.3 and Supplementary Fig. 3.3). The absolute intracellular concentration 
of 5 was determined to be ~ 1.74 mM from the dosing concentration of 50 µM, showing a 35-fold enrichment 
of this compound in cells. To confirm that the observed signal was driven by the activity of antimycin, a 
control experiment was performed by incubating 50 µM PhDY tag with cells. No signal of compound was 
detected inside cells (Supplementary Fig. 3.3), suggesting that the observed Raman signal was not an 
off-target affect caused by the PhDY tag alone. We next probed the antimycin uptake rate and mechanism. 
Time-resolved imaging of 5 uptake into live HeLa cells showed that compound uptake was nearly immediate, 
reaching 75% of the maximum within six minutes (Supplementary Fig. 3.4). 5 appeared to rapidly distribute 
throughout the cytoplasm of the cells and persist through prolonged incubation. In addition, a low-
temperature (4°C) uptake study was performed to investigate possible mechanisms of compound uptake. 
5 was absorbed at comparable levels at both 4°C and 37°C (Supplementary Fig. 3.5), suggesting that 
PhDY-Ant may cross the cell membrane through passive diffusion.   
The non-destructive nature of SRS imaging allows follow-up studies on compound distribution inside 
the cell, as well as correlating compound uptake with any possible phenotypic changes to cellular 
composition using dual-color and multi-modal approaches. For example, using a multi-modal approach to 
probe the subcellular localization of 5, HeLa cells were treated with ER-Tracker Green and MitoTracker 
Deep Red, cell-permeable fluorescent stains selective for the endoplasmic reticulum and mitochondria, 
respectively. Inspection of the merged images demonstrated that 5 correlated well with ER-Tracker (Fig 
3.3). This colocalization agrees with one of its known direct protein targets, Bcl2, an anti-apoptotic protein 
localized primarily in the ER.[27] Notably, a prolonged incubation led to a decrease of correlation between 
ER-Tracker and 5 (Supplementary Fig. 3.6), possibly due to compound dissociation from targets and/or 




electron transport chain by binding to the quinone reduction site Q i of the cytochrome bc1 complex,[16] no 
significant colocalization of 5 with MitoTracker was found (Fig. 3.3). In addition, no obvious phenotypic 
changes were observed in lipids or proteins during the eight-hour incubation, although the merged images 
for 5 and the lipid channel showed a strong correlation, especially in lipid droplets (Fig. 3.3). This correlation 
is likely caused by the lipophilic nature of 5 rather than any specific binding. Further image analysis using 
profile plots demonstrated that the localization of 5 was best explained by a combination of ER-Tracker and 
lipids (Supplementary Fig. 3.7). This result indicates that the intracellular behavior of antimycin is not 
totally dictated by specific protein binding nor non-specific absorption. Instead, there is likely a complex 
interplay between antimycin, its protein targets, and the lipid-rich regions of the cell. 
 
Fig. 3.3 SRS and fluorescence imaging of PhDY-Ant (5) in HeLa cells. (a) CH3 channel at 2940 cm-1 representing 
proteins. (b) Diyne label at 2251 cm-1. (c) Off-resonance channel at 2000 cm-1. (d) CH2 channel at 2845 cm-1, 
representing lipids. (e) Confocal fluorescence imaging of ER-Tracker excited at 488 nm. (f) Confocal fluorescence 
imaging of Mito-Tracker excited at 635 nm. (g) Overlay image of (d) lipids and (b) diyne label. (h) Overlay image of (e) 




We next analyzed the distribution of PhDY-Ant (5) in MCF-7 and compared it to HeLa cells to probe if 
the distribution is cell-line specific. Similar to HeLa cells, 5 colocalized with ER-Tracker, but not MitoTracker 
(Supplementary Fig. 3.8). These data suggest that localization of antimycin in the ER is conserved across 
different cancer cell lines. In addition, MCF-7 cells showed a much smaller number of lipid droplets than 
HeLa cells, but instead contained highly lipid-rich regions at the intercellular boundaries that did not attract 
5 (Supplementary Fig. 3.8). This result further suggests that the characteristics and location of lipids may 
also be important for enrichment of antimycin. Indeed, a profile analysis showed that certain areas of 
localization of 5 in MCF-7 cells were best correlated with ER-Tracker while others were best correlated with 
the lipid channel (Supplementary Fig. 3.9).  
Compared to antimycin, the molecular mechanism for the ring-expanded neoantimycin to inhibit cancer 
cell growth is much less known, and no direct protein target of neoantimycin has been identified. In addition, 
limited structure-activity relationship studies have been performed on the molecular scaffold of 
neoantimycin. It is yet to be determined if a similar tagging strategy, the esterification of the macrolactone 
C-11 hydroxyl moiety that is naturally present in neoantimycin (Fig. 3.2a), can be adopted to produce a 
neoantimycin derivative that is suitable for imaging analysis while retaining its anti-cancer activity. 
Neoantimycin was purified from the culture of S. orinoci and subjected to esterification by a phenyl-diyne 
carboxylic acid to generate phenyl-diyne neoantimycin (PhDY-NeoA, 6) (Fig. 3.2c and Supplementary 
Fig. 3.10). The MTT proliferation assays with both HeLa and MCF-7 cells indicated that 6 had a slightly 
decreased but significant bioactivity, although its GR50 value against HeLa cells could not be determined 
due to solubility limitation (Table 1, Supplementary Fig. 3.11). This response of cell lines to the C-11 
modification is consistent with a recent report in which oxidation of the same hydroxyl to ketone of 
neoantimycin led to slightly increased IC50 values against multiple cancer cell lines.[20] The N-formyl group 
has been conserved in the antimycin-type depsipeptides and linked to respiration inhibition for antimycin.[15] 
To probe the role of the N-formyl group in anti-cancer activities of neoantimycin, we produced deformylated 
neoantimycin (7) and its tagged version (8) through acid degradation of 2 and 6, respectively (Fig. 3.2d, 
Supplementary Fig. 3.12 and 3.13). The growth of HeLa and MCF-7 cells was not inhibited upon treatment 
of up to 1 mM of 7 (Table 1 and Supplementary Fig. 3.11), demonstrating the critical role of this moiety 




type depsipeptides (Fig 3.2a) of which deformylation did not significantly decrease the inhibitory activity 
toward various cancer cell lines,[28,29] suggesting different modes of action for 15- and 18-membered 
compounds. Nonetheless, the generation of both active and inactive tagged neoantimycins provided an 
opportunity to investigate possible differential uptake of these compounds in live cells.  
 
Fig. 3.4 SRS and fluorescence imaging of PhDY-NeoA (6) in MCF-7 cells. (a) CH3 channel at 2940 cm-1 
representing proteins. (b) Diyne label at 2251 cm-1. (c) Off-resonance channel at 2000 cm-1. (d) CH2 channel at 2845 
cm-1, representing lipids. (e) Confocal fluorescence imaging of ER-Tracker excited at 488 nm. (f) Confocal fluorescence 
imaging of Mito-Tracker excited at 635 nm. (g) Overlay image of (d) lipids and (b) diyne label. (h) Overlay image of (e) 
ER-Tracker and (b) diyne label. (i) Overlay image of (f) Mito-Tracker and (b) diyne label. 
PhDY-NeoA (6) and deformylated PhDY-NeoA (8) were then subjected to SRS imaging analysis with 
both HeLa and MCF-7 cells. Enrichment of both compounds in lipid droplets was observed for both cell 
lines, which is likely due to the lipophilic nature of compounds rather than any specific binding to targets 
(Supplementary Fig. 3.14). In addition, 6 was detected by SRS throughout the cytoplasm of the MCF-7 




was also detected throughout the cytoplasm of the HeLa cells, although with a decreased signal intensity, 
demonstrating a positive correlation of compound intracellular enrichment to its cytotoxic activity. This is 
particularly true for intracellular enrichment of 8, for which very weak SRS signals were detected (except 
within lipid droplets) in either cell line (Supplementary Fig. 3.14). Further analysis using dual-color and 
multi-modal approaches showed that the intracellular distribution of PhDY-NeoA (6) differed from that of 
PhDY-Ant (5). In particular, 6 showed no correlation with MitoTracker and a weak correlation with ER-
Tracker in MCF-7 cells (Fig. 3.4). Line plot analysis showed that 6 was much better correlated with lipids 
than with ER-Tracker (Supplementary Fig. 3.15), suggesting that neoantimycin may not target ER. This 
observation is consistent with previous reports that the known antimycin target, Bcl2/Bcl-xL, is not a 
neoantimycin protein target.[30]    
3.3 Conclusion 
In summary, both the 9- and 15- membered antimycin-type depsipeptides have been labeled with an 
alkyne Raman tag and subjected to bioorthogonal SRS imaging analysis in live cancer cells. This work 
provides the first global and dynamic view of the interplay between these anti-cancer complex natural 
products and the complicated network of cellular machinery. We demonstrated the primary localization of 
the 9-membered antimycin in the endoplasmic reticulum despite the previous known protein targets of 
antimycin in various cellular organelles. We further showed that the anti-cancer activity of the 15- membered 
neoantimycin was dependent on the N-formyl moiety and less sensitive toward the C-11 modification. A 
different cellular localization of neoantimycin compared to antimycin was also indicated. Our results suggest 
that the intracellular enrichment and distribution of these compounds are driven by their potency and 
specific protein targets, as well as the lipophilic properties of compounds. This non-destructive imaging 
technique of drug candidates is expected to complement existing biochemical and proteomic techniques in 
the early stages of drug discovery, facilitating efforts in reducing off-target effects and improving efficacy of 
candidate compounds.  
3.4 Methods 
Spontaneous Raman Spectroscopy 
All spontaneous Raman spectra were acquired with a commercial Raman microscope (Xplora, Horiba 




concentration of 50 mM for Raman spectrum acquisition. A 532 nm diode laser beam was guided through 
a 50×, 0.75 N.A. air objective (NPLAN EPI, Leica) to excite samples. All spectra were obtained with 5 s 
acquisition time and 10 times averaging. All Raman spectrum data were processed with LabSpec 6 
software. 
General cell culture 
MCF7 and HeLa cells were obtained from the UCB Cell Culture Facility cultured in DMEM (Gibco) 
supplemented with 10% (vol/vol) fetal bovine serum, GlutaMAX, penicillin, and streptomycin. Cells were 
maintained at 37 °C with 5% CO2 in a water saturated incubator.  
Sample preparation for SRS and fluorescence imaging of live cells 
HeLa and MCF-7 cells were seeded on round coverslips with 800 μL complete growth media in four-
well plates 2 days before the experiment. On the day of the experiment, the culture media was replaced 
with 500 μL fresh culture media supplemented with fluorescent organelle markers (MitoTracker™ Deep 
Red FM, Invitrogen; ER-Tracker™ Green (BODIPY™ FL Glibenclamide), Invitrogen) and diyne-labelled 
compounds at specific concentrations. The cells were incubated for designated time in the incubator until 
washed with phosphate buffered saline (PBS, Gibco) three times. The coverslips with cells were placed 
onto imaging spacers (SecureSeal™ imaging spacers, Sigma-Aldrich) and attached to glass slides. The 
space between coverslips and glass slides was filled with PBS solution to preserve the live cells for a short 
period. 
Confocal Fluorescence Microscopy 
All fluorescence imaging was performed with a commercial Olympus FV1200 confocal microscope with 
standard laser excitation and bandpass filter set for ER-Tracker and Mito-Tracker. The objectives were 
either a 25× 1.05 N.A. water objective (XLPlan N, Olympus) or a 60× 1.2 N.A. water objective (UPlanAPO/IR, 
Olympus). The images were acquired with Olympus FV10 software and processed with ImageJ. 
Stimulated Raman Scattering (SRS) Microscopy 
SRS imaging was performed with the same microscope setup as the fluorescence imaging but with 
customized laser input. A commercial laser source (picoEmerald, Applied Physics & Electronics, Inc.) was 
utilized to produce both the Pump and Stokes beams for SRS. The wavelength of Stokes beam was 1064 




wavelengths within a range of 720 nm to 990 nm. Both beams had 6 ps pulse width and 80 MHz repetition 
rate. The two beams were spatially and temporally overlapped and tightly focused onto the sample, after 
which Pump loss and Stokes Gain were generated. Both transmitted beams were collected by a 1.4 N.A. 
oil condenser. The Stokes beam was filtered off with a high O.D. bandpass filter (890/220 CARS, Chroma 
Technology), while the Pump beam was detected by a silicon photodiode (FDS1010, Thorlabs) with a DC 
voltage of 64 V. The output current was terminated by a 50 Ω terminator and demodulated by a lock-in 
amplifier (SR844, Stanford Research Systems) at 8 MHz frequency. The Pump loss signal at each pixel 
was sent to the FV10 analog channel to generate the images. To obtain sufficient resolution and sensitivity, 
all live cell images were acquired with 100 us time constant and 512 × 512 pixel number. The CH3 channel 
at 2940 cm-1 was obtained with 40 mW Pump power and 100 mW Stokes power on sample. The CH2 
channel at 2845 cm-1, diyne channel at 2251 cm-1 and off-resonance channel at 2000 cm-1 were all obtained 
with 100 mW Pump power and 100 mW Stokes power on sample. 
Image Analysis 
All images were generated by Olympus FV 10 software. Images were taken under strictly the same 
conditions (pump and Stokes power, digital gain and offset) when comparison is performed.  
The Raman beams and the fluorescent beams are not in-line in the microscope set-up. As a result, the 
two modalities have a slight offset in the images that they acquire. Before any image analysis or background 
reduction was performed, this misalignment had to be corrected. MATLAB code was used to align the 
images to achieve the highest possible colocalization coefficient between the Raman and fluorescent 
channels. The non-overlapping regions of the different image channels were then cropped off immediately. 
Subsequent analysis of overlaid images showed that the many channels were very well-aligned. 
All image analysis was performed in FIJI. Because the images had varying levels of background, some 
background reduction had to be performed to facilitate the analysis. Every image channel (except for -CH3) 
of every image set was subjected to an identical rolling ball background reduction with a radius of 200 pixels. 
This relatively large radius ensured against dimming or outright removing features with a homogenous 
intensity.  




HeLa or MCF7 were grown in clear, flat bottom 96 well plates (Olympus plastics). MTT cell growth 
assay reagents (EMD Millipore) were used as purchased. In brief, to cells in 100 µL DMEM media, 10 µL 
of MTT solution was added. The assay was allowed to develop at 37 °C for 4 h. After MTT formazan 
formation 100 µL 0.04 M HCl in isopropanol was added to each well and mixed until all solid MTT formazan 
was dissolved. The 96-well plates were read for absorbance at 570 nm using a Tecan M1000 plate reader.  
For cytotoxicity studies, compounds, dissolved in DMSO, were added to wells (final DMSO 
concentration of 0.5-1%, referenced to control wells containing DMSO alone) at 20% cell confluency. Cells 
were incubated with compounds for 48 h at 37 °C prior to MTT addition. 
Growth response (GR) values were obtained by getting a baseline cell count using the MTT assay 
performed concurrently with cytotoxic compound addition in a separate plate as described by Hafner et al.1 
GR50 values and plots were obtained using the GR metrics software package accessed through github 
(https://github.com/sorgerlab/gr50_tools).1 All data were collected in at least triplicate and GR50 values 
were averaged between at least three biological replicates with error given in standard error of the mean 
(SEM). 
3.5 Supplementary Information 
3.5.1 General synthetic methods 
All reagents were purchased from commercial suppliers and used without further purification. Reaction 
progress was monitored by thin-layer chromatography on silica gel 60 plates (aluminum back, EMD 
Millipore) and visualized by UV light or by LC/MS (Agilent 6120 single quadrupole). Samples were analyzed 
by reverse phase HPLC on a C18 column (Eclipse Plus 3.5 µM 100 x 4.6 mm) with the following elution 
protocol: A 40-80% MeCN in H2O (0.1% FA) linear gradient over 3 min, followed by a 80-100% MeCN in 
H2O (0.1% FA) over 22 min with a flow rate of 0.5 mL/min. Compounds were purified by flash column 
chromatography using Fisher Scientific 230-400 mesh, 60 Å, silica gel. HPLC purifications were performed 
on an Agilent 1260 HPLC with a semipreparative scale were performed using an Altima C18 column 5 µM 
(150 x 10 mm). NMR spectra were acquired with a Bruker Biospin spectrometer with a cryoprobe. All 
spectra were acquired at 298 K. 1H spectra were acquired at 900 MHz, 13C spectra were acquired at 226 




non-deuterated NMR solvent. High resolution mass spectra were collected using an Agilent Technologies 
6520 Accurate-Mass Q-TOF LC-MS instrument. UV data was obtained on an Agilent 1260 series DAD.  
3.5.2 Phenyl-diyne acid synthesis 
The phenyl-diyne acid tag was synthesized according to the method described by Balaraman et. al.2 
First, Cu(Ac)2 monohydrate was added to 50 mL of methylene chloride in a round bottom flask until 
saturation was achieved. Then, 5 equivalents of piperidine was added, followed by 5 equivalents of 
phenylacetylene and 1 equivalent of 4-pentynoic acid. The mixture was left exposed to air for the duration 
of the reaction. After the reaction mixture had stirred at room temperature for 8 hours, the excess Cu(Ac)2 
was removed by centrifugation. The clarified reaction mixture was then concentrated to 10 mL in vacuo. 
The Cu(Ac)2 that had precipitated was once again removed by centrifugation. The concentrated, clarified 
reaction mixture was then fractionated via silica gel chromatography. The fractions containing the acid 
product were identified via TLC analysis and combined. After evaporating the combined fractions in vacuo, 
the purity of the product was confirmed via LC-MS and UV-vis analysis. 
 
3.5.3 Deacylated antimycin production 
Deacylated antimycin was produced using an engineered Streptomyces albus J1074 strain with the 
antB gene deleted in-frame through double crossover. A seed culture was grown in two separate aliquots 
of 5 mL tryptic soy broth at 30˚C for 48 hours. Next, 1 mL of the seed culture was added to 10 separate 1 
L aliquots of mannitol soy broth in 4 L plastic flasks. After incubating for 6 days at 30˚C and 200 RPM, the 
solids were removed from the fermentation media via centrifugation. The clarified media was then extracted 
with 50 g/L of XAD-16 resin. The resin was then washed with 10 L of distilled water and subsequently 
extracted with 3 L of methanol. The methanol extract was then dried in vacuo and purified by silica gel 
column chromatography using a gradient of 0% to 100% ethyl acetate in methylene chloride in 25% 
increments. The fractions containing deacylated antimycin were combined, evaporated, dissolved in 
methanol and further purified by HPLC on a semi-preparative C18 column (10 mm i.d., 250 mm length, 
Vydac) with a linear gradient of 25 to 95% acetonitrile (vol/vol) over 20 min, and 95% acetonitrile (vol/vol) 




collected manually and concentrated under vacuum. Fractions containing S. albus ∆antB antimycins were 
pooled and further separated by HPLC using an Agilent Eclipse Plus C18 column (4.6 x 100 mm) with a 
linear gradient of 25 to 95% acetonitrile (vol/vol) over 20 min, and held at 95% acetonitrile (vol/vol) for 10 
min in H2O with 0.1% (vol/vol) formic acid (FA) at a flow rate of 1 mL/min. Total yield was roughly 5 mg/L. 
3.5.4 Neoantimycin production 
Neoantimycin was produced using a wild-type strain of Streptomyces orinoci. S. orinoci was grown 
three separate 5 mL cultures of TSB for 72 hours. After that 50 µL of seed culture was added to 40 separate 
150 mL plastic shake flasks each containing 50 mL of mannitol soy broth. After 6 days of fermentation, the 
broth was clarified by centrifugation. The 2 L of broth was extracted two times consecutively with 2 L of 
ethyl acetate. The ethyl acetate extract was dried with sodium sulfate and evaporated in vacuo. After 
redissolving the residue in 20 mL of ethyl acetate, it was fractionated by silica gel chromatography using a 
gradient of 0% to 100% ethyl acetate in methylene chloride in 25% increments. The fractions with 
neoantimycin were identified via LC-MS and combined. The fractions containing neoantimycin were 
combined, evaporated, dissolved in methanol and further purified by HPLC on a semi-preparative C18 
column (10 mm i.d., 250 mm length, Vydac) with a linear gradient of 25 to 95% acetonitrile (vol/vol) over 20 
min, and 95% acetonitrile (vol/vol) for a further 10 min in H2O with 0.1% (vol/vol) formic acid (FA) at a flow 
rate of 2 mL/min. Fractions containing S. orinoci neoantimycins were pooled and further separated by HPLC 
using an Agilent Eclipse Plus C18 column (4.6 x 100 mm) with a linear gradient of 25 to 95% acetonitrile 
(vol/vol) over 20 min, and held at 95% acetonitrile (vol/vol) for 10 min in H2O with 0.1% (vol/vol) formic acid 
(FA) at a flow rate of 1 mL/min. Total yield was roughly 10 mg/L. 
3.5.5 Esterification 
Deacylated antimycin (4.00 mg and 0.00886 mmol) and neoantimycin (6.20 mg and 0.00886 mmol) 
were converted to PhDY-Ant and PhDY-NeoA respectively via Steglich esterification with phenyl-diyne acid. 
Phenyl-diyne acid (1.93 mg and 0.00975 mmol), DCC (2.01 mg and 0.00975 mmol), and DMAP (1.19 mg 
and 0.00975 mmol) were added to methylene chloride (5 mL) stirred in a round bottom flask and chilled in 
an ice bath. The round bottom was then evacuated and flushed with and kept under inert atmosphere. After 
stirring for one hour, the alcohol (either deacylated antimycin or neoantimycin) was added to the flask. The 




extracted three times with water. The fractions were combined and back-extracted with methylene chloride. 
The two methylene chloride fractions were then combined and evaporated in vacuo. After dissolving the 
product in methanol, it was purified via HPLC using an Agilent Eclipse Plus C18 column (4.6 x 100 mm) 
with a linear gradient of 55 to 95% acetonitrile (vol/vol) over 20 min, and 95% acetonitrile (vol/vol) for a 
further 10 min in H2O with 0.1% (vol/vol) formic acid (FA) at a flow rate of 2 mL/min. Total yield was roughly 
70% for PhDY-Ant and 35% for PhDY-NeoA. 
PhDY-Ant (5) 
1H NMR (900 MHz, DMSO-d6) ∂ 12.50 (s, 1H), 9.59 (s, 1H), 9.26 (d, J = 8.3 Hz, 1H), 7.96 (d, J = 7.9 
Hz, 1H), 7.88 (d, J = 6.6 Hz, 1H), 7.53 (d, J = 7.2 Hz, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.40 (t, J = 7.7 Hz, 2H), 
6.93 (t, J = 7.9 Hz, 1H), 5.68 (d, J = 8.4 Hz, 1H), 5.52 (p, J = 6.8 Hz, 1H), 5.25 (app t, J = 7.9 Hz, 1H), 4.67 
(dq, J = 9.5, 6.3 Hz, 1H), 3.31-3.30 (overlap m, J = 8.6 Hz, 1H), 2.72 (d, J = 3.8 Hz, 4H), 2.17 (dt, J = 10.5, 
3.0 Hz, 1H), 2.03 – 1.95 (m, 1H), 1.83 (tdd, J = 11.2, 6.2, 2.9 Hz, 1H), 1.51-1.48 (m, 1H), 1.32 (d, J = 6.3 
Hz, 3H), 1.27 (d, J = 6.8 Hz, 3H), 1.09 – 1.02 (m, 2H), 0.85 (d, J = 6.6 Hz, 3H), 0.84 (d, J = 6.7 Hz, 3H). 13C 
NMR (226 MHz, DMSO-d6) ∂ 174.9, 170.0, 169.8, 168.8, 151.1, 132.4, 129.6, 128.8, 127.2, 127.0, 124.3, 
120.7, 118.4, 115.4, 84.9, 76.2, 76.0, 75.0, 74.2, 70.8, 64.9, 53.8, 52.1, 36.1, 34.1, 27.5, 26.5, 22.6, 22.1, 
18.4, 15.20, 15.06, 13.97. MS (ESI) calcd for C35H39N2O9 [M+H]+ m/z 631.2650 found 631.2649. 
PhDY-NeoA (6) 
1H NMR (900 MHz, DMSO-d6) ∂ 12.62 (s, 1H), 9.64 (s, 1H), 9.31 (br s, 1H), 8.13 (s, 1H), 7.98 (d, J = 
7.9 Hz, 1H), 7.74 (d, J = 7.7 Hz, 1H), 7.52 (d, J = 7.7 Hz, 2H), 7.44 (t, J = 7.3 Hz, 1H), 7.39 (t, J = 7.6 Hz, 
2H), 7.32 – 7.27 (m, 4H), 7.22 (t, J = 6.9 Hz, 1H), 6.92 (br s, 1H), 5.39 – 5.34 (m, 2H), 5.18 (d, J = 6.1 Hz, 
1H), 5.13 (d, J = 3.4 Hz, 1H), 5.08 (dt, J = 10.0, 3.6 Hz, 1H), 4.95 (dd, J = 8.4, 5.8 Hz, 1H), 3.82 (app t, J = 
5.4 Hz, 1H), 2.91 (dd, J = 14.6, 9.7 Hz, 1H), 2.81 (dd, J = 14.5, 3.6 Hz, 1H), 2.73-2.71 (m, 4H), 2.26-2.22 
(m, 1H), 1.69-1.66 (m, 1H), 1.36-1.32 (m, 1H), 1.32 (d, J = 6.3 Hz, 3H), 1.28 (s, 3H), 1.11 – 1.07 (m, 1H), 
1.06 (s, 3H), 1.00 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.9 Hz, 3H), 0.77 (d, J = 6.9 Hz, 3H), 0.75 (t, J = 7.4 Hz, 
2H). 13C NMR (226 MHz, DMSO) ∂ 186.5, 184.2, 179.4, 179.3, 173.0, 169.7, 168.4, 163.5, 159.0, 137.5, 
135.2, 132.8, 132.6, 130.0, 129.6, 129.3, 128.82, 128.78, 127.0, 121.1, 118.5, 115.6, 95.2, 85.3, 80.0, 79.1, 
77.1, 75.4, 74.7, 74.6, 69.5, 62.6, 56.1, 44.6, 38.6, 34.9, 34.5, 30.0, 24.1, 22.5, 19.1, 18.4, 17.3, 16.6, 15.6, 




Deformylated NeoA (7) 
Neoantimycin (2), 0.050 g, was dissolved in 0.25 mL EtOH followed by 0.25 mL 0.03 M HCl and the 
reaction was stirred at 55 °C for 3 h. The reaction was quenched with 0.80 mL 100 mM ammonium 
bicarbonate (pH 7) and the EtOH was evaporated in vacuo. The solution was then purified by HPLC (semi-
preparative, reversed phase using the following elution protocol: 30% MeCN for 2 min, followed by a linear 
gradient of 30-90% MeCN in H2O over 24 min, with a flow rate of 1 mL/min) to yield a white solid (0.011 g, 
24%). 1H NMR (900 MHz, MeOD) ∂ 7.3 (app d, J = 4.4, 4H), 7.2 (m, 2H), 6.93 (dd, J = 7.7, 1.5, 1H), 6.72 
(t , J = 7.9, 1H), 5.64 (m, 1H), 5.42 (d , J = 3.7, 1H), 5.19 (d , J = 4.2, 1H), 5.1 (d , J = 3.3, 1H), 5 (dt , J = 
8.4, 3.9, 1H), 4.04 (d , J = 5.1, 1H), 3.05 (dd , J = 14.7, 9.3, 1H), 2.93 (dd , J = 14.6, 4.1, 1H), 2.34 (m, 1H), 
1.8 (m, 1H), 1.5 (m, 1H), 1.4 (d , J = 6.4, 3H), 1.35 (s, 3H), 1.23 (m, 1H), 1.18 (s, 3H), 1.11 (d , J = 6.9, 3H), 
0.98 (d , J = 6.8, 3H), 0.92 (d , J = 6.83, 3H), 0.88 (t , J = 7.5, 3H). 13C NMR (226 MHz, MeOD) ∂ 181.4, 
174.0, 172.8, 170.6, 169.7, 138.2, 138.1, 130.7, 130.31, 130.30, 129.6, 127.8, 125.2, 124.8, 120.1, 119.7, 
81.8, 80.4, 78.6, 76.5, 71.7, 56.8, 46.1, 40.1, 36.3, 31.4, 30.8, 25.2, 23.0, 19.5, 18.9, 17.3, 17.0, 15.6, 12.0. 
MS (ESI) calcd for C35H47N2O11 [M+H]+ m/z 671.3174, found 671.3236. 
Deformylated PhDY-NeoA (8) 
PhDY-NeoA (7), 0.0085 g, was dissolved in 0.30 mL EtOH followed by 0.30 mL 0.03 M HCl and the 
reaction was stirred at 55 °C for 8 h. The reaction was quenched with 0.80 mL 100 mM ammonium 
bicarbonate (pH 7) and the EtOH was evaporated in vacuo. The solution was then purified by HPLC (semi-
preparative, reversed phase, using the following elution protocol: 40% MeCN for 2 min, followed by a linear 
gradient of 40-90% MeCN in H2O over 24 min, with a flow rate of 1 mL/min) to yield a light brown solid 
(0.0029 g, 35%). See NMR table below for spectral information. MS (ESI) calcd for C48H55N2O12 [M+H]+ m/z 
851.3750, found 851.3754.  
Deformylated PhDY-NeoA (8) NMR table includes 2D NMR data to ensure PhDY tag had not migrated 













3.5.6 Supplementary Figures 
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Supplementary Fig. 3.1 NMR, MS, and UV-vis characterization of PhDY-Ant (5). A) 1H NMR spectrum (DMSO-d6, 900 












Supplementary Fig. 3.1 C) Mass spectrum of 5. Calcd for C49H55N2O13 [M+H]+ m/z 631.3650, found 631.3649. 
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Supplementary Fig. 3.2. PhDY-Ant (5) and antimycin (1) dose response curves. Antimycin (100 µM to 0.010 µM, red 
and gold), and PhDY-Ant (5) (67 µM to 0.010 µM, teal and blue lines) dose response curves in HeLa (red and teal lines) 
and MCF-7 (gold and blue lines) cells show the PhDY Raman tag minimally perturbs activity. Concentration of 
compounds is in µM (log scale). Data were collected in triplet and growth response curves were generated as described 









Supplementary Fig. 3.3. Intracellular PhDY-Ant (5) and phenyl-diyne tag imaging at various concentrations in HeLa 
cells. Cells were imaged 2 h post PhDY-Ant addition at 10 µM (a) and 50 µM (b). Phenyl-diyne tag (50 µM) was imaged 
as a negative control (c). SRS images were acquired by tuning the frequency difference between the pump and Stokes 







Supplementary Fig. 3.4. Time course of PhDY-Ant (5) uptake in HeLa cells. a) Calibration curve showing relationship 
of PhDY-Ant concentration with signal intensity. b) Average signal intensity over time. c) SRS images used to analyze 





Supplementary Fig. 3.5. Temperature dependent uptake of PhDY-Ant (5). SRS images showing uptake of 50 µM 5 
during 2h incubation at 4˚C and 37 ˚C. 5 was still absorbed into HeLa cells at 4˚C, indicating that the uptake mechanism 
is energy-independent. 
 
Supplementary Fig. 3.6. Time-dependent colocalization of PhDY-Ant (5) in HeLa cells. Pearson’s correlation 





Supplementary Fig. 3.7. Line plot analysis of PhDY-Ant (5) in HeLa cells. Each line plot shows poor correlation 
between Mitotracker and the diyne channel. Each line plot shows good correlation between the lipid channel and the 
diyne channel. The ER-tracker and diyne channels are very well-correlated, including some features that are excluded 





Supplementary Fig. 3.8. SRS and fluorescence imaging of PhDY-Ant (5) in MCF-7 cells. a) CH3 channel at 2940 cm-
1 representing proteins. b) Diyne label at 2251 cm-1. c) Off-resonance channel at 2000 cm-1. d) CH2 channel at 2845 
cm-1, representing lipids. e) Confocal fluorescence imaging of ER-Tracker excited at 488 nm. f) Confocal fluorescence 
imaging of Mito-Tracker excited at 635 nm. g) Overlay image of d) lipids and b) diyne label. h) Overlay image of e) ER-






Supplementary Fig. 3.9. Line plot analysis of PhDY-Ant (5) in MCF-7 cells. Each line plot shows poor correlation 
between Mitotracker and the diyne channel. The features of the diyne channel can be explained by a combination of 







Supplementary Fig. 3.10. NMR, MS, and UV-vis characterization of PhDY-NeoA (6). A) 1H NMR spectrum (DMSO-d6, 














Supplementary Fig. 3.10. C) Mass spectrum of 6. Calcd for C49H55N2O13 [M+H]+ m/z 879.3699, found 879.3706. 
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Supplementary Fig. 3.11. NMR, MS, and UV-vis characterization of deformylated neoantimycin (7). A) 1H NMR 







Supplementary Fig. 3.11. C) Mass spectrum of compound 7. 
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Supplementary Fig. 3.12. NMR, MS and UV-vis characterization of deformylated PhDY-NeoA (8). A) 1H NMR (DMSO-







































Supplementary Fig. 3.13. Dose response curve for various neoantimycins in MCF-7 cells. Concentration of 
compounds is in µM (log scale). Data were collected in triplet to sextuplet and growth response curves were generated 
as described in methods. The curves shown are representative of three individual biological replicates. A) Neoantimycin 
(2) and PhDY-NeoA (6) (200 µM to 0.10 µM), dose response curves in MCF-7 cells show the Raman-active tag at C-
11 is minimally perturbing. The plateau at higher concentrations of PhDY-NeoA is most likely due to solubility limits of 
the compound. B) Neoantimycin (2) (1.0 mM to 0.10 µM), and deformylated neoantimycin (7) (400 µM to 25 µM) dose 





Supplementary Fig. 3.14. Imaging of differential uptake of PhDY-NeoA (6) and deformylated PhDY-NeoA (8) in HeLa 
and MCF-7 cells. Raman imaging was performed using the diyne channel at 2251 cm-1. Four different sets of Raman 







Supplementary Fig. 3.15. Line plot analysis of PhDY-NeoA (6) in MCF-7 cells. Each line plot shows poor correlation 
between Mitotracker and the diyne channel. Each line plot shows good correlation between the lipid channel and the 





[1] Newman, D. J. & Cragg, G. M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. 
Prod. 79, 629-661 (2016). 
[2] Prescher, J. A. & Bertozzi, C. R. Chemistry in living systems. Nature Chemical Biology 1, 13 (2005). 
[3] DeGuire, S. M. et al. Fluorescent Probes of the Apoptolidins and their Utility in Cellular Localization 
Studies. Angew. Chem. Int. Ed. 54, 961-964 (2015). 
[4] Yan, Y. et al. Multiplexing of combinatorial chemistry in antimycin biosynthesis: expansion of molecular 
diversity and utility. Angew. Chem. 52, 12308-12312 (2013). 
[5] Conway, J. R. W., Carragher, N. O. & Timpson, P. Developments in preclinical cancer imaging: 
innovating the discovery of therapeutics. Nature Reviews Cancer 14, 314 (2014). 
[6] Wei, L. et al. Live-cell imaging of alkyne-tagged small biomolecules by stimulated Raman scattering. 
Nat Methods 11, 410-412 (2014). 
[7] Wei, L. et al. Live-Cell Bioorthogonal Chemical Imaging: Stimulated Raman Scattering Microscopy of 
Vibrational Probes. Acc Chem Res 49, 1494-1502 (2016). 
[8] Tipping, W. J., Lee, M., Serrels, A., Brunton, V. G. & Hulme, A. N. Stimulated Raman scattering 
microscopy: an emerging tool for drug discovery. Chemical Society Reviews 45, 2075-2089 (2016). 
[9] Freudiger, C. W. et al. Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman 
Scattering Microscopy. Science 322, 1857-1861 (2008). 
[10] Yamakoshi, H. et al. Alkyne-Tag Raman Imaging for Visualization of Mobile Small Molecules in Live 
Cells. J Am Chem Soc 134, 20681-20689 (2012). 
[11] Tipping, W. J., Lee, M., Serrels, A., Brunton, V. G. & Hulme, A. N. Imaging drug uptake by 
bioorthogonal stimulated Raman scattering microscopy. Chemical Science 8, 5606-5615 (2017). 
[12] Gaschler, M. M. et al. Determination of the Subcellular Localization and Mechanism of Action of 
Ferrostatins in Suppressing Ferroptosis. ACS Chem Biol 13, 1013-1020 (2018). 
[13] Yamakoshi, H. et al. Imaging of EdU, an Alkyne-Tagged Cell Proliferation Probe, by Raman 
Microscopy. J Am Chem Soc 133, 6102-6105 (2011). 
[14] El-Mashtoly, S. F. et al. Label-free imaging of drug distribution and metabolism in colon cancer cells 
by Raman microscopy. Analyst 139, 1155-1161 (2014). 
[15] Liu, J., Zhu, X., Kim, S. J. & Zhang, W. Antimycin-type depsipeptides: discovery, biosynthesis, chemical 
synthesis, and bioactivities. Natural product reports 33, 1146-1165 (2016). 
[16] Huang, L. S., Cobessi, D., Tung, E. Y. & Berry, E. A. Binding of the respiratory chain inhibitor antimycin 
to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-
bonding pattern. J. Mol. Biol. 351, 573-597 (2005). 
[17] Tzung, S. P. et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature cell 
biology 3, 183-191 (2001). 
[18] Salim, A. A. et al. Rare Streptomyces N-formyl amino-salicylamides inhibit oncogenic K-Ras. Org. Lett. 
16, 5036-5039 (2014). 
[19] Barrow, C. J. et al. Antimycins, inhibitors of ATP-citrate lyase, from a Streptomyces sp. J Antibiot 
(Tokyo) 50, 729-733 (1997). 
[20] Zhou, Y. et al. Directed Accumulation of Anticancer Depsipeptides by Characterization of 
Neoantimycins Biosynthetic Pathway and an NADPH-Dependent Reductase. ACS Chemical Biology 
13, 2153-2160 (2018). 
[21] Izumikawa, M., Ueda, J. Y., Chijiwa, S., Takagi, M. & Shin-ya, K. Novel GRP78 molecular chaperone 
expression down-regulators JBIR-04 and -05 isolated from Streptomyces violaceoniger. The Journal 
of antibiotics 60, 640-644 (2007). 
[22] Umeda, Y. et al. Prunustatin A, a novel GRP78 molecular chaperone down-regulator isolated from 
Streptomyces violaceoniger. The Journal of antibiotics 58, 206-209 (2005). 
[23] Lee, A. S. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat 
Rev Cancer 14, 263-276 (2014). 
[24] Zhu, T. et al. Hit Identification and Optimization in Virtual Screening: Practical Recommendations 
Based on a Critical Literature Analysis. J. Med. Chem. 56, 6560-6572 (2013). 
[25] Lee, H. J. et al. Assessing Cholesterol Storage in Live Cells and C. elegans by Stimulated Raman 




[26] Sandy, M., Zhu, X., Rui, Z. & Zhang, W. Characterization of AntB, a promiscuous acyltransferase 
involved in antimycin biosynthesis. Org. Lett. 15, 3396-3399 (2013). 
[27] Schinzel, A., Kaufmann, T. & Borner, C. Bcl-2 family members: intracellular targeting, membrane-
insertion, and changes in subcellular localization. Biochimica et Biophysica Acta (BBA) - Molecular Cell 
Research 1644, 95-105 (2004). 
[28] Pettit, G. R. et al. Antineoplastic agents. 560. Isolation and structure of kitastatin 1 from an Alaskan 
Kitasatospora sp. J. Nat. Prod. 70, 1069-1072 (2007). 
[29] Pettit, G. R. et al. Antineoplastic agents. 561. Total synthesis of respirantin. J. Nat. Prod. 70, 1073-
1083 (2007). 
[30] Vanner, S. A. et al. Chemical and biosynthetic evolution of the antimycin-type depsipeptides. Molecular 





Chapter 4: 9-Cyanopyronin Probe Palette for Super-
Multiplexed Vibrational Imaging 
The contents of this chapter are currently in publication process as accepted by Nature Communications. 
4.1 Introduction 
Fluorescence microscopy has served biomedical imaging community for decades. [1-3]  However, one 
of the bottlenecks with fluorescence-based techniques is the limited ability for multiplexing. The fast 
electronic dephasing of fluorophores at ambient temperature dramatically broadens their excitation and 
emission spectra to 50~100 nm, resulting in accommodation of no more than 6 fluorophores 
simultaneously.[4-6] This so-called “color barrier” becomes increasingly problematic, as we enter the 
blooming era of system biology in which gathering multi-parameter information is critical in broad 
applications such as profiling brain circuits, building tissue atlases, and phenotyping tumor heterogeneity.[7-
10] Although sequential labeling and imaging, such as cyclic immunofluorescence and DNA exchange-
based multiplexing (Exchange-PAINT), was developed to expand the multiplexing capacity,[11-14]  these 
methods cannot work with live samples and they are clearly time- and labor-consuming. Moreover, these 
repeated cycles likely lead to accumulative structural changes that alter epitope antigenicity [15] and cause 
physical distortion or even histology damage that prevents accurate image co-registration across repeated 
staining cycles.  
Vibrational microscopy provides a direct physical solution to break the “color barrier” with great promise, 
because vibrational signatures of molecules are inherently much narrower than fluorescence spectrum.[16-
19] For example, Cy5 dye shows a ~500 cm-1 FWHM in the emission spectrum, but the Raman signature of 
its double bond stretching mode exhibits FWHM of merely 10 cm-1.[18] Therefore, employing Raman signal 
as imaging contrast could potentially offer many more colors than fluorescence. Yet, the sensitivity of 
Raman microscopy (typically in the mM range) is far from ideal for imaging specific proteins inside cells. In 
2017, we developed a nonlinear Raman imaging technique named electronic pre-resonance Stimulated 
Raman Scattering Microscopy (epr-SRS) (Fig. 4.1).[18] When the pump laser energy approaches 




from the fluorophore backbone can be enhanced by >104 through the vibrational and electronic coupling.[20] 
Harnessing this electronic pre-resonance effect with SRS microscopy leads to a desirable combination of 
high detection sensitivity (down to 250 nM) and fine Raman contrast (~10 cm-1). To create the matching 
imaging probes with resolvable Raman peaks, a dye palette named Manhattan Raman scattering (MARS) 
was proposed, each containing a triple bond (such as nitriles and alkynes) in the conjugated system.[18] As 
such, epr-SRS microscopy of MARS probes has emerged as an ultrasensitive method to image specific 
biological targets inside cells with vibrational contrast. 
 
Fig. 4.1. Spectroscopy principle and probe design of electronic pre-resonance SRS microscopy. (a) 
Schematic illustration of electronic pre-resonance SRS. Two synchronized laser beams were tightly focused on 
molecules of interest. When energy difference between two photons matches vibrational transition, one pump photon 
can be converted to stokes photon and the intensity fluctuation will be detected. As pump energy approaches 
electronic transition (pre-resonance), such process will be greatly enhanced. ω0, ωpump, and ωvib represents for 
frequencies of electronic transition, pump beam photon, and vibrational transition, respectively. Γ is the 
homogeneous linewidth, typically around 700 cm-1. (b) Design and engineering principles of 9-cyanopyronin library. 
Three key structural features were rationally tuned to generate new MARS dye library. One sidechain was installed 
on the amino group to facilitate facile functionalization. 
However, as the key component of the super-multiplexed imaging technology, MARS probes palette 
is in its infancy for several reasons that are intertwined. First, regarding synthetic chemistry, we lacked 
robust and efficient methods to synthesize MARS dyes from common starting materials. In our prior report, 
most of the MARS dyes had to rely on commercial pyronin dyes which are generally short of choices, and 




4.1). Second, regarding physical chemistry and rational design, the structure-spectroscopy relationship of 
MARS dyes is elusive. Such lack of knowledge prevented us from expanding the MARS palette through 
rational design. Third, regarding chemical biology of probe development, both the number and the type of 
available functionalized probes were severely limited. Because of the reliance on commercial pyronin dyes, 
the proposed MARS dyes had to be symmetric in structure and consequentially had no functionalizable 
sidechains for targeting capability – in other words, they were just dyes but not imaging probes yet. In fact, 
there were only 4 NHS ester functionalized probes (all in the same type) in the original MARS palette. Other 
broadly used labeling techniques such as click chemistry were not explored, and the imaging application 
scope was severely restrained.  
To address the underlying synthetic chemistry challenges, herein we have developed robust methods 
for synthesizing MARS dyes of different core atoms, conjugation ring numbers, and stable isotope 
substitutions with great efficiency. Systematic spectroscopy study on the newly synthesized dyes has 
revealed four rules governing the vibrational tuning mechanisms by diverse structure features. Remarkably, 
a quantitative model can be established by integrating these four rules to predict vibrational frequencies 
directly from overall MARS dye structures. We then employed this structure-spectroscopy model to 
rationally design MARS probes that are spectrally resolvable with existing probes. Moreover, the robust 
synthetic methods allowed us to readily derivatize asymmetric dye structure and introduce a set of 30 MARS 
probes (more than 10 types) with specific labeling capability. With this greatly expanded MARS probe 
palette, we have demonstrated a variety of epr-SRS imaging applications in cells and tissues including 
many new versatile labeling modalities (such as click chemistry, peptide and organelle labels) and 
increased multiplexing capacity than previously available. Therefore our work has established integrated 
framework for the synthetic chemistry, physical chemistry and chemical biology of multicolor vibrational 
probes, paving the way for next-generation super-multiplexed imaging. 
4.2 Results 
4.2.1 General design principles for functionalized MARS probes.  
9-cyano xanthene was first reported in 1993.[21] It’s intriguing that the substitutions at C-9 position play 
important roles in the wavelengths of absorption maxima, especially in the cases of electron-withdrawing 




position bringing a +20 nm bathochromic shift. As comparison, cyano group causes an even remarkable 
shift of more than 100 nm, pushing the dye into the near-infrared region (> 650 nm). We realized these 
nitrile-bearing molecules can fulfill the requirements of both (1) long wavelength absorption for necessary 
epr-SRS excitation and (2) triple bonds for bio-orthogonal Raman imaging in the desirable cell-silent region. 
Therefore, 9-cyano xanthene was selected as the parent structure to generate MARS dye library for epr-
SRS microscopy.  
To develop systematic synthetic methodology, we sought to modify 9-cyano xanthene dyes by 
changing four key structural features:[24] (Fig. 4.1b) (1) The mass of the cyano group by means of isotope 
doping on CN bond. As described in the classic oscillator model, the vibrational frequency is proportional 
to the inversed square root of the reduced mass of two bonding atoms. Hence changing the mass of the 
CN bond can greatly shift its vibrational frequency. (2) The atom at the C-10 position. Our previous study 
showed replacing O with C or Si atoms can not only shift the absorption maxima but also affect the 
vibrational frequency of nitrile.[18] (3) The number of expanded rings on xanthene. The substituents on 
positions other than C-9 may also have influences on the vibrational frequency by remotely modulating the 
electron density on the CN bond. (4) A sidechain needs to be installed on the dye structure to facilitate 
subsequent functionalization and convert the dyes into probes with specific targeting abilities. For example, 
N-hydroxysuccinimide (NHS) is one of the useful functionalizations.  
4.2.2 Newly developed Synthetic methods for building MARS dyes.  
We first synthesized a series of pyronin intermediates which are essential precursors for nitrile group 
addition. In general, O-cored pyronin rings were built up by condensation reactions between various 
alkylated 3-aminophenol and corresponding aldehydes with the catalysis of protic acids. Products with 
intense magenta color could be easily obtained with good yields (Fig. 4.2a and Supplementary Table 1). 
The C- or Si- cored pyronins were formed firstly through Friedel-Crafts reactions catalyzed by Lewis acid 
to connect two scaffolds, and the corresponding intermediates were treated with either protic acid or butyl 
lithium to finish the ring closures. Next, all the afforded pyronin intermediates were treated with excessive 
potassium cyanide in a mixed solvent of water and acetonitrile. The electron-deficient C-9 position is readily 
attacked by cyanide anions, and the reaction completes rapidly within a few minutes. The resulting 




desirable 9-cyanopyronins with high yields up to 89% over 2 steps (Fig. 4.2b and Supplementary Table 
1). This entire one-pot cyano-addition-oxidation process can be finished rapidly within one hour. 
Furthermore, to facilitate downstream functionalization for targeted labeling, a sidechain with a carboxylic 
acid terminal was pre-installed on the amino group. As shown in Supplementary Table 1, the addition of 
the sidechain didn’t affect the yields of condensation and cyano addition. The resulting acids were treated 
with four isotopic potassium cyanides and FeCl3 to afford twelve 9-cyanopyronin carboxyl derivatives and 
converted to corresponding NHS esters 6a-d, 7a-d, and 8a-d shown in Fig. 4.2b), which can later be directly 
used for bioconjugation.  
 
Fig. 4.2. Synthesis and spectroscopic study of model MARS probes. (a) Synthetic methods to build asymmetric 9-
cyanonpyronins. Reaction conditions: i. H3PO4, 90 °C, overnight. ii. 1) BCl3, DCM, overnight; 2) H3PO4/PPA, 90 °C, 4h; 
3) FeCl3/HCl(aq), DCM, 2h. iii. 1) BCl3, DCM, overnight; 2) n-BuLi, THF, -78 °C, overnight. (b) Structures of the model 
compounds used for spectroscopic study. The first set was used to verify the effect of ring expansion and the second 
set was used for isotope and core atom effect. (c) Fitted and normalized epr-SRS spectra of compound 1-5 at triple 
bond region. Curves were Voight fitted to obtain accurate peak positions. (d) Normalized epr-SRS spectra of compound 
6a-d, 7a-d, and 8a-d at triple bond region. (e) Additivity and commutativity of three individual effects induced by isotope 
doping, core atom substitution, and ring expansions. The three axis represents three dimensions of structural 




Comparing the absorption spectra of 1-5 with those of corresponding pyronin precursors, the addition 
of cyano groups at pyronin C-9 positions caused 120 nm red shifts on absorption maximum, resulting in a 
color change from magenta to dark blue (Supplementary Fig. 4.2). Similar effects were observed on C 
and Si based compounds. The huge change in the dye absorption is a strong manifestation that the nitrile 
bond is indeed participating in the conjugation system of the dye, which is also required in resonance 
Raman spectroscopy for a favorable coupling between electronic transition and vibrational transition. In this 
sense, the absorption spectrum serves a good starting point to verify the electronic resonance condition for 
the vibrational mode.  
Herein we have established robust synthetic methods to build MARS dyes of different core atoms, 
conjugation ring numbers, and stable isotope substitutions. The new methods greatly improved the 
synthesis efficiency compared to our prior work in 2017. The previous synthesis routes of MARS dyes highly 
rely on the commercial availability of pyronin dyes. They either needed commercial Pyronin Y to insert 
cyanides or Rhodamine 800 to knock out cyano group first and reinsert isotopic cyanides, which resulted 
in poor overall yields (less than 9% over 3 steps from Rhodamine 800). We revisited the synthesis of pyronin 
intermediates and developed simple but robust one-pot condensation to build pyronin cores. All 9-
cyanopyronin isotopologues now start with pyronins, directly affording all desired MARS dyes with high 
yields (up to 89%). 
4.2.3 A quantitative model predicting the structure-spectroscopy relationship of MARS dyes 
Thanks to the developed synthetic methodology, the resulting expanded MARS dyes allowed us to 
systematically study the mechanisms by which the vibrational frequency is tuned by various structure 
features. Four notable rules have been revealed concerning the coarse, medium and fine tuning 
mechanisms and their mutual relations, respectively.  
The isotope editing offers a classic approach to alter the vibrational spectrum, as demonstrated in our 
earlier editing of alkyne tags in the non-electronic-resonant cases.[25-27] In the current electronic pre-
resonance scenario, isotope editing still works on the nitrile bonds coupled to the core of the dye conjugation 
system. As expected, isotope doping doesn’t change the absorption or emission spectrum. However, the 
vibrational frequencies were changed dramatically through the modulation of the reduced mass. For 




2184 cm-1, and 2155 cm-1 respectively (Fig 4.2c). The frequency dropped by approximately 26~28 cm-1 
with isotopes added on the bond, which is a significant shift compared to the peak width itself (~10 cm -1). 
Similar trends were observed in series 7a-d and 8a-d (Fig 4.2c). Hence, isotope editing alters the vibrational 
frequency in a relatively coarse manner.  
Table 4.1. Photophysical properties of newly synthesized MARS model compounds. 
















2241 2241 670 75 
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2240 2240 675 86 
3 
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2239 2239 680 93 
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3 
2238 2238 690 108 
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a, b: Measured in DMSO solution. See supplementary information for spectroscopic data measured in PBS buffer. 




Replacing O with C or Si atoms can also affect the vibrational frequency of nitrile, likely due to the 
change of electron density on the nitrile bond. The C-rhodamine and Si-rhodamine were well known to have 
significant UV-vis redshifts compared with rhodamines.[28,29] This trend was well preserved in 9-
cyanopyronin compounds (Supplementary Fig. 4.3a and 4.4). The absorption maximum of O-cored MARS 
dyes 6a-d was around 690 nm, while the C-cored cyanopyronin showed a 70 nm redshift and Si-cored 
compound showed an even larger redshift of 100 nm. Replacing core atoms from O- to C- and Si- also 
results in a substantial shift in the Raman peak of CN. Molecule 6a with O atom showed CN stretching 
frequency at 2238 cm-1. After replacing the O atom with C core, the peak of molecule 7a shifted to 2228 
cm-1. Molecule 8a bearing a Si core showed an even smaller Raman shift of 2222 cm-1. Hence, the center 
atom alters the vibrational frequency in a relatively moderate manner.  
Different numbers of rings on the pyronin can lead to a subtle vibrational shift of CN stretching. With 
the increasing number of rings, the absorption maxima of compound 1-5 showed gradual redshifts in 5~10 
nm increments (Supplementary Fig. 4.3b). For vibrational spectroscopy, each ring brought an 
approximately 1 cm-1 decrease in the Raman shifts of CN stretching mode, as shown in Fig 4.2e. Hence 
this is a fine-tuning mechanism relating structure to vibrational spectroscopy.  
Close examination of the interplay among the above coarse, moderate and fine tuning mechanisms 
indicated that these effects could be nearly additive and commutative. For instance, the MARS molecule 
bearing 13C and 15N with ring expansions also showed the same difference compared to those without 
isotope doping, as shown between MARS2159 and MARS2242, and between MARS2155 and MARS2238 
in Fig. 4.2e (Molecules are named according to the Raman shifts measured in DMSO). In addition, the 
frequency changes brought by center atoms were also observed on isotopologues listed in Fig 4.2e.  
Furthermore, ring expansion and center atom substitution are also two orthogonal tuning rules from each 
other, as suggested by comparing MARS2233 with MARS2242, and MARS2228 with MARS2238.  
Finally we are in a position to integrate the above four rules into a quantitative model to predict 
vibrational frequencies directly from overall MARS dye structures. As shown in Fig. 4.3a, a simple linear 
flow chart with three accumulative layers can be established to estimate the Raman shifts of MARS dyes. 
In the first layer, the isotope substitution will bring the largest effects on Raman shifts, resulting in 4 nearly 




O to C then Si, sequentially afforded around 8 cm-1 changes in peak positions. The last step was determined 
by the number of 6-membered rings on the chromophore. As each ring gives about 1 cm-1 shift, the Raman 
shifts need to subtract the number of rings prior to resulting in final Raman shifts. To test this model, we 
combined newly synthesized MARS dyes with compounds demonstrated in previous report, and plotted all 
the predicted Raman shifts against the experimentally measured Raman shifts in Fig 4.3b (exact 
wavenumbers were listed in Table 1). The plotted curve showed great linearity and root-mean-square (RMS) 
of merely 1.3 cm-1, indicating the high precision of our model in predicting the vibrational frequencies of 
nitrile modes in MARS dyes.  
4.2.4 Rational design of new MARS dyes using the new prediction model  
The new quantitative model established above permits us to precisely predict probes Raman features 
directly from structures. Conversely, this model would also assist us to design and evaluate new structures 
when targeting specific frequency range. In our previous study, we have successfully used the four C-cored 
MARS NHS esters 7a-d to demonstrated multiplexed optical imaging with a high signal-to-noise ratio. 
Seeking for higher multiplexing, we aimed to leverage the new quantitative model to design and synthesize 
new MARS NHS esters that are compatible with the existing four probes. 
The four C-cored MARS NHS esters are spaced with nearly uniform intervals of 28 cm-1 in the spectral 
domain, which is the result of coarse tuning from isotope editing. If we generate a new set of MARS probes 
that differ only in isotope editing in the nitrile bond, we should have their peaks spaced in the same intervals 
of 28 cm-1. Considering a typical FWHM of the nitrile peaks for our MARS probes is only 12 cm-1, it is 
possible for the Raman peaks of the previous set and the new set to be interleaved, thereby separating 
from each other. The key to this design is how to fill in the spectral interval between 7a and 7b by a new 
dye, as the rest of isotopes will follow the same trend to achieve the interleaving. As shown in Fig 4.3c, to 
fill this interval between 7a (at 2228 cm-1) and 7b (at 2200 cm-1) with minimized spectral crosstalk, the ideal 
range for this new nitrile peak should be 2212-2216 cm-1.  
According to the quantitative model, we have two potential ways to approach this desired range, as 
illustrated in Fig 4.3c. One can either redshift the peak of 7a by substituting the core atom from C into Si or 
blueshift the peak of 7b from the other side by substituting the core atom from C to O, accompanied by 




expansion and the center atom substitution from C into Si work in opposite directions -- an overall red shift 
of less than 8 cm-1 can be expected to give new peaks ranging between 2220 and 2223 cm-1, which could 
not reach our ideal range unfortunately. In contrast, in the strategy of blueshifting 7b, changing the core 
atom into O and further decreasing the ring numbers work synergistically, which could lead to a relatively 
large blue shift (Strategy II). More quantitatively, our model predicts that changing the core atom into O and 
removing two of the periphery rings from 7b (with six 6-member rings) could theoretically generate a new 
nitrile peak around 2212 cm-1, which lies exactly within our desired range of 2212-2216 cm-1.  
 
Fig. 4.3. Super-multiplexed optical imaging with new MARS probes generated by precise prediction.  (a) Flow 
chart used to estimate Raman shifts of MARS dyes. Starting from the reference structure, three layers were used to 
modify the expected Raman shifts: isotope doping, core atom substitution, and ring expansion. The three effects can 
be used to precisely control Raman shifts of nitriles. (b) Linear fitting of calculated Raman shifts versus measured 
Raman shifts. The good linearity and RMS indicate the precision of the propose prediction method. (c) Schematic 
illustration of two possible strategies to generate new MARS probes that have resolvable frequencies with MARS2200 
and MARS2228. Combining core atom substitution and ring expansions can both tune the probe away but the two 
effects in strategy I unfortunately work in opposite direction, resulting in crosstalk with MARS2228. (d) Structures of 4 




matched the predicted Raman shifts and the compounds were named accordingly. Top: epr-SRS spectra of MARS2228 
series. Bottom: epr-SRS spectra of MARS2240 series. The two groups of four peaks evenly spaced to fit into each 
other, showing good spectral resolvability. (e) Simultaneous 10-target imaging on mouse cerebellum thin sections. 
Fluorescence: DAPI (total DNA), RCA (Ricinus Communis Agglutinin I-FTIC), NeuN (rabbit, Alexa568), LEL 
(Lycopersicon Esculentum lectin Dy-Light 647). SRS: WGA (MARS2240-WGA), Calbindin (mouse, MARS2228), 
Vimentin (chicken, MARS2200), MBP (myelin basic protein, rat, MARS2176), GFAP (glial fibrillary acidic protein, goat, 
MARS2157), GABA B receptor 2 (guinea pig, MARS2147). Scale bars, 50 μm. Replicates = 5. 
Guided by this rational design, we performed the synthesis of a set of such MARS probes equipped 
with O-core atom and only four 6-member rings (Fig. 4.3d), which are later named according to the 
measured Raman shifts. The results well matched our prediction: one of the isotopologues indeed exhibits 
an epr-SRS peak at 2212 cm-1, and the four peaks of the new set are interleaved and can be clearly resolved 
with those from the previous set of 7a-d, as shown in Fig. 3d, which was further validated in mixed solutions 
(Supplementary Fig. 4.5). We then conjugated them with 6 designated secondary antibodies. Upon 
coalition with 4 fluorescent dye conjugated antibodies, a 10-color one-shot immunostaining was performed 
on fixed mouse cerebellum thin section (Fig. 4.3d). The imaging result clearly showed the cell type 
heterogeneity in cerebellum tissue, and different structures can be unambiguously resolved. In contrast, 
only 8-color immunostaining (4 NHS ester functionalized MARS probes plus 4 fluorescent probes) was 
previously possible. The tissue imaging results presented here clearly showed that our newly synthesized 
NHS ester functionalized MARS probes can collaborate with fluorescence imaging and that the multiplexing 
capacity can be increased without the need of cyclic labeling and imaging. 
4.2.5 Four-dimensional expansion of functionalized MARS probes with diverse labeling abilities 
The newly developed prediction model and synthetic methods allowed us to systematically expand the 
palette of functionalized MARS probes. Along the spectral tunning dimension, the proposed model 
facilitated three tunning strategies: major tunning by isotope doping, minor tunning by core atom substitution, 
and fine tuning by ring expansions. Based on this framework, a 3D library of MARS NHS ester probes was 
be established (Fig. 4.4a, detailed structures and photophysical parameters are listed in Supplementary 
Fig. 4.6). Their epr-SRS spectra were acquired and presented in Fig. 4.4b, covering a wide spectral window 
of the cell-silent-region, and they are named according to the measured Raman shifts of the conjugated 




Next, we verified the versatile labeling and imaging capability of the new NHS MARS probes (total 20 
probes) in cells. Prior to be used in cellular imaging, we tested the MARS probes’ performance in aqueous 
conditions. With the positively charged nature, the MARS NHS esters exhibit good aqueous solubility. The 
absorption spectra in PBS buffer were shown in Supplementary Fig. 4.3 and the detailed parameters were 
listed in Supplementary Table 2. Blueshifts around 15 nm in absorption spectra were observed for all 
MARS dyes, while slight shifts around 3~6 cm-1 towards larger wavenumbers in SRS spectra were found. 
Furthermore, the stability of probes was tested in PBS buffer at physiological pH (Supplementary Fig. 4.7). 
The O-cored compounds could preserve 80% effective concentration while the C- and Si- cored compounds 
could retain 60%. Such difference is in consistency with previous studies on the electrophilicity of pyronins 
with different core atoms.[30-32] 
When conjugating with proteins, the probes’ degree of labeling can reach 2-4 dye molecules per protein 
for secondary antibodies. Following the standard immunostaining method, various cellular protein targets 
can be labeled by secondary antibodies conjugated with MARS probes and subsequently imaged by epr-
SRS microscopy. As shown in Fig. 4.4c, all imaged protein targets showed clear subcellular structure 
patterns including α-tubulin (microtubule marker) and fibrillarin (nucleoli marker). In addition to NHS esters, 
our newly developed synthetic methods readily allow construction of MARS probes bearing other functional 
groups, giving access to many new versatile labeling modalities beyond the prior report, thus affording a 
new fourth dimension to expand MARS library. To save the relatively expensive isotope materials, we 
presumed the functionalization can be carried out prior to the cyano group addition. The resulting pyronin 
can later be assigned a nitrile isotope to be compatible with other existing probes. By direct amidation 
followed by cyanide addition, a group of 10 new MARS probes were obtained (Fig. 4.4d and 4f), which 
were aimed for various labeling modalities such as click reaction[33]. Notably, 5 MARS probes were 
specifically designed for live cell subcellular structure imaging such as mitochondria, lysosome, and lipid 
structures.[34,35]  
We then demonstrated imaging with newly functioned MARS probes with diverse labeling modalities. 
Two clickable MARS probes with azide or alkyne motifs were utilized to react with 5-ethynyl-2 -́deoxyuridine 
(EdU, newly synthesized DNA marker) or L-azidohomoalanine (AHA, nascent protein marker) for metabolic 




and intracellular distribution for newly synthesized protein, respectively (Fig. 4.4e, top row). Furthermore, 
we synthesized a MARS2228 conjugate with phalloidin, which is a peptide that can tightly bind with F-
actin.[36] After HeLa cells were treated with MARS2228-phalloidin for 30 min, the clear epr-SRS signal was 
observed with actin’s bundle pattern (Fig. 4.4e, bottom left). Moreover, MARS2241 was conjugated with 
wheat-germ-agglutinin (WGA), a lectin widely used as plasma membrane marker. Imaging results showed 
signal locates at the plasma membrane predominantly, indicating the probe can target membrane 
selectively (Fig. 4.4e, bottom right). Besides applications with fixed cells, we can also demonstrate 
functionalized MARS probes for live-cell applications, which was not possible with the previous MARS 
molecules. MARS2237, without any side chain derivatization, was used to label mitochondria because of 
its positive charge and good lipophilicity.[37] Live HeLa cells were incubated with 400 nM MARS2237 and 
commercially available MitoTracker Green together. The obtained correlative fluorescence and SRS 
images show a clear overlap between the fluorescent signal from MitoTracker Green and the SRS signal 
from MARS2237 (Fig. 4.4g and Supplementary Fig. 4.8). Another organelle, lysosome was also imaged 
with the MARS probe. We equipped MARS2238 with a terminal dimethylamino group, whose basicity can 
be used to target lysosome.[35] The colocalization experiment shows a good overlap between MARS2238-
Lyso and LysoTracker Orange (Fig. 4.4g and Supplementary Fig. 4.6). Moreover, we designed and 
synthesized a MARS2239 derivative that bears a negative charge and a long lipophilic chain, which is a 
classic strategy to anchor the probe onto live cell plasma membrane. As a control, MARS2238-C18 (without 
the negative charge) shows serious internalization and stains almost all intracellular membrane structures. 
Due to the negative charge from the sulfonate group, MARS2156-Sulfo-C18 stops internalization and 
retains it on the plasma membrane (Fig. 4.4g).   
Finally, we selected four newly functionalized MARS probes of different types and three commercial 
fluorescent probes to demonstrate a simultaneous multiplexed optical imaging. Four isotopologues of 
MARS2238 with different functionalized conjugations were selected to image fibrillarin via immunostaining, 
α-tubulin via immunostaining, newly synthesized DNA via click reaction with EdU and nascent protein via 
click reaction with L-azidohomoalanine, respectively. Fluorescent probes were used to label plasma 
membrane, nucleus, mitochondria, and actin, respectively. Meanwhile, label-free SRS detection at CH3 




all eight targets could be clearly visualized and resolved from each other, demonstrating that the new MARS 
probes of different types are capable of working with each other to break the color barrier, as well as 
coordinating with conventional fluorescence probes. 
 
Fig. 4.4 Multidimensional tunning strategy to generate spectrally resolvable MARS probe library. (a)The probes 




were named according to fitted nitrile peak positions. (b) Fitted spectra of nitrile stretching modes of 20 MARS NHS 
esters. 20 peaks can be grouped into 4 sets of isotopologues and clearly resolved. (c) Exemplar images of 
immunostaining using individual MARS NHS ester probes in fixed cells. Top: Imaging α-tubulin with MARS2155 
conjugated secondary antibody; Imaging fibrillarin with MARS2155 conjugated secondary antibody. Bottom: α-tubulin 
imaging with MARS2172 conjugated secondary antibody; Fibrillarin imaging with MARS2222 conjugated secondary 
antibody. Scale bars: 20 μm. Replicates = 3. (d) and (f) The fourth dimension to expand MARS library. (d) MARS probes 
developed for fixed sample imaging. (e) Imaging EdU or AHA labelled HeLa cells with MARS2238-Azide or 
MARS2184-PEG2-Alkyne through click reaction; Imaging F-actin structure with MARS2228 conjugated phalloidin; 
Imaging plasma membrane with MARS2238 conjugated wheat-germ-agglutinin. Scale bars: 20 μm. Replicates = 3. (f) 
MARS probes developed for live cell imaging. (g) Imaging mitochondria with MARS2237 in live cells; Imaging lysosome 
with MARS2184-Lyso in live cells; Imaging intracellular lipids or plasma membrane with C18 derivatized MARS probes. 
Scale bars: 20 μm. Replicates = 3. (h) 8-color multiplexed cell imaging with 3 fluorescent probes and 4 epr-SRS probes. 
Fluorescence: NucBlue for nucleus, Alexa-488-WGA for plasma membrane, and MitoTracker Orange for mitochondria. 
SRS: Label-free at 2945 cm-1 for proteins, MARS2155-Azide with EdU for newly synthesized DNA, MARS2210-NHS 
labeled antibody for α-tubulin, MARS2184-PEG2-Alkyne with AHA for nascent proteins, and MARS2155-NHS labeled 
antibody for fibrillarin. Scale bar: 20 μm. Replicates = 3. 
4.3 Conclusion 
Major advances in optical imaging have been largely driven by novel spectroscopy and imaging probes. 
In the context of vibrational imaging, the recently developed epr-SRS microscopy significantly boosts the 
sensitivity of Raman imaging by several orders of magnitude, from the standard millimolar under non-
resonance to sub-micromolar level under proper electronic pre-resonance excitation of NIR 
chromophores.[20]  Meanwhile, the proposed MARS palette provides the matching probes to potentially 
allow for simultaneous imaging of a large number of targets through precisely controlling the sharp 
vibrational spectrum of the triple bond. While this is a powerful strategy, the development of MARS probe 
palette is relatively lagging behind, partly due to the different and understudied synthetic chemistry, physical 
chemistry and chemical biology of MARS probes from the conventional fluorescence probes. As a result, 
the structure-spectroscopy relationship of MARS dyes was elusive, and the MARS palette was rather limited 
in both the absolute number of probes and the types of labeling ability – only 4 NHS ester functionalized 
probes were synthesized in 2017.  
In this work, we developed a robust and efficient methodology to build MARS dyes with different core 
atoms, conjugation ring numbers, and stable isotope substitutions. Meanwhile, the synthesized MARS dyes 
allowed us to discover a quantitative model relating the structure features to the vibrational spectroscopy 




in terms of both the number (as many as 30) and the type (more than 10). This expanded palette not only 
allows increased optical multiplexing capacity than previously available (due to many more NHS ester 
functionalized probes but also includes many versatile labeling methods such as click chemistry, peptide 
vectors, and membrane/organelle targeting, far beyond just the NHS ester functionalization. A clear 
comparison between the previous MARS molecules and the newly developed palette was summarized in 
Supplementary Table 3, demonstrating the great significance of chemistry improvements. 
As this work is the first systematic study on the chemistry of MARS probes, we envision many further 
developments beyond what have been demonstrated here. With the facile side chain, MARS probes are 
ready for exploring more functionalities such as sensing other analytes and micro-environment. Indeed, a 
large number of interesting sensors have been developed based on xanthenes,[29,38,39] the parent structures 
of MARS probes. In fact, a very recent work reported MARS-derivatized probes for detecting enzyme 
activities.[40] Hence, we expect MARS probes to make important contribution to the multiplexed sensing 
applications. Besides, the rapidly growing genetically encoded labeling strategies such as SNAP tag and 
Halo tag have facilitated site-specific live-cell imaging.[3,41] Considering that epr-SRS microscopy is 
compatible with live cell imaging and that MARS dyes are well compatible to equip with these hybrid 
chemical tags, we anticipate that genetically encoded MARS probes will be built up soon to achieve 
multicolor imaging with high protein specificity inside live cells.  
4.4 Methods 
4.4.1 Synthesis and characterization.  
Detailed synthetic routes and characterization data of all newly developed compounds can be found in 
the synthesis notes section 4.6. 
4.4.2 Instrumentation of epr-SRS microscopy  
SRS imaging was performed with a commercial confocal laser-scanning microscope (FV1200, 
Olympus) but with customized laser sources. An integrated commercial laser source (picoEmerald, Applied 
Physics & Electronics, Inc.) was utilized to produce both the Pump and Stokes beams for SRS. The 
wavelength of Stokes beam was fixed as 1064 nm. The beam was modulated at 8 MHz by an electro-optic 
modulator (EOM) with >90% modulation depth. The Pump beam was controlled by an optical parametric 




ps pulse width and 80 MHz repetition rate. The two beams were spatially and temporally synchronized and 
tightly focused onto the sample with a 25× water objective (XLPlan N, 1.05 NA MP, Olympus). After passing 
through the sample, both transmitted beams were collected by a 1.4 N.A. oil condenser. The Stokes beam 
was filtered off by a high O.D. bandpass filter (890/220 CARS, Chroma Technology), while the Pump beam 
was detected by a silicon photodiode (FDS1010, Thorlabs) with a DC voltage of 64 V. The output current 
was terminated by a 50 Ω terminator and demodulated by a high-frequency lock-in amplifier (HF2LI, Zurich 
instrument) at 8 MHz frequency. The Pump loss signal at each pixel was digitized and sent to the FV10 
analog channel to generate the images. Unless otherwise mentioned, all cell images were acquired with 4 
μs×10 dwelling time and 320 × 320 pixel number. The on-sample power was 10-25 mW for pump and 25-
100 mW for Stokes depending on the detectability of signal from imaging targets. 
All fluorescence images were collected on the same microscope platform using CW laser (488, 542, 
and 635 nm) as excitation source. Two-photon imaging of NucBlue was performed with 780 nm pump beam 
without Stokes. All images were analyzed with ImageJ. 
4.4.3 Secondary antibody conjugation with new MARS NHS esters 
All MARS NHS esters were stored as 20 mM DMSO solutions. Secondary antibody solution (~2mg/mL, 
see antibody summary in Supplementary Table 4) was adjusted to pH~8.3 using PBS and sodium 
bicarbonate. 10 e.q. dye solutions were added to 250 μL antibody solution and the mixture was gently 
stirred in the dark for 2 hr at room temperature. The conjugated antibodies were purified using gel 
permeation chromatography (GPC) with Sephadex G-25 (Sigma, G25250). The column (0.5 cm in diameter, 
15 cm in length) was filled with swelled Sephadex G-25 and equilibrated with PBS buffer. After loaded with 
crude antibody solution, the column was eluted with PBS buffer and the first band with light blue (for O-
cored MARS) or green (for C and Si cored MARS) was collected. The combined fractions were centrifuged 
and concentrated with Amicon Ultra centrifugal Filters to reach a final concentration around 1 mg/mL. The 
resulted antibody solutions were kept in PBS with 5mM sodium azide and stored at -20 °C. The WGA 




4.4.4 Cell culture, labeling, and sample preparation for epr-SRS imaging.  
HeLa cells were cultured with Dulbecco’s Modified Eagle’s Medium (DMEM, 11965) supplemented 
with 10% FBS and 1% penicillin-streptomycin. All cell cultures were maintained in humidified incubator at 
37 °C with 5% CO2.  
Immunostaining of fixed cell samples. HeLa cells were seeded on a round glass coverslip in a 4-well 
plate with 500 μL DMEM full growth media for 48 h before reaching a confluence of 70-80%. After removal 
of media, cells were fixed with 4% PFA for 15 min, blocked with 3% bovine serum albumin (BSA) solution 
for 30 min, and permeabilized with 0.1-0.5% Triton X-100 solution for 15 min. Primary antibodies (Anti-
alpha tubulin monoclonal antibody (mouse, Invitrogen, A11126, 1:50) or Anti-fibrillarin antibody (mouse, 
Abcam, ab4566, 1:50)) were added to the cells at 1:100 dilution in BSA solution and incubated overnight 
at 4 °C. After washing off the primary antibody solution, cells were blocked with 10% goat serum for 30 min 
and treated with MARS labelled secondary antibody with 1:100 or 1:200 dilution in 10% goat serum. The 
cells were cultured overnight at 4 °C and washed with PBS prior to imaging. The labeling experiments were 
replicated 3 times as quality control, and for each sample, at least 3 random field of views (FoVs) were 
selected to ensure the consistency among cells. 
10-color super-multiplexed imaging on fixed mouse cerebellum. PFA fixed 40-m-thick mouse 
cerebellum slices were used. Tissues were first blocked with 5% donkey-serum in 0.5% PBST (0.5% Triton 
X-100 in PBS) for 30 min. After blocking, the solution was replaced by primary antibody solution (desired 
primary antibodies with 2% donkey serum in 0.5% PBST: Recombinant Alexa Fluor® 568 anti-NeuN 
antibody (rabbit, Abcam, ab207282), Monoclonal anti-calbindin-D-28K antibody (mouse, Sigma-Aldrich, 
c9848), Anti-vimentin antibody (chicken, Abcam, ab24525), Anti-Myelin Basic Protein antibody (rat, Abcam, 
ab7349), Anti-GFAP antibody (goat, Abcam, ab53554), Anti-GABA B Receptor R2 Antibody (guinea pig, 
Sigma-Aldrich, AB2255)) for 2 days at 4 °C. After primary antibody staining, tissues were washed with 0.5% 
PBST for 5 min three times followed by blocking solution for 30 min. After blocking, add the secondary 
antibody solution (desired secondary antibodies with 2% donkey serum in 0.5% PBST), RCA-FITC 
(ThermoFisher Scientific, L32477), LEL-DyLight 647 (ThermoFisher Scientific, L32472), and WGA-




tissue was transformed to Superfrost microscopy slide after washing in PBS. Mount and cover slip each 
slide using a drop of ProLong Gold antifade. 
Imaging newly synthesized DNA in fixed HeLa cells by EdU incorporation and MARS2238-Azide. HeLa 
cells were seeded on a round glass coverslip and cultured with DMEM full growth medium until reaching 
50% confluence. The medium was then replaced with FBS depleted DMEM for synchronization. After 24 h, 
the medium was replaced with DMEM full growth medium containing 5 μM EdU and the cells were further 
incubated for 15 h before fixed with 4% PFA. The fixed cells were permeabilized with 0.5% Triton-X for 10 
min. 1 μM MARS2238-Azide in Click-iT cell reaction buffer (C10259, Invitrogen) was then added to react 
with incorporated EdU for 30 min. Cells were washed three times prior to imaging. 3 biological replicates 
and 3 technical replicates were performed with consistent results. 
Imaging newly synthesized protein in fixed HeLa cells by AHA incorporation and MARS2184-PEG2-
Alkyne. HeLa cells were seeded on a round glass coverslip and cultured with DMEM full growth medium 
until reaching 50% confluence. The medium was then replaced with methionine-deficient DMEM containing 
1 mM AHA. After incubating for 18 h, cells were fixed with 4% PFA and permeabilized with 1% Triton-X for 
10 min. 5 μM MARS2184-PEG2-Alkyne was added to the PBS buffer and hatched for 1 h to complete 
copper-free click reaction. Cells were washed three times prior to imaging. 3 biological replicates and 3 
technical replicates were performed with consistent results.  
Imaging F-actin in fixed HeLa cells with MARS2228-Phalloidin. MARS2228-NHS ester (0.1 mM) was 
incubated with phalloidin amine (0.1 mM, AAT Bioquest 5302) in basic PBS buffer (pH = 8.3) for 1h. The 
reaction was monitored and confirmed by mass spectroscopy. The resulting mixture was directly used for 
fixed and permeabilized HeLa cells labeling with 100X dilution. Cells were washed three times prior to 
imaging. 3 technical replicates were performed with consistent results. 
Imaging subcellular structures of live HeLa cells with organelle-targeting MARS probes. HeLa cells 
were incubated with DMEM medium until reaching 70% confluence. Designated MARS probes: MARS2237 
(500 nM), MARS2184-Lyso (5 μM), MARS2238-C18 (5 μM), MARS2156-Sulfo-C18 (2 μM) were added 
into culture media and hatched for 30 min. Cells were washed with PBS and directly placed on glass slide 




adding to cells. The labeling was replicated 3 times as quality control, and for each sample, at least 3 
random field of views (FoVs) were selected to ensure the consistency among cells. 
8 color epr-SRS and fluorescence tandem imaging of fixed HeLa cells. HeLa cells were seeded on 
round coverslip and cultured to 70% confluence. The medium was replaced with methionine free DMEM 
containing 5 μM EdU and 100 μM AHA. The cells were incubated for 2 h followed by the addition of 200 
nM MitoTracker Orange and 10 μg/mL WGA-Alexa 488 conjugate. Cells were further hatched for 30 min 
before fixed with 4% PFA for 15 min and permeabilized with 2% Triton-X for 10 min. 3% BSA was used to 
block cells for 30 min. The treated HeLa cells were subject to primary antibody labeling (anti-fibrillarin from 
rabbit, (Invitrogen PA5-29801, 1:50), and anti-tubulin from mouse, (Invitrogen A11126, 1:25)) in BSA 
overnight, then secondary antibody labeling (MARS2155-goat-anti-rabbit and MARS2210-goat-anti-mouse) 
in goat serum for 6 h. After washing with PBS, click reactions were performed on cells. 1 μM MARS2238-
Azide in Click-iT buffer was added and reacted for 30 min. The sample was thoroughly washed before the 
addition of 1 μM MARS2184-PEG2-Alkyne. After incubation for 1 h, cells were labeled with NucBlue Fixed 
Cell Ready Probes reagent (Invitrogen, R37606) for 10 min. Cells were washed again prior to imaging. 3 





4.5 Supplementary Figures 
  
Supplementary Fig. 4.1 Comparison between previously reported synthesis and current work on synthesis of 












Supplementary Fig. 4.2 Normalized absorbance and fluorescence emission spectra of five O-cored pyronin 
intermediates. (a) Normalized absorption spectra taken in DMSO. Inset: appearance of 100 μM molecule 13e and 5 






Supplementary Fig. 4.3 (a) Normalized absorption spectra of 1-5 measured in DMSO showing the gradual shift in 
maximum wavelength. (b) Normalized absorption spectra of O-, C-, and Si- cored MARS dyes. (c) and (d): 





Supplementary Fig. 4.4. Normalized fluorescence emission spectra of representative 9-cyanopyronin dyes in 
DMSO. 
 
Supplementary Fig. 4.5. In-vitro unmixing of MARS2228-NHS and MARS2240-NHS. Two probes were diluted with 
DMSO to obtain a mixture displaying similar SRS intensities. The deconvolution was performed based on Voigt multi-






Supplementary Fig. 4.6 (a) Comprehensive listing of spectroscopic properties of all MARS model compounds and 
NHS ester derivatives measured in DMSO. (b) Graphic presentation of MARS molecules’ nitrile Raman shifts versus 












Supplementary Fig. 4.7. Stability of 9-cyanopyronin probes in aqueous conditions. 10 μM of three representative 
9-cyanopyronin probes in PBS buffer were stored in dark at room temperature and the absorbance was monitored 






Supplementary Fig. 4.8 Colocalization between commercial organelle markers and specialized MARS probes. (a) 
Mito-Tracker Green probes excited at 488 nm. (b) Fluorescence imaging of MARS2237 excited at 635 nm. (c) SRS 
imaging of MARS2237. (c) Lyso-Tracker Red probes excited at 543 nm. (e) Fluorescence imaging of MARS2184-











Supplementary Table 4.4. List of secondary antibodies used for conjugation. 
 
Target Vendor Catalog# 
Donkey anti-Mouse IgG (H+L)  Invitrogen A16013 
Donkey anti-Rat IgG (H+L)  Invitrogen A18747 
Donkey anti-Rabbit IgG (H+L)  Invitrogen A31238 
Donkey anti-Chicken IgY (H+L)  Invitrogen SA1-72002 
Donkey anti-Goat IgG (H+L)  Invitrogen A16007 
Donkey anti-Guinea Pig IgG (H+L) Sigma-Aldrich SAB3700384 
Goat anti-Mouse IgG (H+L)  Invitrogen 31160 





4.6 Synthesis Notes 
 
4.6.1 General experimental methods.  
Unless otherwise noted, all chemical reagents and solvents were purchased from Sigma-Aldrich, 
Fisher Scientific and Alfa-Aesar without further purification. Deuterated solvents and isotopic potassium 




and K13C15N: CNLM-1961-PK). All cyanide-contaminated glassware was quenched with potassium 
permanganate (KMnO4) before washing and disposal. Thin layer chromatography (TLC) was performed 
with MilliporeSigma™ silica gel 60 F254 coated aluminum-backed TLC sheets and visualized by UV-light at 
254 nm. Normal phase flash chromatography was performed on Biotage Selekt system equipped with dual-
channel UV-Vis detector. Preparative reverse phase high performance liquid chromatography (prep-HPLC) 
was performed on customized Gilson GX271 liquid handling system with dual-channel UV-Vis detector. 
Unless otherwise noted, all prep-HPLC used acetonitrile/H2O with 0.1% trifluoroacetic acid (TFA) gradient 
as eluents. Typical gradient was from 20% to 90% within 15 min with 20 mL/min flow rate. 
Nuclear magnetic resonance (NMR) spectra were recorded on Bruker 400 (400 MHz) or Bruker 500 
(500 MHz) Fourier Transform (FT) NMR spectrometers in Department of Chemistry, Columbia University. 
Chemical shifts were calibrated using either residual undeuterated solvents: CDCl3 (7.16 ppm for 1H, 77.16 
ppm for 13C), CD3OD (3.31 ppm for 1H, 49.00 ppm for 13C), DMSO-d6 (2.50 ppm for 1H, 39.52 ppm for 13C), 
CD3CN (1.94 ppm for 1H, 118.26 ppm for 13C) or trimethyl silane (TMS, 0.00 ppm for 1H). NMR multiplicities 
were marked with following abbreviations: s=singlet, d=doublet, t=triplet, q=quartet, p=quintet, m=multiplet, 
and br=broad. High resolution mass spectra (HRMS) were obtained from a XEVO G2-XS Waters mass 
spectrometer equipped with a QTOF detector with multiple inlet and ionization capabilities. UV-Vis 
absorption spectra and fluorescence emission spectra were all recorded on a TECAN infinite-200 using 96-
well plates as container. 





Supplementary Fig. 4.9. Preparation of related precursors for O-cored pyronins and MARS model compounds. 
Reaction conditions: (a) LiAlH4, THF, reflux, overnight. (b) NaBH4, acetic acid, acetaldehyde, r.t., 4 h. (c) Methyl 4-
bromobutyrate, DIPEA, DMF, 90 °C, overnight. (d) POCl3, DMF, 90 °C, 5 h. (e) NaBH4, acetic acid, r.t., 4h. 
 
 
1,2,3,4-tetrahydroquinolin-7-ol (S1). S1 was synthesized according to previously published 
protocol.[23] A slurry of 7-hydroxy-3,4-dihydroquinolin-2(1H)-one (9.80 g, 60.0 mmol) in anhydrous THF (250 
mL) was cooled within an ice bath and stirred vigorously. The slurry was carefully treated with LiAlH4 (3.64 
g, 96.9 mmol, 1.60 eq.) portionwise (bubbles evolved rapidly). Upon complete addition, the reaction mixture 
was heated up and refluxed overnight. After cooled to room temperature, the reaction was cautiously 
quenched by addition of 100 mL saturated NH4Cl solution. The resulted mixture was filtered through a pad 
of sand and washed with DCM (100 mL). The filtrate was further extracted with DCM (100 mL ×3) and the 
combined organic layers were dried over Na2SO4 and filtered. The solvent was then removed upon 
evaporation to afford S1 as pale-yellow solid (8.80 g, 98%). The characterization data matches previous 
report. 1H NMR (400 MHz, Chloroform-d) δ 6.80 (d, J = 8.1 Hz, 1H), 6.11 (dd, J = 8.1, 2.5 Hz, 1H), 5.98 (d, 
J = 2.5 Hz, 1H), 4.28 (br, 2H), 3.27 (t, J = 5.2 Hz, 2H), 2.69 (t, J = 6.4 Hz, 2H), 1.92 (m, 2H). HRMS (ASAP+) 
m/z Calcd. for C9H12NO [M+H]+: 150.0919. Found: 150.0915 
 
 
1-ethyl-1,2,3,4-tetrahydroquinolin-7-ol (12b). 12b was synthesized following previously published 
procedures.[23] A solution of S1 (1.00 g, 6.70 mmol) in 25 mL acetic acid was slowly treated with NaBH4 
(1.02 g, 26.8 mmol, 4 eq.). After stirring at room temperature for 2 h, a solution of acetaldehyde (0.295 g, 
6.70 mmol, 1 eq.) in 4 mL DCM was slowly injected into the reaction, which was closely monitored with TLC 
until starting material was fully consumed. The entire mixture was evaporated in vacuo to afford a thick 




with solid NaHCO3 and extracted with ethyl acetate (30 mL ×3). The combined organic layers were dried 
over Na2SO4 and concentrated. The residue was purified with silica gel chromatography (Hexane → 
Hexane:EA = 2:1, v/v) to yield 12b as white solid (1.08g, 91%). 1H NMR (400 MHz, CDCl3) δ 6.77 (d, J = 
7.9 Hz, 1H), 6.12 (d, J = 2.4 Hz, 1H), 6.03 (dd, J = 7.9, 2.4 Hz, 1H), 4.47 (s, 1H), 3.30 (q, J = 7.1 Hz, 2H), 
3.25 – 3.21 (m, 2H), 2.66 (t, J = 6.3 Hz, 2H), 1.97 – 1.87 (m, 2H), 1.13 (t, J = 7.1 Hz, 3H).  
 
 
1-ethyl-7-hydroxy-1,2,3,4-tetrahydroquinoline-6-carbaldehyde (11b). To an Ar flushed flask was 
added 4 mL anhydrous N, N-dimethylformamide (DMF). After cooled to 0 °C, phosphoryl chloride (POCl3, 
0.33 mL, 3.6 mmol, 1.2 eq) was added to DMF and kept stirring for 30 min followed by the addition of 12b 
(531 mg, 3.0 mmol) in 4 mL dry DMF. The temperature was raised to 90 °C and kept for 5 h while stirring. 
After cooled to room temperature, the reaction was quenched upon addition of 30 mL iced water and the 
pH was adjusted to 8 with solid NaHCO3. The aqueous phase was extracted with ether (50 mL ×3) and the 
combined organic layers were dried over Na2SO4. The solvents were removed in vacuo to afford 11b as 
brown solid, which has sufficient purity to be used in next step (461 mg, 75%). 1H NMR (500 MHz, CDCl3) 
δ 11.64 (s, 1H), 9.43 (s, 0H), 7.00 – 6.94 (m, 1H), 6.04 (s, 1H), 3.43 – 3.34 (m, 4H), 2.69 (td, J = 6.1, 1.0 
Hz, 2H), 1.95 (dq, J = 7.4, 5.9 Hz, 2H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 191.5, 163.4, 
151.9, 133.0, 114.8, 110.9, 95.5, 48.7, 46.0, 27.2, 21.8, 11.1. HRMS (ASAP+) m/z Calcd. for C12H16NO2 
[M+H]+: 206.1181. Found: 206.1180 
 
 
Methyl 4-(7-hydroxy-3,4-dihydroquinolin-1(2H)-yl)butanoate (12e). Compound S1 (1.49 g, 10.0 




mL, 12.0 mmol, 1.2 eq) were dissolved in 20 mL anhydrous DMF. The solution was heated to 90 oC and 
stirred for 48 h. After cooled to r.t., the mixture was diluted with 50 mL saturated brine. The aqueous phase 
was extracted with DCM (50 mL ×3). The combined organic layers were dried upon Na2SO4 and 
concentrated to get crude product, which was further purified with chromatography to afford 12e as 
yellowish oil (1.82 g, 73%). 1H NMR (400 MHz, Chloroform-d) δ 6.79 (d, J = 8.0 Hz, 1H), 6.16 (d, J = 2.4 
Hz, 1H), 6.08 (dd, J = 7.9, 2.4 Hz, 1H), 5.41 (s, 1H), 3.72 (s, 3H), 3.31 – 3.19 (m, 4H), 2.68 (t, J = 6.4 Hz, 
2H), 2.39 (t, J = 7.2 Hz, 2H), 1.99 – 1.85 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 174.1, 155.3, 145.8, 129.9, 
115.0, 103.1, 98.4, 51.9, 51.1, 49.4, 31.4, 27.3, 22.3, 21.5. HRMS (ESI+) m/z Calcd. for C14H20NO3 [M+H]+: 
250.1438. Found: 250.1442 
 
 
Methyl 4-(6-formyl-7-hydroxy-3,4-dihydroquinolin-1(2H)-yl)butanoate (S2). Similar to the 
synthesis of 1b, POCl3 (66 μL, 0.71 mmol, 1.2 eq.) was added to 1 mL anhydrous DMF cooled to 0 °C and 
stirred for 30 min, followed by the addition of 12e (147 mg, 0.59 mmol) dissolved in 1 mL dry DMF. The 
mixture was then heated to 90 °C and kept stirring for 5 h. After cooled to r.t., the reaction was quenched 
with 20 mL saturated NaHCO3 solution. The aqueous phase was extracted with DCM (20 mL ×3). The 
combined organic layers were dried over Na2SO4 and the solvents were removed thoroughly in vacuo. The 
residue was dissolved in 10 mL DCM and passed through a short pad of silica. The pad was washed with 
100 mL DCM and 100 mL ethyl acetate. The collected fractions were evaporated to afford S2 as yellowish 
oil (130 mg, 80%). 1H NMR (500 MHz, CDCl3) δ 9.45 (s, 1H), 6.98 (s, 1H), 6.05 (s, 1H), 3.72 (s, 3H), 3.41 
– 3.35 (m, 4H), 2.72 – 2.67 (m, 2H), 2.40 (t, J = 7.2 Hz, 2H), 2.01 – 1.92 (m, 4H). 13C NMR (126 MHz, 
CDCl3) δ 191.8, 173.4, 163.5, 152.1, 133.3, 114.9, 111.3, 96.0, 77.4, 77.2, 76.9, 51.9, 50.9, 49.9, 31.1, 






1-ethylindolin-6-ol (12d). To a solution of 6-hydroxyindole (1.0 g, 7.5 mmol) in 20 mL acetic acid, 
NaBH4 (1.42 g, 37.3 mmol, 5 eq.) was added portionwise. The reaction was kept stirring for 4 h at room 
temperature until evaporated to obtain a thick brown residue. The crude was diluted with 50 mL saturated 
NaHCO3 and further neutralized with solid NaHCO3. The aqueous phase was extracted with ethyl acetate 
(50 mL ×3). The combined organic layers were washed with brine, dried over Na2SO4 and further purified 
by silica gel flash chromatography to afford 12d as yellowish oil, which later crystalized slowly to pale yellow 
solid (1.02 g, 83%). 1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 7.8 Hz, 1H), 6.07 (dd, J = 7.8, 2.3 Hz, 1H), 
5.99 (d, J = 2.2 Hz, 1H), 4.88 (br, 1H), 3.34 (t, J = 8.2 Hz, 2H), 3.09 (q, J = 7.2 Hz, 2H), 2.87 (t, J = 8.2 Hz, 
2H), 1.17 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 155.9, 153.9, 124.7, 122.6, 103.7, 95.7, 77.4, 
77.2, 76.9, 52.9, 43.1, 27.8, 11.9. 
 
 
1-ethyl-6-hydroxyindoline-5-carbaldehyde (11d). POCl3 (0.40 mL, 4.25 mmol, 1.2 eq.) was added 
to 5 mL anhydrous DMF under Ar protection. The solution was cooled to 0 °C and stirred for 30 min followed 
by the addition of 12d (577 mg, 3.54 mmol) in 5 mL dry DMF. The temperature was allowed to rise to 90 °C 
and the reaction was kept stirring for 5 h. After cooled to room temperature, the reaction was quenched 
upon addition of 30 mL iced water and the pH was adjusted to neutral with solid NaHCO3. The aqueous 
phase was extracted with DCM (50 mL ×3) and the combined organic layers were dried over Na2SO4, 
filtered through a pad of silica. The solvent was removed in vacuo to yield 11d as brown oil, which slowly 
crystalized to solid (444 mg, 66%). 1H NMR (400 MHz, CDCl3) δ 12.28 (s, 1H), 9.39 (s, 1H), 6.98 (s, 1H), 
5.82 (s, 1H), 3.63 (t, J = 8.3 Hz, 2H), 3.29 (q, J = 7.2 Hz, 2H), 2.98 (t, J = 8.3 Hz, 2H), 1.21 (t, J = 7.2 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 191.0, 166.4, 158.5, 127.8, 122.3, 111.3, 91.6, 77.4, 77.1, 76.8, 51.4, 





4.6.3 Synthesis of O-cored MARS model compounds. 
General methods to synthesize O-cored pyronin intermediates and 9-cyanopyronins are described as 
following: 
Method A: 4-(dialkylamino)-2-hydroxybenzaldehyde (11a-c, 0.1 mmol, 1 eq.) and 3-
dialkylaminophenol (12a-e, 0.1 mmol, 1 eq.) were placed in a 25 mL round-bottom flask followed by the 
addition of 2.0 mL protonic acids (MsOH or 85% H3PO4). The flask was sealed, and the reaction was heated 
to 90 °C and kept stirring overnight. After cooled to room temperature, to the reaction was added 20 mL 
saturated brine. The aqueous phase was extracted with DCM (20 mL×3). The combined organic layers 
were washed with saturated brine, dried over Na2SO4 and concentrated. The crude product was purified 
with silica gel flash chromatograph (MeOH:DCM, 1:15, v/v) to afford desired pyronins (13a-i) as purple solid.  
Method B: Freshly obtained pyronin (13a-i, 25 μmol, 1 eq.) was dissolved in a mixed solvent of 5 mL 
acetonitrile and 1 mL H2O. To the vial was slowly added 0.5 mL 0.1 M KCN aqueous solution (50 μmol, 2 
eq.). The reaction was stirred at room temperature for 30 min monitored by TLC until the strong magenta 
color disappeared. The intermediate was sensitive to oxidation and quickly treated with 0.5 mL 0.5 M FeCl3 
in 1 N HCl (0.25 mmol, 10 eq.) solution. After stirred for additional one hour, the reaction was quenched 
upon addition of 20 mL saturated brine. The aqueous phase was extracted with DCM (20 mL×3). The 
combined organic layers were washed with saturated brine and dried over Na2SO4. The solvent was 
removed in vacuo and the residue was purified via silica gel flash chromatography (MeOH:DCM, 1:15, v/v) 
to give desired 9-cyanopyronins as dark blue solid. 
 
Supplementary Fig. 4.10. Syntheses of five pyronin intermediates (13a-e) and corresponding 9-cyanopyronin model 







Pyronin intermediate 13a. Method A was used to synthesize molecule 13a. 11a (11.7 mg, 61 μmol) 
and 12a (10.0 mg, 61 μmol) were treated with phosphoric acid to obtain 13a as purple solid (14.0 mg, 64%). 
1H NMR (400 MHz, MeOD) δ 8.58 (s, 1H), 7.82 (d, J = 9.4 Hz, 2H), 7.20 (dd, J = 9.3, 2.4 Hz, 2H), 6.95 (d, 
J = 1.8 Hz, 2H), 3.73 (q, J = 7.1 Hz, 8H), 1.35 (t, J = 7.2 Hz, 12H).13C NMR (101 MHz, MeOD) δ 159.7, 







Pyronin intermediate 13b. 13b was obtained from 11a (11.0 mg, 56 μmol) and 12b (10.0 mg, 56 
μmol) using method A with methenesulfonic acid (MsOH). Purification using silica gel chromatography 
yielded 13b as purple solid (15.0 mg, 72%). 1H NMR (400 MHz, MeOD) δ 8.42 (s, 1H), 7.76 (d, J = 9.3 Hz, 
1H), 7.47 (s, 1H), 7.14 (dd, J = 9.3, 2.4 Hz, 1H), 6.88 (d, J = 2.1 Hz, 1H), 6.87 (s, 1H), 3.73 – 3.61 (m, 8H), 
2.89 (t, J = 6.3 Hz, 2H), 2.03 (p, J = 6.1 Hz, 2H), 1.37 – 1.30 (m, 9H). 13C NMR (101 MHz, MeOD) δ 159.2, 
159.1, 157.0, 156.0, 145.6, 134.1, 131.3, 127.2, 116.0, 115.1, 115.1, 97.1, 96.0, 50.7, 46.7, 39.5, 28.3, 
22.0, 12.8, 11.4. HRMS (ESI+) m/z Calcd. for C22H27N2O+ [M]+: 335.2123. Found: 335.2143 
 
 
Pyronin intermediate 13c. 13c was obtained from 11b (11.5 mg, 56 μmol) and 12b (10.0 mg, 56 μmol) 
using method A with MsOH. Purification with silica gel chromatography afforded 13c as purple solid (16.1 
mg, 75%). 1H NMR (400 MHz, MeOD) δ 8.31 (s, 1H), 7.44 (s, 2H), 6.84 (s, 2H), 3.70 – 3.59 (m, 8H), 2.92 
– 2.85 (m, 4H), 2.02 (p, J = 6.0 Hz, 4H), 1.33 (t, J = 7.2 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 158.7, 155.4, 
144.6, 130.9, 126.9, 115.6, 95.8, 50.5, 48.0, 28.4, 22.0, 11.3. HRMS (ESI+) m/z Calcd. for C23H27N2O+ [M]+: 
347.2123. Found: 347.2144 
 
 
Pyronin intermediate 13d. 13d was obtained from 11c (12.1 mg, 56 μmol) and 12b (10.0 mg, 56 
μmol) using method A with MsOH. Purification with silica gel chromatography yielded 13d as purple solid 
(14.3 mg, 65%). 1H NMR (400 MHz, MeOD) δ 8.22 (s, 1H), 7.41 (s, 1H), 7.32 (s, 1H), 6.84 (s, 1H), 3.69 – 
3.55 (m, 8H), 3.00 (t, J = 6.4 Hz, 2H), 2.92 – 2.86 (m, 4H), 2.13 – 1.98 (m, 6H), 1.33 (t, J = 7.2 Hz, 3H). 13C 




106.4, 95.8, 52.1, 51.6, 50.4, 47.8, 28.4, 28.4, 22.1, 21.7, 20.7, 20.7, 11.3. HRMS (ESI+) m/z Calcd. for 
C24H27N2O+ [M]+: 359.2123. Found: 359.2143 
 
 
Pyronin intermediate 13e. 13e was obatained from 11c (434 mg, 2.0 mmol) and 12c (378 mg, 2.0 
mmol) following method A. Purification with silica gel chromatography yielded 13e (637 mg, 78%) as purple 
crystal. 1H NMR (500 MHz, MeOD) δ 8.18 (s, 1H), 7.32 (s, 2H), 3.60 – 3.53 (m, 8H), 3.00 (t, J = 6.4 Hz, 
4H), 2.92 – 2.86 (m, 4H), 2.09 (p, J = 6.4 Hz, 4H), 2.04 (p, J = 6.2 Hz, 4H). 13C NMR (126 MHz, MeOD) δ 
153.8, 152.9, 144.1, 129.2, 125.3, 115.0, 106.5, 52.0, 51.5, 28.5, 21.8, 20.8, 20.8. HRMS (ESI+) m/z Calcd. 
for C25H27N2O+ [M]+: 371.2123. Found: 371.2143 
 
 
Pyronin intermediate 13f. 13f was obtained from 11d (34 mg, 0.18 mmol) and 12d (29 mg, 0.18 mmol) 
following method A. Purification with silica gel chromatography yielded 13f as purple solid (32 mg, 50%). 
1H NMR (400 MHz, MeOD) δ 8.18 (s, 1H), 7.36 (s, 2H), 6.57 (s, 2H), 3.91 (t, J = 7.7 Hz, 4H), 3.54 (q, J = 
7.1 Hz, 4H), 3.19 (t, J = 7.7 Hz, 4H), 1.29 (t, J = 7.2 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 160.9, 160.7, 
143.7, 135.2, 125.9, 116.4, 91.4, 53.0, 42.3, 26.9, 11.9. 
 
 
MARS2241 (1). Method B was used to synthesize compound 1. 13a (8.8 mg, 24 μmol) was treated 
with KCN and FeCl3 sequentially to afford 1 as dark blue film (8.1 mg, 88%). 1H NMR (500 MHz, MeOD) δ 
7.95 (d, J = 9.5 Hz, 2H), 7.37 (dd, J = 9.5, 2.4 Hz, 2H), 7.03 (d, J = 2.4 Hz, 2H), 3.79 (q, J = 7.2 Hz, 8H), 
1.37 (t, J = 7.2 Hz, 12H). 13C NMR (126 MHz, MeOD) δ 157.4, 156.6, 129.9, 122.4, 116.1, 114.2, 111.9, 






MARS2240 (2). 2 was obtained from 13b (6.7 mg, 18 μmol) using method B as described above. After 
silica gel chromatograph purification, 2 was obtained as dark blue film (6.3 mg, 89%). 1H NMR (500 MHz, 
MeOD) δ 7.88 (d, J = 9.4 Hz, 1H), 7.61 (t, J = 1.3 Hz, 1H), 7.30 (dd, J = 9.4, 2.4 Hz, 1H), 6.99 (s, 1H), 6.96 
(d, J = 2.4 Hz, 1H), 3.79 – 3.69 (m, 10H), 2.97 (t, J = 5.8 Hz, 2H), 2.06 (p, J = 6.2 Hz, 2H), 1.38 – 1.32 (m, 
9H). 13C NMR (126 MHz, MeOD) δ 158.5, 158.2, 157.2, 156.6, 130.8, 130.1, 127.9, 122.3, 116.8, 116.7, 
114.6, 113.4, 97.9, 97.1, 51.3, 47.2, 28.3, 21.8, 12.9, 11.6. HRMS (ESI+) m/z Calcd. for C23H26N3O+ [M]+: 
360.2076. Found: 360.2060 
 
 
MARS2239 (3). 3 was obtained from 13c (7.1 mg, 18 μmol) using method B as described above. 
Purificiation with silica gel chromatography afforded 3 as dark blue solid (6.0 mg, 82%). 1H NMR (500 MHz, 
MeOD) δ 7.57 (s, 2H), 6.95 (s, 2H), 3.72 (dt, J = 13.2, 6.5 Hz, 8H), 2.97 (t, J = 6.1 Hz, 4H), 2.07 (p, J = 6.1 
Hz, 4H), 1.36 (t, J = 7.1 Hz, 6H). 13C NMR (126 MHz, MeOD) δ 156.4, 154.3, 128.0, 126.1, 119.7, 114.1, 




MARS2238 (4). 4 was obtained from 13d (8.3 mg, 21 μmol) following method B as described before. 




MeOD) δ 7.52 (s, 1H), 7.46 (s, 1H), 6.94 (s, 1H), 3.75 – 3.62 (m, 8H), 3.01 (t, J = 6.3 Hz, 2H), 2.99 – 2.93 
(m, 4H), 2.08 (dq, J = 15.7, 5.7 Hz, 8H), 1.35 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, MeOD) δ 157.6, 155.2, 
154.0, 152.7, 128.6, 127.4, 126.1, 120.5, 116.2, 114.2, 113.7, 107.8, 96.7, 52.7, 52.2, 50.8, 48.4, 28.4, 
28.4, 21.9, 21.5, 20.7, 20.4, 11.5. HRMS (ESI+) m/z Calcd. for C25H26N3O+ [M]+: 384.2076. Found: 384.2090 
 
 
MARS2237 (5). 5 was obtained from 13e (16.0 mg, 39 μmol) following method B. After silica gel 
chromatography, 5 was afforded as dark blue solid (14.7 mg, 87%). 1H NMR (500 MHz, MeOD) δ 7.38 (s, 
2H), 3.69 – 3.62 (m, 8H), 2.99 – 2.92 (m, 8H), 2.15 – 2.05 (m, 8H). 13C NMR (126 MHz, MeOD) δ 152.0, 
151.0, 126.4, 124.4, 118.5, 113.3, 112.4, 106.4, 51.1, 50.6, 27.0, 20.2, 19.4, 19.1. 
 
 
MARS2239P (14). 14 was obtained from 13f (7.8 mg, 22 μmol) using method B as described above. 
Yield: 4.0 mg, 48%. 1H NMR (400 MHz, MeOD) δ 7.58 (s, 2H), 6.74 (s, 2H), 4.05 (t, J = 7.0 Hz, 4H), 3.67 
(q, J = 7.0 Hz, 4H), 3.31 (t, J = 7.1 Hz, 4H), 1.35 (t, J = 7.1 Hz, 6H), 13C NMR (101 MHz, MeOD) δ 161.1, 
160.1, 138.1, 122.7, 120.4, 116.4, 113.8, 92.4, 53.6, 42.7, 27.1, 12.1. HRMS (ESI+) m/z Calcd. for 
C22H22N3O+ [M]+: 344.1763. Found: 344.1789 
 
4.6.4 Synthesis of O-cored MARS NHS esters. 
Supplementary Fig. 4.11. Syntheses of pyronin intermediates bearing a carboxylic acid side chain. Conditions: (1) 






Pyronin intermediate 13g. To a mixture of 11a (135 mg, 0.70 mmol) and 12e (175 mg, 0.70 mmol) 
was added 7 mL methanesulfonic acid. The solution was heated to 90 °C and stirred overnight. 7 mL DI 
water was added into the reaction and the mixture was further stirred for 4h at 90 °C. After cooled down to 
r.t., the mixture was poured into 20 g ice and diluted with 40 mL brine. The aqueous phase was extracted 
with DCM (40 mL ×5). The organic phase was combined, washed with brine, dried over Na2SO4 and 
concentrated. The crude product was purified through silica gel chromatography (MeOH: DCM 15:1, v/v) to 
give 13g as dark purple film (168 mg, 56%). 1H NMR (400 MHz, MeOD) δ 8.47 (s, 1H), 7.79 (d, J = 9.2 Hz, 
1H), 7.51 (s, 1H), 7.17 (dd, J = 9.3, 2.4 Hz, 1H), 7.04 (s, 1H), 6.91 (d, J = 2.5 Hz, 1H), 3.78 – 3.60 (m, 8H), 
2.92 (t, J = 6.3 Hz, 2H), 2.51 (t, J = 6.7 Hz, 2H), 2.04 (dq, J = 12.9, 6.6 Hz, 4H), 1.34 (t, J = 7.1 Hz, 6H). 13C 
NMR (101 MHz, MeOD) δ 176.4, 159.3, 159.2, 157.1, 156.4, 145.8, 134.2, 131.3, 127.2, 115.3, 115.2, 97.1, 
96.4, 52.8, 51.5, 46.8, 39.5, 31.4, 28.4, 22.2, 21.9, 12.8. HRMS (ESI+) m/z Calcd. for C24H29N2O3+ [M]+: 





Pyronin intermediate 13h. 13h was obtained from 11b (41 mg, 0.2 mmol) and 12e (50 mg, 0.2 mmol) 
following the same protocol used for 13g. Yield: 45 mg, 51%. 1H NMR (400 MHz, MeOD) δ 8.33 (s, 1H), 
7.45 (s, 2H), 7.02 (s, 1H), 6.84 (s, 1H), 3.65 (m, 8H), 2.92 – 2.86 (m, 4H), 2.37 (t, J = 6.9 Hz, 2H), 2.05 – 
1.99 (m, 6H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, MeOD) δ 158.7, 158.6, 155.6, 155.3, 144.6, 
130.9, 126.8, 126.7, 115.6, 96.3, 95.7, 53.1, 51.3, 50.5, 48.0, 33.8, 30.8, 28.4, 23.0, 22.0, 22.0, 11.3. HRMS 




Pyronin intermediate 13i. 13i was obtained from 11c (43 mg, 0.2 mmol) and 12e (50 mg, 0.2 mmol) 
following the same protocol used for 13g. Yield: 60 mg, 66%. 1H NMR (400 MHz, MeOD) δ 8.22 (s, 1H), 
7.40 (d, J = 1.2 Hz, 1H), 7.33 (d, J = 1.3 Hz, 1H), 6.97 (s, 1H), 3.65 – 3.52 (m, 8H), 3.02 (t, J = 6.3 Hz, 2H), 
2.90 – 2.85 (m, 4H), 2.33 (t, J = 7.0 Hz, 2H), 2.10 – 1.97 (m, 8H). 13C NMR (126 MHz, MeOD) δ 177.1, 
158.4, 155.1, 153.8, 153.3, 144.2, 130.8, 129.5, 126.2, 125.8, 115.8, 114.8, 106.4, 96.3, 52.6, 52.1, 51.6, 








Supplementary Fig. 4.12. Syntheses of 3 sets of O-cored MARS NHS esters each containing 4 nitrile isotopologues. 
The first two steps followed aforementioned method B. Counter ions for all NHS esters purified via HPLC are TFA anion.  
 
 
MARS2240-COOH (15). Following method B, freshly prepared 13g (16 mg, 33 μmol) was dissolved in 
a mixture of 5 mL acetonitrile and 1 mL water. To the solution was added 0.66 mL 0.1 M KCN (66 μmol, 2 
eq.) aqueous solution dropwise via syringe. The reaction was stirred at r.t. for 30 min until reactant was 
fully consumed (solution turned into light blue). 0.66 mL 0.5 FeCl3 (in 1 N HCl solution, 0.66 mmol, 10 eq.) 
was then added to the reaction, which was further stirred for 1h. The reaction was diluted with 20 mL 
saturated brine and extracted with DCM (20 mL ×3). The combined organic layers were dried over Na2SO4 
and concentrated to afford crude product, which was further purified with chromatography (MeOH:DCM 
30:1-10:1) to get 15 as dark blue film (12 mg, 81%). 1H NMR (400 MHz, MeOD) δ 7.89 (d, J = 9.4 Hz, 1H), 




(m, 8H), 2.98 (t, J = 5.7 Hz, 2H), 2.44 (t, J = 6.8 Hz, 2H), 2.11 – 1.99 (m, 4H), 1.34 (t, J = 7.1 Hz, 6H). 13C 
NMR (101 MHz, MeOD) δ 175.3, 158.4, 158.3, 157.2, 156.9, 130.8, 130.0, 127.9, 122.4, 116.9, 116.6, 
114.7, 113.4, 97.9, 97.6, 53.7, 52.1, 47.3, 28.3, 23.0, 21.8, 12.9.  
 
 
MARS2241-NHS (9a). A round-bottom flask was filled with 15 (12 mg, 26 μmol), N-Hydroxysuccinimide 
(NHS, 8.9 mg, 78 μmol, 3 eq.), and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 
19.8 mg, 104 μmol, 4 eq.). 3 mL Anhydrous DCM was added into the flask to dissolve the solid. The solution 
was stirred overnight at r.t. and evaporated upon vacuum. The residue was dissolved in 2 mL acetonitrile 
and purified with HPLC (eluent: MeCN/H2O, TFA, 20%-90%) to afford 9a as dark blue film (TFA salt, 11.7 
mg, 72%). 1H NMR (400 MHz, MeOD) δ 7.89 (d, J = 9.4 Hz, 1H), 7.61 (s, 1H), 7.32 (dd, J = 9.5, 2.5 Hz, 
1H), 7.03 (s, 1H), 6.97 (d, J = 2.4 Hz, 1H), 3.84 – 3.69 (m, 8H), 2.98 (t, J = 6.3 Hz, 2H), 2.91 – 2.85 (m, 6H), 
2.18 (p, J = 6.9 Hz, 2H), 2.07 (p, J = 6.5 Hz, 2H), 1.34 (t, J = 7.1 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 
170.4, 168.7, 157.0, 157.0, 156.0, 155.4, 129.5, 128.4, 126.6, 121.2, 115.8, 115.0, 113.7, 112.0, 96.5, 95.9, 








MARS2212-NHS (9b). 9b was obtained from 13g following the same protocols as for 15 and 9a. KCN 
was replaced by KC15N. 1H NMR (400 MHz, MeOD) δ 7.91 (d, J = 9.5 Hz, 1H), 7.64 (s, 1H), 7.33 (dd, J = 
9.5, 2.4 Hz, 1H), 7.05 (s, 1H), 6.99 (d, J = 2.4 Hz, 1H), 3.84 – 3.69 (m, 8H), 2.98 (t, J = 5.8 Hz, 2H), 2.88 
(d, J = 4.5 Hz, 6H), 2.19 (dt, J = 14.8, 6.8 Hz, 2H), 2.07 (p, J = 6.3, 5.9 Hz, 2H), 1.34 (t, J = 7.1 Hz, 6H). 13C 
NMR (101 MHz, MeOD) δ 171.8, 170.1, 158.5, 158.4, 157.4, 156.8, 130.9, 129.9, 128.0, 122.7 (d, J = 2.8 
Hz), 117.2, 116.4, 115.1, 113.4 (d, J = 17.2 Hz), 97.9, 97.3, 52.7, 52.0, 47.3, 28.7, 28.3, 26.5, 22.3, 21.7, 




MARS2186-NHS (9c). 9c was obtained from 13g following the same protocols as for 15 and 9a. 1H 
NMR (400 MHz, MeOD) δ 7.88 (d, J = 9.5 Hz, 1H), 7.60 (s, 1H), 7.32 (dd, J = 9.5, 2.5 Hz, 1H), 7.02 (s, 1H), 
6.97 (d, J = 2.4 Hz, 1H), 3.85 – 3.69 (m, 8H), 3.01 – 2.94 (m, 2H), 2.88 (d, J = 3.3 Hz, 6H), 2.18 (dt, J = 
14.6, 6.9 Hz, 2H), 2.07 (p, J = 6.5 Hz, 2H), 1.35 (t, J = 7.1 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 171.8, 
170.1, 158.4 (d, J = 4.5 Hz), 158.3 (d, J = 4.2 Hz), 157.4, 156.8, 130.9 (d, J = 3.1 Hz), 129.9, 128.0 (d, J = 
3.2 Hz), 122.6 (d, J = 81.9 Hz), 117.2, 116.4 (d, J = 2.1 Hz), 115.1 (d, J = 2.1 Hz), 113.4, 97.9, 97.3, 52.7, 








MARS2157-NHS (9d). 9d was obtained from 13g following the same protocols as for 15 and 9a. 1H 
NMR (400 MHz, MeOD) δ 7.90 (d, J = 9.5 Hz, 1H), 7.62 (s, 1H), 7.34 (dd, J = 9.5, 2.4 Hz, 1H), 7.04 (s, 1H), 
6.99 (d, J = 2.2 Hz, 1H), 3.85 – 3.71 (m, 8H), 2.99 (t, J = 5.9 Hz, 2H), 2.90 (d, J = 3.0 Hz, 6H), 2.20 (p, J = 
6.9 Hz, 2H), 2.09 (p, J = 6.4 Hz, 2H), 1.37 (t, J = 7.1 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 171.8, 170.1, 
158.4 (d, J = 4.7 Hz), 158.3 (d, J = 4.7 Hz), 157.4, 156.8, 130.9 (d, J = 3.0 Hz), 129.9, 128.0 (d, J = 3.2 Hz), 
122.6 (dd, J = 81.9, 3.0 Hz), 117.2, 116.4 (d, J = 1.8 Hz), 115.1 (d, J = 2.3 Hz), 113.4 (d, J = 16.9 Hz), 97.9, 
97.3, 52.7, 52.0, 47.3, 28.7, 28.3, 26.5, 22.3, 21.7, 12.9. HRMS (ESI+) m/z Calcd. for C2813CH31N315NO5+ 




MARS2239-COOH (16). 16 was obtained from 13h (17 mg, 38 μmol) following method B. Yield: 12 
mg, 69%. 1H NMR (500 MHz, MeOD) δ 7.53 (s, 1H), 7.52 (s, 1H), 7.06 (s, 1H), 6.91 (s, 1H), 3.70 (dp, J = 
15.6, 8.2, 7.8 Hz, 8H), 2.95 (t, J = 5.9 Hz, 4H), 2.46 (t, J = 6.3 Hz, 2H), 2.09 – 1.98 (m, 6H), 1.35 (t, J = 7.1 
Hz, 3H). 13C NMR (126 MHz, MeOD) δ 178.2, 157.8, 157.7, 156.0, 155.8, 129.5, 129.3, 127.5, 127.5, 121.0, 






MARS2239-NHS (10a). 10a was obtained from 16 (10 mg, 21 μmol) following the same protocol for 
9a. Yield: 8.8 mg, 65%. 1H NMR (400 MHz, MeOD) δ 7.62 – 7.54 (m, 2H), 7.00 (s, 1H), 6.96 (s, 1H), 3.81 
– 3.66 (m, 8H), 3.02 – 2.92 (m, 4H), 2.87 (d, J = 1.7 Hz, 6H), 2.17 (p, J = 6.9 Hz, 2H), 2.06 (p, J = 5.9 Hz, 
4H), 1.35 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, MeOD) δ 171.8, 170.2, 158.0, 157.8, 156.0, 156.0, 129.7, 
129.2, 127.7, 127.6, 121.4, 116.1, 115.3, 113.5, 97.0, 96.9, 52.4, 51.8, 51.1, 28.7, 28.4, 26.5, 22.2, 21.8, 
21.8, 11.6. HRMS (ESI+) m/z Calcd. for C30H31N4O5+ [M]+: 527.2289. Found: 527.2284. 
 
 
MARS2211-NHS (10b). 1H NMR (400 MHz, MeOD) δ 7.58 (s, 2H), 6.99 (s, 1H), 6.96 (s, 1H), 3.80 – 
3.66 (m, 8H), 2.96 (t, J = 6.3 Hz, 4H), 2.91 – 2.83 (m, 6H), 2.17 (p, J = 7.0 Hz, 2H), 2.06 (p, J = 6.2 Hz, 4H), 
1.35 (t, J = 7.1 Hz, 3H).13C NMR (101 MHz, Methanol-d4) δ 171.8 , 170.2 , 158.0 , 157.8 , 156.0 , 156.0 , 
129.8 , 129.2 , 127.7 , 127.6 , 121.4 (d, J = 2.9 Hz), 116.1 , 115.3 , 113.5 (d, J = 16.9 Hz), 97.0 , 96.9 , 
52.4 , 51.8 , 51.1 , 28.7 , 28.4 , 26.5 , 22.2 , 21.8 , 21.8 , 11.6 . HRMS (ESI+) m/z Calcd. for C30H31N315NO5+ 






MARS2185-NHS (10c). 1H NMR (400 MHz, MeOD) δ 7.57 (s, 2H), 6.98 (s, 1H), 6.95 (s, 1H), 3.83 – 
3.62 (m, 8H), 2.96 (t, J = 6.3 Hz, 4H), 2.92 – 2.82 (m, 6H), 2.17 (p, J = 6.9 Hz, 2H), 2.06 (p, J = 6.2 Hz, 4H), 
1.35 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, Methanol-d4) δ 171.8 , 170.2 , 158.0 (d, J = 4.4 Hz), 157.8 (d, 
J = 4.9 Hz), 156.0 , 155.9 , 129.8 , 129.2 , 127.6 (d, J = 3.1 Hz), 127.5 (d, J = 3.3 Hz), 121.3 (d, J = 81.8 
Hz), 116.1 (d, J = 1.3 Hz), 115.3 (d, J = 1.5 Hz), 113.5 , 97.0 , 96.9 , 52.4 , 51.8 , 51.1 , 28.7 , 28.4 , 26.5 , 
22.2 , 21.8 , 21.8 , 11.6. HRMS (ESI+) m/z Calcd. for C2913CH31N4O5+ [M]+: 528.2328. Found: 528.2332. 
 
 
MARS2156-NHS (10d). 1H NMR (400 MHz, MeOD) δ 7.57 (s, 2H), 6.98 (s, 1H), 6.95 (s, 1H), 3.82 – 
3.60 (m, 8H), 2.96 (t, J = 6.2 Hz, 4H), 2.92 – 2.83 (m, 6H), 2.17 (p, J = 6.9 Hz, 2H), 2.06 (p, J = 6.2 Hz, 4H), 
1.35 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, Methanol-d4) δ 171.8 , 170.2 , 158.0 (d, J = 4.4 Hz), 157.8 (d, 
J = 4.4 Hz), 156.0 , 155.9 , 129.8 , 129.2 , 127.6 (d, J = 3.1 Hz), 127.5 (d, J = 3.3 Hz), 121.3 (dd, J = 81.8, 
3.3 Hz), 116.1 (d, J = 1.9 Hz), 115.3 (d, J = 2.2 Hz), 113.5 (d, J = 16.9 Hz), 97.0 , 96.9 , 52.4 , 51.8 , 51.1 , 






MARS2238-COOH (17). 17 was obtained from 13i (12.2 mg, 27 μmol) following method B. Yield: 10.0 
mg, 77%. 1H NMR (500 MHz, Methanol-d4) δ 7.42 (d, J = 1.3 Hz, 1H), 7.37 (d, J = 1.4 Hz, 1H), 7.03 (s, 1H), 
3.69 (m, 6H), 3.65 – 3.59 (t, 2H), 2.99 – 2.90 (m, 6H), 2.48 (t, J = 6.7 Hz, 2H), 2.13 – 1.96 (m, 8H). 13C 
NMR (126 MHz, MeOD) δ 175.1, 155.9, 154.1, 152.6, 151.1, 127.4, 127.1, 125.9, 124.6, 118.7, 114.8, 
112.5, 112.2, 106.4, 95.8, 51.8, 51.3, 50.8, 50.2, 27.0, 21.2, 20.4, 20.1, 19.2, 19.0. HRMS (ESI+) m/z Calcd. 
for C27H28N3O3+ [M]+: 442.2131. Found: 442.2132 
 
 
MARS2238-NHS (6a). 6a was obtained from 17 (10.0 mg, 21 μmol) following same method used to 
synthesize 9a. Yield: 5.0 mg, 36%. 1H NMR (400 MHz, Methanol-d4) δ 7.51 (s, 1H), 7.46 (s, 1H), 7.02 (s, 
1H), 3.73 (t, J = 7.3 Hz, 2H), 3.70 – 3.63 (m, 6H), 3.01 (t, J = 6.4 Hz, 2H), 2.98 – 2.92 (m, 4H), 2.88 (s, 4H), 
2.85 (t, J = 6.9 Hz, 2H), 2.16 (p, J = 7.3 Hz, 2H), 2.11 – 2.01 (m, 6H). 13C NMR (101 MHz, MeOD) δ 170.4, 
168.6, 156.1, 154.0, 152.8, 127.6, 127.0, 126.1, 124.7, 119.3, 115.4, 112.6, 112.3, 106.5, 95.7, 51.3, 50.9, 
50.1, 27.5, 27.0, 27.0, 25.2, 21.0, 20.4, 20.1, 19.2, 19.0. HRMS (ESI+) m/z Calcd. for C31H31N4O5+ [M]+: 






MARS2210-NHS (6b). 1H NMR (400 MHz, MeOD) δ 7.55 (s, 1H), 7.50 (s, 1H), 7.05 (s, 2H), 3.74 (d, J 
= 7.3 Hz, 2H), 3.72 – 3.62 (m, 6H), 3.02 (t, J = 6.4 Hz, 2H), 2.99 – 2.92 (m, 4H), 2.87 (s, 4H), 2.84 (d, J = 
6.8 Hz, 2H), 2.17 (p, J = 7.0 Hz, 2H), 2.07 (dt, J = 12.3, 5.7 Hz, 6H). 13C NMR (101 MHz, Methanol-d4) δ 
170.4 , 168.6 , 156.0 , 154.0 , 152.8 , 151.3 , 127.6 , 127.0 , 126.1 , 124.7 , 119.1 (d, J = 3.5 Hz), 115.3 , 
112.5 , 112.2 (d, J = 16.9 Hz), 106.5 , 95.6 , 51.4 , 50.9 , 50.1 , 27.5 , 27.0 , 27.0 , 20.9 , 20.4 , 20.1 , 19.2 , 
19.0. HRMS (ESI+) m/z Calcd. for C31H31N315NO5+ [M]+: 540.2265. Found: 540.2267. 
 
 
MARS2184-NHS (6c). 1H NMR (400 MHz, Methanol-d4) δ 7.53 (s, 1H), 7.48 (s, 1H), 7.04 (s, 1H), 3.74 
(t, J = 7.3 Hz, 2H), 3.72 – 3.62 (m, 6H), 3.02 (t, J = 6.4 Hz, 2H), 3.00 – 2.92 (m, 5H), 2.87 (s, 4H), 2.84 (t, 
J = 6.8 Hz, 2H), 2.17 (p, J = 7.3 Hz, 2H), 2.13 – 2.00 (m, 6H). 13C NMR (101 MHz, Methanol-d4) δ 170.4 , 
168.6 , 156.2 (d, J = 4.6 Hz), 154.0 , 152.8 , 151.4 (d, J = 4.8 Hz), 127.6 , 127.0 , 126.1 (d, J = 2.9 Hz), 
124.7 (d, J = 3.3 Hz), 119.4 (d, J = 81.7 Hz), 115.4 (d, J = 1.8 Hz), 112.6 (d, J = 2.7 Hz), 112.3 , 106.5 , 
95.7 , 51.3 , 50.8 , 50.1 , 27.5 , 27.0 , 20.9 , 20.4 , 20.1 , 19.2 , 19.0. HRMS (ESI+) m/z Calcd. for 






MARS2155-NHS (6d). 1H NMR (400 MHz, MeOD) δ 7.56 (s, 1H), 7.51 (s, 1H), 7.07 (s, 1H), 3.76 (d, J 
= 7.3 Hz, 2H), 3.74 – 3.64 (m, 6H), 3.04 (t, J = 6.4 Hz, 2H), 3.02 – 2.94 (m, 4H), 2.89 (s, 4H), 2.86 (t, J = 
6.9 Hz, 2H), 2.19 (p, J = 7.1 Hz, 2H), 2.15 – 2.03 (m, 6H). 13C NMR (101 MHz, Methanol-d4) δ 170.4 , 168.6 , 
156.1 (d, J = 4.1 Hz), 154.0 , 152.8 , 151.3 (d, J = 4.9 Hz), 127.6 , 127.0 , 126.1 (d, J = 3.0 Hz), 124.7 (d, J 
= 3.4 Hz), 119.2 (dd, J = 81.7, 3.2 Hz), 115.3 (d, J = 1.6 Hz), 112.5 (d, J = 2.7 Hz), 112.2 (d, J = 17.3 Hz), 
106.5 , 95.6 , 51.4 , 50.9 , 50.1 , 27.5 , 27.0 , 27.0 , 20.9 , 20.4 , 20.1 , 19.2 , 19.0. HRMS (ESI+) m/z Calcd. 
for C3013CH31N315NO5+ [M]+: 541.2299. Found: 541.2301. 
 
4.6.5 Synthesis of C-cored MARS NHS esters. 
Supplementary Fig. 4.13. Syntheses of C-cored MARS NHS esters. Counter ions for all NHS esters purified via HPLC 







9-Formyl-2,3,6,7-tetrahydro-1H,5H-benzo[ij]-quinolizine (S3).  Anhydrous DMF (10 mL) was placed 
into a round-bottom flask and cooled to 0 °C. POCl3 (1.0 mL, 1.1 eq.) was then added dropwise while stirring. 
After 30 min, a solution of julolidine (1.73 g, 10.0 mmol) in 10 mL anhydrous DMF was added into flask. 
The reaction was then heated up to 90 °C for 5 h. After cooled to r.t., the reaction was quenched upon 
addition of 100 mL iced water and then the pH was adjusted to ~8 with solid NaHCO3. The mixture was 
extracted with ethyl ether (50 mL ×3). The combined organic layers were dried over Na2SO4 and 
concentrated. The crude product was purified via silica gel column (eluent: DCM) to afford S3 as yellowish 
oil (1.69 g, 84%). This compound has been characterized elsewhere showing a good match with our 
result.[42] 1H NMR (400 MHz, CDCl3) δ 9.62 (s, 1H), 7.31 (s, 2H), 3.35 – 3.27 (m, 4H), 2.79 (t, J = 6.3 Hz, 
4H), 1.98 (dq, J = 7.0, 5.8 Hz, 4H). 
 
 
(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)methanol (20). To a solution of S3 (402 mg, 
2.0 mmol) in 15 mL dry THF cooled at 0 °C was added LiAlH4 (76 mg, 2.0 mmol, 1.0 eq) portionwise. The 
reaction was stirred for 1 h while allowed to warm up to room temperature. The reaction was quenched with 
25 mL H2O (caution when adding water!), filtered through a short pad of silica and washed with 30 mL DCM. 
The aqueous phase was further extracted with DCM (20 mL ×3). The combined organic layers were dried 
over Na2SO4 and evaporated to give 20 as yellow solid (348 mg, 86%). The product was sufficiently pure 
without further purification. Characterization of of 10 was previously reported showing a good match with 
our result.[43] 1H NMR (400 MHz, CDCl3) δ 6.82 (s, 2H), 4.49 (s, 2H), 3.20 – 3.12 (m, 4H), 2.78 (t, J = 6.5 






Methyl 4-(7-(((trifluoromethyl)sulfonyl)oxy)-3,4-dihydroquinolin-1(2H)-yl)butanoate (18). To a 
solution of 12e (520 mg, 2.1 mmol) and triethylamine (1.16 mL, 8.4 mmol, 4 eq.) in anhydrous DCM (10 
mL) was added trifluoromethanesulfonic anhydride (2.3 mL, 1 M solution in anhydrous DCM, 1.1 eq.) 
dropwise at 0 °C. After addition, the reaction was warmed up to r. t. and stirred for another 2 h before 
quenched with 1 N HCl (10 mL). The organic layer was separated and remaining aqueous layer was 
extracted with DCM (20 mL × 2). The combined organic layers were dried over Na2SO4 and evaporated in 
vacuo to give the crude product, which was further purified with silica gel flash chromatography (Hexane:EA 
= 10:1, v/v) to yield 18 as yellowish oil (606 mg, 79%).1H NMR (400 MHz, CDCl3) δ 6.91 (d, J = 8.4 Hz, 1H), 
6.43 – 6.38 (m, 2H), 3.69 (s, 3H), 3.33 – 3.24 (m, 4H), 2.72 (t, J = 6.3 Hz, 2H), 2.37 (t, J = 7.1 Hz, 2H), 1.97 
– 1.87 (m, 4H). 
 
 
Methyl 4-(7-(prop-1-en-2-yl)-3,4-dihydroquinolin-1(2H)-yl)butanoate (19). Following a reported 
protocol[18], to a round-bottom flask was added 18 (376 mg, 0.98 mmol), Pd(dppf)2Cl2 (164 mg, 0.2 mmol, 
20% eq.) and K2CO3 (276 mg, 2.0 mmol, 2 eq.). The flask was flushed with Ar followed by addition of 12 
mL dioxane and 2 mL H2O via syringe. Isopropenylboronic acid pinacol ester (282 μL, 1.50 mmol) was 
added into the flask and the reaction was stirred at 70 °C for 6 h before cooled to room temperature. The 
mixture was filtered through a short pad of silica, washed with DCM (100 mL) and the filtrate was evaporated 
to dry. The crude product was purified with silica gel flash chromatography (Hexane to Hexane: EA = 20:1, 




– 6.66 (m, 2H), 5.31 (dd, J = 1.8, 0.9 Hz, 1H), 5.03 (p, J = 1.6 Hz, 1H), 3.70 (s, 3H), 3.38 – 3.32 (m, 2H), 
3.31 – 3.27 (m, 2H), 2.76 (t, J = 6.4 Hz, 2H), 2.42 (t, J = 7.2 Hz, 2H), 2.15 (dd, J = 1.5, 0.8 Hz, 3H), 2.02 – 
1.93 (m, 4H). 
 
 
Pyronin intermediate 21. Following a previously reported protocol[18], 19 (145 mg, 0.53 mmol) and 10 
(106 mg, 0.53 mmol) were dissolved in 10 mL dry DCM under Ar. To the mixture cooled to 0 °C was added 
BCl3 (1 M in dry DCM) dropwise. The reaction was stirred overnight before a premixed solution of 
polyphosphoric acid (9.0 g) and H3PO4 (9.0 g, 85%) was added. The whole mixture was kept at 60 °C for 
30 min until DCM thoroughly evaporated. The reaction was then heated to 110 °C and stirred vigorously 
for 4 h. After cooled to 80 °C, the reaction was treated with 20 mL H2O, and kept stirring for additional 4 h 
until poured onto 30 g ice. The aqueous solution was neutralized carefully with 50% NaOH solution and 
extracted with DCM (30 mL ×3). To the combined organic phase were added 7.0 mL H2O and 3.0 mL FeCl3 
solution (0.5 M in 1 N HCl) and the mixture was stirred vigorously for 2 h until the colorless intermediate 
was fully depleted. The organic layer was separated, dried over Na2SO4, and the solvent was removed in 
vacuo. The crude product was further purified with silica gel chromatography (DCM to DCM: MeOH = 20:1, 
v/v) to afford 21 as dark blue solid (168 mg, 66% overall). 1H NMR (400 MHz, MeOD) δ ppm: 7.78 (s, 1 H), 
7.27 (s, 1 H), 7.25 (s, 1 H), 7.23 (s, 1 H), 3.65-3.57 (m, 8 H), 3.17 (t, J = 5.8 Hz, 2 H), 2.80 (t, J = 5.8 Hz, 4 
H), 2.48 (t, J = 6.4 Hz, 2 H), 2.04-2.00 (m, 8 H), 1.82 (s, 6 H). 13C NMR (126 MHz, MeOD) δ ppm: 176.3, 
160.0, 154.8, 154.5, 154.1, 151.1, 137.9, 135.5, 124.5, 124.5, 124.4, 122.7, 120.5, 111.6, 53.2, 52.5, 52.3, 
51.5, 42.5, 31.1, 30.4, 28.3, 28.1, 27.8, 22.3, 22.2, 21.7, 21.6. HRMS (ESI+) m/z Calcd. for C29H35N2O2 






MARS2228-NHS (7a). Freshly prepared 21 (26 mg, 54 μmol) was dissolved in 6 mL MeCN and 2 mL 
H2O. 2 mL 0.1 M KCN aqueous solution was injected dropwise. The reaction was stirred at r.t. for 30 min 
and closely monitored with TLC until 11 was fully consumed and the solution turned to almost colorless. 2 
mL FeCl3 (0.5 M solution in 1N HCl) was then added into the solution and the reaction was stirred for 
additional 1 h at r.t.. 20 mL brine was added and the aqueous phase was extracted with DCM (20 mL ×3) 
and combined organic layers were dried over Na2SO4 and concentrated. The crude product, N-
hydroxylsuccinimide (NHS, 7.4 mg, 65 μmol, 1.2 eq.) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC, 15.5 mg, 81 μmol, 1.5 eq.) were dissolved in 2 mL anhydrous DCM and the reaction 
was stirred at r.t. overnight before DCM was removed in vacuo. The crude product was purified by prep-
HPLC (eluent: MeCN/H2O, 20%→90%) to afford 7a as dark green film (TFA salt, 6.8 mg, 18% over 3 steps). 
1H NMR (400 MHz, MeOD) δ ppm: 7.62 (s, 1H), 7.49 (s, 1H), 7.06 (s, 1H), 3.79 (t, J = 7.8 Hz, 2H), 3.72-
3.66 (m, 6H), 3.19 (t, J = 5.8 Hz, 2H), 2.88 (s, 4H), 2.88-2.85 (m, 6H), 2.17-2.12 (m, 2H), 2.07-2.05 (m, 6H), 
1.82 (s, 6 H). 13C NMR (126 MHz, DMSO-d6) δ ppm: 170.3, 168.9, 155.5, 153.4, 152.6, 147.2, 131.7, 129.9, 
126.1, 125.6, 125.1, 124.0, 121.4, 117.5, 115.5, 111.4, 52.6, 51.8, 50.5, 50.4, 40.5, 30.1, 27.6, 26.7, 26.6, 
26.2, 25.5, 21.7, 20.4, 19.8, 19.7. HRMS (ESI+) m/z Calcd. for C34H37N4O4 [M]+: 565.2815. Found: 565.2812 
 
 
MARS2220-NHS ester (7b). 1H NMR (400 MHz, MeOD) δ ppm: 7.63 (s, 1H), 7.50 (s, 1H), 7.07 (s, 








MARS2176-NHS ester (7c). 1H NMR (400 MHz, MeOD) δ ppm: 7.63 (s, 1H), 7.51 (s, 1H), 7.07 (s, 1H), 
3.79 (t, J = 8.0 Hz, 2H), 3.73-3.67 (m, 6H), 3.19 (t, J = 6.0 Hz, 2H), 2.88 (s, 4H), 2.88-2.85 (m, 6H), 2.18-
2.15 (m, 2H), 2.09-2.03 (m, 6H), 1.82 (s, 6H). 13C NMR (101 MHz, MeOD) δ 116.3. HRMS (ESI+) m/z Calcd. 
for C3313CH37N4O4 [M]+: 566.2848. Found: 566.2859 
 
 
MARS2147-NHS ester (7d). 1H NMR (400 MHz, MeOD) δ ppm: 7.63 (s, 1H), 7.51 (s, 1H), 7.07 (s, 
1H), 3.79 (t, J = 7.8 Hz, 2H), 3.73-3.67 (m, 6H), 3.19 (t, J = 6.0 Hz, 2H), 2.88 (s, 4H), 2.88-2.85 (m, 6H), 
2.18-2.12 (m, 2H), 2.09-2.03 (m, 6H), 1.82 (s, 6H). 13C NMR (101 MHz, MeOD) δ 116.2 (d, J = 16.8 Hz). 





4.6.6 Synthesis of Si-cored MARS NHS esters 
 
Supplementary Fig. 4.14. Syntheses of Si-cored MARS NHS esters. Counter ions for all NHS esters purified via HPLC 
are TFA anion.  
 
 
1-allyl-7-bromo-1,2,3,4-tetrahydroquinoline (23). 7-Bromo-1,2,3,4-Tetrahydroquinoline (1.0 g, 4.7 
mmol) and cesium carbonate (7.6 g, 23.5 mmol, 5 eq.) was suspended in acetonitrile (100 mL). Allyl 
bromide (0.61mL, 7.05 mmol, 1.5 eq) was added in dropwise. The reaction was heated to 50 °C and stirred 
for 24 h before another portion of allyl bromide (0.61mL, 7.05 mmol) was added and stirred for another 24 
h. The suspension was filtrated before the filtrate was concentrated and residue was purified by silica gel 
chromatography (EtOAc/Hexane= 5%) to obtain 23 as colorless oil (1.07 g, 90%). 1H NMR (400 MHz, CDCl3) 
δ 6.78 (dt, J = 7.8, 1.0 Hz, 1H), 6.69 – 6.61 (m, 2H), 5.89 – 5.75 (m, 1H), 5.24 – 5.13 (m, 2H), 3.84 (dt, J = 
4.9, 1.8 Hz, 2H), 3.32 – 3.23 (m, 2H), 2.69 (t, J = 6.3 Hz, 2H), 1.99 – 1.87 (m, 2H). 13C NMR (101 MHz, 






8-bromo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinoline (S4). S4 was synthesized based on a 
previously published protocol.[44] 
 
 
8-bromo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinoline-9-carbaldehyde (S5). Anhydrous 
DMF (2.6 mL) was charged in a flask under Argon and cool to 0 °C before POCl3 was added dropwise. The 
reaction was stirred under 0 °C for 30 min and S4 (506 mg, 2 mmol) in dry DMF (2.6 mL) was added. The 
reaction was then heated to 90 °C and stirred for 5 hours before poured to ice. The mixture was then added 
saturated NaHCO3 solution to neutral and evaporated. The residue was re-dissolved in water, extract with 
methylene chloride, dried over Na2SO4 and evaporated. The residue was then purified by silica gel flash 
chromatography (EtOAc/Hexane= 0% -20%) to obtain S5 (478 mg, 85%) as white solid. 1H NMR (400 MHz, 
CDCl3) δ 10.10 (s, 1H), 7.43 (d, J = 1.0 Hz, 1H), 3.33 – 3.23 (m, 4H), 2.84 (t, J = 6.5 Hz, 2H), 2.74 – 2.67 
(m, 2H), 2.02 – 1.87 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 191.1, 149.0, 129.7, 128.5, 121.6, 119.8, 119.4, 
50.3, 49.9, 28.2, 27.5, 21.3, 21.1.  
  
 
(8-bromo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)methanol (24). S5 (458 mg, 1.63 
mmol) was dissolved in methylene chloride (4 mL) and methanol (4 mL) and cooled to 0 ℃ before sodium 
borohydride (296 mg, 2.4 mmol) was added in portion. The reaction was then warmed to room temperature 




with ethyl acetate. The combined organic layers were then washed with water and brine, dried over Na2SO4 
and evaporated. The residue was further purified by silica gel flash chromatography (Ethyl acetate/Hexane= 
0% -20%) to obtain 24 (394.8 mg, 86%) as white solid.1H NMR (400 MHz, CDCl3) δ 6.86 (s, 1H), 4.61 (d, 
J = 5.5 Hz, 2H), 3.12 (dt, J = 16.4, 5.6 Hz, 4H), 2.80 (t, J = 6.7 Hz, 2H), 2.71 (t, J = 6.5 Hz, 2H), 2.01 – 1.92 
(m, 4H). 13C NMR (101 MHz, CDCl3) δ 144.3, 128.3, 127.1, 124.3, 121.3, 120.7, 66.1, 50.1, 49.6, 29.0, 
27.6, 22.1, 21.9. 
 
9-((1-allyl-7-bromo-1,2,3,4-tetrahydroquinolin-6-yl)methyl)-8-bromo-2,3,6,7-tetrahydro-1H, 5H-
pyrido[3,2,1-ij]quinoline (25). 23 (646.3 mg, 3.18 mmol) and 24 (801.8 g, 3.18 mmol) was dissolved in 
dichloromethane (15 mL). BF3•OEt2 complex (628 μL, 5.1 mmol) was added to the solution at 0 °C. The 
reaction mixture was refluxed overnight. The saturated NaHCO3 aqueous solution was added to it after 
cooling to room temperature. The aqueous phase was extracted with dichloromethane and the combined 
organic phase was washed with brine and dried over Na2SO4. After filtration, the filtrate was evaporated 
and the residue was purified by silica gel flash chromatography (EtOAc /Hexane =5%) to obtain 25 (1.13 g, 
69 %) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.74 (s, 1H), 6.60 (d, J = 4.6 Hz, 1H), 6.48 (s, 1H), 5.84 
(ddt, J = 17.2, 10.2, 5.0 Hz, 1H), 5.25 – 5.13 (m, 2H), 3.93 (s, 2H), 3.83 (dt, J = 5.1, 1.7 Hz, 2H), 3.30 – 
3.17 (m, 2H), 3.09 (dt, J = 11.4, 5.6 Hz, 4H), 2.83 (t, J = 6.7 Hz, 2H), 2.63 (q, J = 7.0 Hz, 4H), 2.05 – 1.86 
(m, 6H).  13C NMR (101 MHz, CDCl3) δ 144.8, 143.1, 133.2, 130.8, 128.6, 127.4, 126.5, 125.7, 123.0, 122.1, 








Reduced Si-pyronin precursor 26. 25 (1.13 g, 2.18 mmol) was dissolved in dry THF (60 mL) under 
Argon. The solution was cooled to -78 °C before sec-Butyl lithium hexane solution (1.4 M, 5.1 mL, 7.14 
mmol) was added dropwise over 8 minutes. The reaction was left stirring under -78 °C for 20 minutes and 
then dichlorodimethylsilane (523.6 μL, 4.35 mmol) in dry THF (12mL) was slowly added. The reaction 
mixture was warmed up to room temperature, stirred for 3h and quenched by adding 1N HCl solution. 
Saturated NaHCO3 solution was added to basify it, and the mixture was extracted with ethyl acetate. The 
organic phase was washed again with saturated NaHCO3 solution, dried over Na2SO4 and evaporated. The 
residue was purified by silica gel flash chromatography (EtOAc/ Hexane = 2%, with 0.5% Et3N) to obtain 
26 (734.2 mg, 81 %) as colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.87 (s, 1H), 6.79 (s, 1H), 6.76 (s, 1H), 
5.89 (ddt, J = 17.3, 10.2, 5.2 Hz, 1H), 5.28 – 5.13 (m, 2H), 3.91 (s, 2H), 3.35 – 3.20 (m, 2H), 3.14 – 3.02 
(m, 6H), 2.93 (t, J = 6.5 Hz, 2H), 2.88 – 2.71 (m, 4H), 2.23 – 1.82 (m, 8H), 0.47 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ 143.3, 141.1, 134.5, 134.2, 133.8, 133.5, 131.5, 128.2, 127.7, 127.5, 124.1, 123.6, 116.2, 115.9, 




Reduced Si-pyronin precursor 27. 26 (722 mg, 1.74 mmol), 1,3-dimethylbarbituric acid (2.28 g, 14.6 
mmol) and tetrakis(triphenylphosphine)palladium (386 mg, 0.33 mmol) was charged in a flask under argon. 
Deoxygenated methylene chloride (22 mL) was added and the reaction was stirred at room temperature 
overnight. Saturated NaHCO3 solution was added and the reaction mixture was extracted with methylene 
chloride and the combined organic layers were washed with water and saturated NaHCO3 before 
evaporation. The residue was purified by silica gel flash chromatography (Ethyl acetate/ Hexane = 5%- 
15%, with 0.5% Et3N) to obtain 27 (402.4 mg, 62%) as light blue oil. 1H NMR (400 MHz, CDCl3) δ 6.88 (s, 
1H), 6.77 (s, 1H), 6.72 (s, 1H), 3.90 (s, 2H), 3.74 (br, 1H), 3.34 – 3.25 (m, 2H), 3.16 – 3.08 (m, 4H), 2.94 (t, 
J = 6.5 Hz, 2H), 2.81 – 2.72 (m, 4H), 2.22 – 1.78 (m, 6H), 0.47 (s, 6H).  13C NMR (101 MHz, CDCl3) δ 142.6, 
141.1, 135.0, 134.5, 133.7, 131.5, 128.4, 127.7, 127.6, 123.6, 123.0, 119.1, 50.7, 50.1, 42.4, 40.1, 29.7, 






Si-pyronin 29. 27 (259.6 mg, 0.69 mmol) was dissolved in acetonitrile (11 mL) under argon. N, N-
diisopropylethylamine (361 μL, 2.08 mmol), methyl 4-bromobutyrate (719 μL, 5.76 mmol) was added and 
the reaction was refluxed at 80 °C overnight. Water was added after cooling to room temperature. The 
mixture was extracted with DCM and the combined organic layer was washed with 2 N HCl for three time, 
dried over Na2SO4 and evaporated. FeCl3 solution in HCl/H2O (0.5 M in 1 N HCl, 13.6 mL, 6.8 mmol) was 
added to the residue. The reaction was stirred at room temperature overnight before extracting with 
methylene chloride. The combined organic layers were washed 2 N HCl, dried over Na2SO4 and evaporated. 
The residue was purified by silica gel flash chromatography (MeOH/CH2Cl2 = 3%-10%) to obtain 29 (273.6 
mg, 77%) as dark blue solid. 1H NMR (400 MHz, MeOD) δ 7.54 (s, 1H), 7.38 (s, 1H), 7.30 (s, 1H), 7.29 (s, 
1H), 3.70 (s, 3H), 3.67 – 3.58 (m, 8H), 2.98 (dd, J = 7.1, 5.4 Hz, 2H), 2.78 (t, J = 6.3 Hz, 4H), 2.50 (t, J = 
6.4 Hz, 2H), 2.11 – 1.96 (m, 8H), 0.59 (s, 6H). 13C NMR (101 MHz, MeOD) δ 175.3, 159.0, 153.1, 152.6, 
147.0, 142.6, 141.9, 140.2, 134.3, 129.1, 128.6, 126.0, 125.4, 120.4, 53.0, 52.4, 52.2, 52.2, 51.7, 31.1, 
29.8, 28.3, 28.1, 22.6, 22.2, 21.9, 21.7, -1.2. 
 
 
Si-pyronin 30. Freshly prepared 29 (273.6 mg, 0.54 mmol) was dissolved in phosphoric acid (20 mL, 
85% wt. in water) and water (20 mL) and heated to 80°C. The reaction was stirred for 5h and cooled to 
room temperature before water was added to dilute the acidic mixture. The reaction was then extracted 
with methylene chloride. The combined organic layer was washed with brine, dried over Na2SO4 and 




to obtain 30 as blue solid (135.9 mg, 50%). 1H NMR (400 MHz, MeOD) δ 7.54 (s, 1H), 7.40 (s, 1H), 7.30 (s, 
1H), 7.28 (s, 1H), 3.73 – 3.56 (m, 8H), 3.02 – 2.94 (m, 2H), 2.78 (t, J = 6.2 Hz, 4H), 2.50 – 2.42 (m, 2H), 
2.11 – 1.95 (m, 2H), 0.58 (s, 6H). 13C NMR (101 MHz, MeOD) δ 177.4, 159.0, 153.2, 152.5, 147.1, 142.5, 
141.9, 140.3, 134.1, 129.1, 128.6, 126.0, 125.3, 120.5, 53.0, 52.5, 52.3, 51.8, 30.7, 29.8, 28.3, 28.2, 23.4, 
22.2, 21.9, 21.7, -1.2. 
 
 
MARS2222-NHS ester (8a). 30 (6 mg, 0.012 mmol) was dissolved in acetonitrile (2 mL) and cooled to 
0 °C before KCN solution in H2O (0.1 M, 360 uL, 0.036 mmol) was added dropwise. The reaction was stirred 
under 0 °C for 20 minutes. FeCl3 solution in HCl/H2O (1 M in 1N HCl, 360 μL, 0.36 mmol) was added and 
the reaction was stirred at room temperature for 1 h. The reaction was extracted with methylene chloride 
and the combined organic layer was washed with brine, dried over Na2SO4 and evaporated. The residue 
was purified over a flash silica gel chromatography (MeOH: CH2Cl2=10%).  
The obtained green solid together with N-hydroxylsuccinimide (3.6 mg, 0.031 mmol) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (8.4 mg, 0.44 mmol) was dissolved in dichloromethane anhydrous (2 
mL)  and stirred overnight. The reaction was then diluted with DCM, washed brine and dried over Na2SO4. 
The solvent was evaporated under vacuum and residue was purified through HPLC to obtain 8a as green 
film (1.3 mg, 15.6%). 1H NMR (400 MHz, MeOD) δ 7.80 (s, 1H), 7.73 (s, 1H), 7.26 (s, 1H), 3.87 – 3.65 (m, 
8H), 3.06 – 2.95 (m, 2H), 2.92 – 2.80 (m, 10H), 2.21 – 1.95 (m, 8H), 0.58 (s, 6H). 13C NMR (101 MHz, 
MeOD) δ 171.8, 170.4, 162.3, 153.1, 152.6, 145.1, 140.8, 138.3, 137.0, 136.4, 130.4, 130.2, 128.2, 127.8, 
121.3, 118.0, 54.0, 53.2, 52.1, 51.8, 29.9, 28.7, 28.4, 28.2, 26.6, 23.0, 22.1, 21.8, 21.5, -1.0. HRMS (ESI+) 






MARS2200-NHS ester (8b). 8b was obtained from 30 following same protocol as stated above for 8a 
except using KC15N. 1H NMR (400 MHz, MeOD) δ 7.79 (s, 1H), 7.71 (s, 1H), 7.26 (s, 1H), 3.80 (t, J = 8.2 
Hz, 2H), 3.71 (q, J = 6.2 Hz, 6H), 3.00 (t, J = 6.2 Hz, 2H), 2.91 – 2.80 (m, 10H), 2.24 – 1.95 (m, 8H), 0.57 
(s, 6H). 13C NMR (126 MHz, MeOD) δ 171.8, 170.5, 162.4, 153.1, 152.5, 145.0, 140.7, 138.3, 137.0, 136.3, 
130.3 (d, J=3.0 Hz), 130.2, 128.2, 127.7, 121.3, 118.0 (d, J=16.4 Hz), 54.0, 53.2, 52.1, 51.8, 29.9, 28.7, 




MARS2176-NHS ester (8c). 1H NMR (500 MHz, MeOD) δ 7.81 (s, 1H), 7.73 (s, 1H), 7.26 (s, 1H), 3.80 
(t, J = 8.2 Hz, 2H), 3.75 – 3.68 (m, 8H), 3.00 (t, J = 6.3 Hz, 2H), 2.90 – 2.83 (m, 10H), 2.18 – 1.99 (m, 8H), 
0.58 (s, 6H). 13C NMR (126 MHz, MeOD) δ 171.8, 170.5, 162.2, 153.0, 152.5, 144.8 (d, J= 5 Hz), 140.7, 
138.3 (d, J= 5 Hz), 137.0, 136.4 (d, J= 4 Hz), 130.4, 130.2, 128.2, 127.8, 121.3, 118.0, 54.0, 53.2, 52.1, 






MARS2147-NHS ester (8d). 1H NMR (500 MHz, MeOD) δ 7.79 (s, 1H), 7.72 (s, 1H), 7.26 (s, 1H), 3.80 
(t, J = 8.2 Hz, 2H), 3.72 (p, J = 6.2 Hz, 6H), 3.00 (t, J = 6.3 Hz, 2H), 2.96 – 2.79 (m, 10H), 2.26 – 1.91 (m, 
8H), 0.57 (s, 6H). 13C NMR (126 MHz, MeOD) δ 171.8, 170.5, 162.3, 153.1, 152.5, 145.0 (d, J=5 Hz), 140.7 
(d, J= 6 Hz), 138.3 (d, J= 4 Hz), 137.0, 136.3 (d, J= 3 Hz), 130.9, 130.2, 128.2, 127.8, 121.3, 118.0 (d, J= 
18 Hz), 54.0, 53.2, 52.1, 51.8, 29.9, 28.7, 28.4, 28.2, 26.5, 23.0, 22.1, 21.8, 21.5, -1.0. 
 
 
4.6.7 Synthesis of functionalized MARS probes for multiplexed imaging 




General methods for conjugated pyronins (31-35) and MARS probes (36-40) (Method C): A 
solution of 3i (9.0 mg, 20 μmol) in 5 mL DMF was cooled to 0 °C followed by addition of 1-




45.6 mg, 120 μmol, 6 eq.), , and DIPEA (7.0 μL, 40 μmol, 2 eq.). The reaction was stirred for 10 min until 
the addition of corresponding amines (60 μmol, 3 eq.). The mixture was kept stirred overnight at room 
temperature and diluted with 20 mL saturated brine. The aqueous phase was extracted with DCM (20 mL 
×3) and the combined organic layers were dried over Na2SO4 and concentrated. The residue was purified 
with silica gel chromatography (eluent: DCM to DCM: MeOH = 10:1, v/v). The obtained pyronins (31-35) 
were treated with method B to afford desired functionalized MARS probes (36-40) as dark blue solid. 
  
 
Pyronin intermediate for MARS2184-alkyne (31). 1H NMR (500 MHz, MeOD) δ 8.25 (s, 1H), 7.43 (s, 
1H), 7.35 (s, 1H), 6.93 (s, 1H), 4.01 (d, J = 2.5 Hz, 2H), 3.59 (dq, J = 10.7, 5.2 Hz, 8H), 3.05 (t, J = 6.3 Hz, 
2H), 2.89 (t, J = 6.1 Hz, 4H), 2.60 (t, J = 2.5 Hz, 1H), 2.38 (t, J = 7.0 Hz, 2H), 2.11 – 2.00 (m, 8H). 13C NMR 
(126 MHz, MeOD) δ 174.5, 158.5, 155.2, 154.0, 153.5, 144.3, 130.8, 129.5, 126.3, 125.9, 115.9, 114.9, 
106.5, 96.3, 80.6, 72.2, 52.5, 52.1, 51.6, 51.2, 33.2, 29.5, 28.5, 28.4, 22.8, 22.0, 21.7, 20.7, 20.7. 
 
MARS2184-alkyne (36). 1H NMR (500 MHz, MeOD) δ 7.54 (s, 1H), 7.50 (s, 1H), 7.04 (s, 1H), 4.01 (d, 
J = 2.5 Hz, 2H), 3.72 – 3.62 (m, 8H), 3.06 (t, J = 6.4 Hz, 2H), 3.00 – 2.95 (m, 4H), 2.60 (t, J = 2.6 Hz, 1H), 
2.39 (t, J = 6.9 Hz, 2H), 2.15 – 2.03 (m, 8H). 13C NMR (126 MHz, MeOD) δ 174.4, 157.5 (d, J = 4.4 Hz), 
155.5, 154.1, 152.8 (d, J = 4.6 Hz), 128.8, 128.5, 127.4 (d, J = 3.2 Hz), 126.1 (d, J = 3.2 Hz), 120.7 (d, J = 
82.4 Hz), 116.5 (d, J = 2.0 Hz), 114.1 (d, J = 2.1 Hz), 113.7, 107.9, 97.2, 80.6, 72.3, 52.9, 52.7, 52.2, 51.6, 
33.0, 29.5, 28.4, 28.4, 22.9, 21.9, 21.5, 20.7, 20.5. HRMS (ESI+) m/z Calcd. for C2913CH31N4O2+ [M]+: 






Pyronin intermediate for MARS2184-PEG2-Alkyne (32). 1H NMR (500 MHz, CD3CN) δ 8.14 (s, 1H), 
7.38 (s, 1H), 7.30 (s, 1H), 6.94 (s, 1H), 6.64 (s, 1H), 5.63 (s, 1H), 4.07 (d, J = 8.0 Hz, 2H), 3.58 – 3.50 (m, 
14H), 3.48 (t, J = 5.5 Hz, 2H), 3.37 (q, J = 5.5 Hz, 2H), 3.24 (q, J = 5.7 Hz, 2H), 2.97 (t, J = 6.4 Hz, 2H), 
2.87 – 2.81 (m, 4H), 2.30 (t, J = 7.0 Hz, 2H), 2.27 – 2.10 (m, 6H), 2.04 (dt, J = 12.5, 6.7 Hz, 2H), 2.02 – 
1.95 (m, 8H), 1.53 (q, J = 11.1, 9.8 Hz, 2H), 1.33 – 1.26 (m, 1H), 0.94 – 0.85 (m, 2H). 13C NMR (126 MHz, 
CD3CN) δ 173.4, 158.5, 158.2, 155.2, 153.9, 153.5, 144.2, 130.8, 129.5, 126.4, 125.9, 115.7, 114.7, 106.5, 
100.1, 96.5, 71.3, 71.3, 71.0, 70.8, 63.5, 52.8, 52.2, 51.8, 51.3, 41.9, 40.3, 33.5, 30.2, 28.5, 28.4, 23.0, 
22.2, 22.0, 21.7, 21.3, 20.8, 20.7, 19.1. 
 
MARS2184-PEG2-Alkyne (37). 1H NMR (500 MHz, MeOD) δ 7.55 (s, 1H), 7.50 (s, 1H), 7.03 (s, 1H), 
4.08 (d, J = 8.1 Hz, 2H), 3.66 (q, J = 9.6, 7.6 Hz, 8H), 3.61 – 3.59 (m, 4H), 3.57 (t, J = 5.4 Hz, 2H), 3.50 (t, 
J = 5.6 Hz, 2H), 3.41 (t, J = 5.4 Hz, 2H), 3.24 (t, J = 5.6 Hz, 2H), 3.04 (t, J = 6.4 Hz, 2H), 2.96 (q, J = 6.0 
Hz, 4H), 2.38 (t, J = 7.0 Hz, 2H), 2.26 – 2.15 (m, 4H), 2.14 – 2.01 (m, 10H), 1.59 – 1.48 (m, 2H), 1.37 – 
1.30 (m, 1H), 0.94 – 0.82 (m, 2H). 13C NMR (126 MHz, MeOD) δ 174.9, 159.2, 157.6 (d, J = 4.8 Hz), 155.5, 
154.1, 152.8 (d, J = 4.5 Hz), 128.8, 128.5, 127.5 (d, J = 3.1 Hz), 126.2 (d, J = 3.2 Hz), 120.8 (d, J = 81.9 
Hz), 116.6 (d, J = 2.1 Hz), 114.2 (d, J = 2.0 Hz), 113.7, 107.9, 99.5, 97.2, 71.3, 71.3, 71.0, 70.5, 63.7, 53.0, 
52.7, 52.2, 51.6, 41.6, 40.4, 33.3, 30.1, 28.4, 28.4, 23.1, 22.0, 21.9, 21.5, 21.4, 20.7, 20.5, 18.9. HRMS 






Pyronin intermediate for MARS2238-Azide (33). 1H NMR (500 MHz, MeOD) δ 8.24 (s, 1H), 7.43 (s, 
1H), 7.34 (s, 1H), 6.93 (s, 1H), 3.64 – 3.54 (m, 8H), 3.37 (t, J = 6.7 Hz, 2H), 3.30 (t, J = 6.9 Hz, 2H), 3.04 
(t, J = 6.3 Hz, 2H), 2.89 (s, 4H), 2.37 (t, J = 7.0 Hz, 2H), 2.12 – 2.00 (m, 8H), 1.78 (p, J = 6.8 Hz, 2H). 13C 
NMR (126 MHz, MeOD) δ 175.0, 158.5, 155.2, 153.9, 153.5, 144.3, 130.8, 129.5, 126.3, 125.9, 115.9, 
114.8, 106.5, 96.3, 52.5, 52.1, 51.6, 51.1, 50.1, 37.8, 33.4, 29.7, 28.5, 28.4, 23.0, 22.0, 21.7, 20.7, 20.7. 
 
MARS2238-Azide (38). 1H NMR (400 MHz, MeOD) δ 7.54 (s, 1H), 7.50 (s, 1H), 7.04 (s, 1H), 3.73 – 
3.62 (m, 8H), 3.37 (t, J = 6.7 Hz, 2H), 3.30 (d, J = 5.3 Hz, 2H), 3.05 (t, J = 7.4 Hz, 2H), 2.97 (s, 4H), 2.38 (t, 
J = 7.0 Hz, 2H), 2.08 (s, 8H), 1.78 (p, J = 7.6 Hz, 2H). 13C NMR (101 MHz, MeOD) δ 174.9, 157.5, 155.6, 
154.1, 152.8, 128.8, 128.5, 127.4, 126.1, 120.7, 116.5, 114.1, 113.7, 107.9, 97.2, 53.0, 52.7, 52.2, 51.5, 
50.1, 37.8, 33.2, 29.7, 28.4, 28.4, 23.0, 21.9, 21.5, 20.7, 20.5. HRMS (ESI+) m/z Calcd. for C30H34N7O2+ 
[M]+: 524.2774. Found: 524.2772. 
 
Pyronin intermediate for MARS2184-Lyso (34). 1H NMR (400 MHz, MeOD) δ 8.29 (s, 1H), 7.46 (s, 
1H), 7.38 (s, 1H), 6.99 (s, 1H), 3.62 (ddd, J = 18.7, 10.5, 5.0 Hz, 10H), 3.30 (d, J = 5.8 Hz, 2H), 3.06 (t, J = 
6.4 Hz, 2H), 2.98 (s, 6H), 2.94 – 2.88 (m, 4H), 2.44 (t, J = 7.3 Hz, 2H), 2.14 – 2.00 (m, 8H). 13C NMR (101 
MHz, MeOD) δ 176.2, 158.5, 155.2, 153.9, 153.5, 144.3, 130.8, 129.5, 126.3, 125.9, 115.9, 114.8, 106.5, 
96.3, 58.6, 52.6, 52.1, 51.6, 51.2, 43.9, 38.9, 35.8, 33.4, 28.5, 28.4, 22.7, 22.0, 21.7, 20.7, 20.7.  
 
MARS2184-Lyso (39). 1H NMR (400 MHz, MeOD) δ 7.57 (s, 1H), 7.52 (s, 1H), 7.07 (s, 1H), 3.74 – 
3.64 (m, 8H), 3.61 (t, J = 5.6 Hz, 2H), 3.29 (d, J = 5.7 Hz, 2H), 3.04 (t, J = 6.0 Hz, 2H), 3.00 – 2.94 (m, 10H), 




155.5, 154.1, 152.8, 128.8, 128.4, 127.5 (d, J = 3.0 Hz), 126.2 (d, J = 3.4 Hz), 120.8 (d, J = 81.9 Hz), 116.6 
(d, J = 2.4 Hz), 114.1 (d, J = 2.3 Hz), 113.7, 107.8, 97.2, 58.5, 53.1, 52.7, 52.2, 51.6, 43.8, 35.7, 33.2, 28.4, 





Pyronin intermediate for MARS2238-C18 (35). 1H NMR (500 MHz, MeOD) δ 8.29 (s, 1H), 7.45 (s, 
1H), 7.38 (s, 1H), 6.95 (s, 1H), 3.65 – 3.56 (m, 8H), 3.22 (t, J = 7.0 Hz, 3H), 3.07 (t, J = 6.3 Hz, 2H), 2.94 – 
2.88 (m, 4H), 2.36 (t, J = 6.9 Hz, 2H), 2.13 – 2.00 (m, 8H), 1.51 (p, J = 7.1 Hz, 2H), 1.39 – 1.18 (m, 30H), 
0.91 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, MeOD) δ 174.8, 158.6, 155.3, 154.0, 153.5, 144.4, 130.9, 
129.6, 126.4, 126.0, 115.9, 114.9, 106.5, 96.3, 52.5, 52.1, 51.7, 51.1, 40.4, 33.5, 33.1, 30.8, 30.7, 30.7, 
30.7, 30.5, 30.4, 28.5, 28.5, 28.0, 23.7, 23.0, 22.0, 21.7, 20.8, 20.7, 14.4. 
 
MARS2238-C18 (40). 1H NMR (500 MHz, MeOD) δ 7.56 (s, 1H), 7.51 (s, 1H), 7.04 (s, 1H), 3.73 – 3.63 
(m, 8H), 3.22 (t, J = 7.0 Hz, 2H), 3.06 (t, J = 6.4 Hz, 2H), 3.00 – 2.95 (m, 4H), 2.37 (t, J = 6.9 Hz, 2H), 2.13 
– 2.02 (m, 8H), 1.51 (p, J = 7.2 Hz, 2H), 1.37 – 1.21 (m, 30H), 0.92 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
MeOD) δ 174.7, 157.6, 155.6, 154.1, 152.8, 128.8, 128.5, 127.4, 126.1, 120.7, 116.5, 114.1, 113.7, 107.9, 
97.2, 53.0, 52.7, 52.2, 51.5, 40.4, 33.3, 33.1, 30.8, 30.7, 30.7, 30.5, 30.4, 28.4, 28.4, 28.0, 23.7, 23.1, 21.9, 
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